Processing 00000000.tx.1: -Synuclein Promotes Cancer Cell Survival and Inhibits Stress- and Chemotherapy Drug-induced Apoptosis by Modulating MAPK Pathways* Zhong-Zong Pan, Wendy Bruening, Benoit I. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "Cancer Cell Survival"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007620:Cell Survival [Cell Function]
   827   C0038952:Survival [Activity]
   827   C0220921:survival [Functional Concept]
   734   C0334227:Cancer Cell [Cell]

Phrase: "and"

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Stress-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038435:Stress [Finding]
   928 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "Chemotherapy Drug-induced Apoptosis by Modulating MAPK Pathways"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0458082:Drug-induced [Functional Concept]
   750   C0162638:Apoptosis Pathway [Cell Function]
           Apoptosis
   750   C2984580:Drug Pathway [Functional Concept]
   744   C0013227:Drug [Pharmacologic Substance]
   744   C0205263:Induced [Functional Concept]
   744   C1254351:Drug [Pharmacologic Substance]
   729   C0812987:Chemotherapy Drugs [Therapeutic or Preventive Procedure]

Phrase: "* Zhong-Zong Pan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0085999:Pan [Mammal]

Phrase: "Wendy Bruening,"

Phrase: "Benoit I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.2: Giasson**, Virginia M.-Y. 

Phrase: "Giasson"

Phrase: "*"

Phrase: "*,"

Phrase: "Virginia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042753:Virginia [Geographic Area]
  1000   C1256310:Virginia [Reptile]

Phrase: "M.-"

Phrase: "Y."
Processing 00000000.tx.3: Lee**, and Andrew K. 

Phrase: "Lee"

Phrase: "*"

Phrase: "*,"

Phrase: "and"

Phrase: "Andrew K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.4: Godwin From the Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111and the **Center for Neurodegenerative Diseases, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 Received for publication, February 18,2002, and in revised form, May 20,2002  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Synucleins are a family of highly conserved small proteins predominantly expressed in neurons. 

Phrase: "Godwin From the Department of Medical Oncology,"

Phrase: "Fox Chase Cancer Center,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517306:Fox Chase Cancer Center [Health Care Related Organization]
   861   C1513817:Cancer Center [Health Care Related Organization]
   812   C0205099:Center [Spatial Concept]

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "Pennsylvania 19111and"

Phrase: "the **Center for Neurodegenerative Diseases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205099:Center [Spatial Concept]

Phrase: "University of Pennsylvania School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "Pennsylvania 19104"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030853:Pennsylvania [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "February 18,"

Phrase: "2002,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "May 20,"

Phrase: "2002  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "a family of highly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015576:Family [Family Group]
   770   C1704727:Family [Conceptual Entity]

Phrase: "conserved"

Phrase: "small proteins predominantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "expressed in neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.5: Recently we and others have found that -synuclein is dramatically up-regulated in the vast majority of late-stage breast and ovarian cancers and that -synuclein over-expression can enhance tumorigenicity. 

Phrase: "Recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "dramatically"

Phrase: "up-regulated in the vast majority of late-stage breast"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C1279941:Late stage [Temporal Concept]
   739   C0006141:Breast [Body Part, Organ, or Organ Component]
   739   C0205087:Late [Temporal Concept]
   739   C0205390:Stage [Temporal Concept]
   739   C0547043:Up [Spatial Concept]
   739   C0680220:majority [Social Behavior]
   739   C0814230:VAST [Intellectual Product]
   739   C0851285:Regulated [Governmental or Regulatory Activity]
   739   C1268990:Breast [Body Part, Organ, or Organ Component]
   739   C1282911:Up [Spatial Concept]
   739   C1300072:Stage [Clinical Attribute]
   739   C1306673:Stage [Qualitative Concept]

Phrase: "and"

Phrase: "ovarian cancers"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancers [Neoplastic Process]
  1000   C1140680:Ovarian Cancers [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "and"

Phrase: "that -synuclein over-expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "tumorigenicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519697:Tumorigenicity [Pathologic Function]
Processing 00000000.tx.6: In the current study, we have found that -synuclein is associated with two major mitogen-activated kinases (MAPKs), i.e. extracellular signal-regulated protein kinases (ERK1/2) and c-Jun N-terminal kinase 1(JNK1), and have shown that over-expression of -synuclein leads to constitutive activation of ERK1/2 and down-regulation of JNK1 in response to a host of environmental stress signals, including UV, arsenate, and heat shock. 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "associated with two major mitogen-activated kinases (MAPKs),"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0026249:Mitogen [Pharmacologic Substance]
   748   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205164:Major [Qualitative Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C1879547:Activated [Activity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1515877:Activate [Functional Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "i.e. extracellular signal-regulated protein kinases"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   879   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   879   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   877   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "c-Jun N-terminal kinase 1"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
  1000   C0380051:c-jun N-Terminal Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
           c-JUN N-Terminal Kinase
           c-jun Kinase-1
   947   C0248813:c-jun N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   913   C1367731:C-JUN KINASE 1 [Gene or Genome]
           JUN N-terminal kinase
   895   C1418485:C-1 [Gene or Genome]
   885   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   858   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   858   C1334482:Jun kinase [Gene or Genome]
   858   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   858   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0162508:c-Jun [Gene or Genome]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0205088:Terminal [Temporal Concept]
   799   C1553033:[c] [Quantitative Concept]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   799   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that over-expression of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "leads to constitutive activation of ERK1/2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C2346661:Lead 2+ [Element, Ion, or Isotope]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0181586:leads [Medical Device]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1879547:Activation [Activity]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "down-regulation of JNK1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0013081:Down-Regulation [Cell Function,Molecular Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to a host"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1167395:Host [Organism]

Phrase: "of environmental stress signals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1710082:Signal [Phenomenon or Process]
   734   C0871732:environmental stress [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "UV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041625:UV [Natural Phenomenon or Process]
  1000   C1961129:uV [Quantitative Concept]

Phrase: "arsenate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0104238:arsenate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "heat shock."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282498:Heat Shock [Physiologic Function]
   861   C0018837:Heat [Natural Phenomenon or Process]
   861   C0036974:Shock [Pathologic Function]
Processing 00000000.tx.7: We also tested the effects of -synuclein on apoptosis and activation of JNK and ERK in response to several chemotherapy drugs. 

Phrase: "We also"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the effects of -synuclein on apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "ERK in response"

Phrase: "to several chemotherapy drugs."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   901   C0812987:Chemotherapy Drugs [Therapeutic or Preventive Procedure]
   827   C0013227:Drugs [Pharmacologic Substance]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.8: We have found that -synuclein-expressing cells are significantly more resistant to the chemotherapeutic drugs paclitaxel and vinblastine as compared with the parental cells. 

Phrase: "We"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that -synuclein-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "significantly more resistant to the chemotherapeutic drugs paclitaxel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332325:Resistant to [Functional Concept]
           Resistant
   744   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "vinblastine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "as"

Phrase: "compared with the parental cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0030551:Parental [Family Group]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.9: The resistance to paclitaxel can be partially obliterated when ERK activity is inhibited using a MEK1/2 inhibitor. 

Phrase: "The resistance to paclitaxel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0332325:Resistant to [Functional Concept]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]

Phrase: "can"

Phrase: "be"

Phrase: "partially"

Phrase: "obliterated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700134:Obliterated [Functional Concept]

Phrase: "when"

Phrase: "ERK activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a MEK1/2 inhibitor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.10: Activation of JNK and its downstream caspase-3 by paclitaxel or vinblastine is significantly down-regulated in -synuclein-expressing cells, indicating that the paclitaxel- or vinblastine-activated apoptosis pathway is blocked by -synuclein. 

Phrase: "Activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "its downstream caspase-3 by paclitaxel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "vinblastine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "significantly"

Phrase: "down-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "in -synuclein-expressing cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the paclitaxel-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0144576:Paclitaxel [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "vinblastine-activated apoptosis pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0162638:Apoptosis Pathway [Cell Function]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "blocked by -synuclein."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0028778:Blocked [Pathologic Function]
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.11: In contrast to paclitaxel and vinblastine, etoposide does not activate JNK, and -synuclein over-expression has no apparent effect on this drug-induced apoptosis. 

Phrase: "In contrast to paclitaxel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0144576:Paclitaxel [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "vinblastine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "etoposide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "and -"

Phrase: "synuclein over-expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "no apparent effect on this drug-induced apoptosis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   789   C0542119:NO DRUG EFFECT [Finding]
   767   C0728866:Drug effect [Functional Concept]
   767   C0728867:Drug effect [Pathologic Function]
   767   C1301751:No effect [Qualitative Concept]
   767   C1411996:drug effect [Biologic Function]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.12: Taken together, our data indicate that oncogenic activation of -synuclein contributes to the development of breast and ovarian cancer by promoting tumor cell survival under adverse conditions and by providing resistance to certain chemotherapeutic drugs.  

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that oncogenic activation of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contributes to the development of breast"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   831   C0518181:Development of the breasts [Finding]
           breast development
   753   C0006141:Breast [Body Part, Organ, or Organ Component]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1268990:Breast [Body Part, Organ, or Organ Component]
   753   C1527148:Development [Functional Concept]
   753   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "ovarian cancer by promoting tumor cell survival"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0029925:ovarian cancer [Neoplastic Process]
   778   C1140680:Ovarian Cancer [Neoplastic Process]
   774   C0334227:Cancer Cell [Cell]
   774   C0919267:Ovarian tumor [Neoplastic Process]
   748   C0006826:Cancer [Neoplastic Process]
   748   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   748   C0998265:Cancer [Eukaryote]
   748   C1306459:Cancer [Finding]

Phrase: "under adverse conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and by providing resistance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1515981:And [Idea or Concept]
   737   C1999230:Provide [Activity]

Phrase: "to certain chemotherapeutic drugs."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0013227:Drugs [Pharmacologic Substance]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.13: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Breast carcinoma is the second leading cause of cancer-related deaths in women of the Western world. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Breast carcinoma"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0006142:Breast Carcinoma [Neoplastic Process]
  1000   C0678222:Breast Carcinoma [Neoplastic Process]
   861   C0006141:Breast [Body Part, Organ, or Organ Component]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C1268990:Breast [Body Part, Organ, or Organ Component]
   805 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   805 E C1521735:Pectoral [Qualitative Concept]
   777 E C0817096:Chest [Body Location or Region]
   777 E C1527391:Chest [Body Location or Region]

Phrase: "is"

Phrase: "the second leading cause of cancer-related deaths"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   789   C3262232:Secondary cause of death [Clinical Attribute]
   789   C3262233:Cause of death.secondary [Finding]
   782   C0007465:Cause of Death [Finding]
           Death Cause
   782   C0804771:Cause of death [Clinical Attribute]
   767   C1516195:Cancer Cause [Biomedical Occupation or Discipline]
   744   C0015127:cause [Functional Concept]
   744   C1524003:Cause [Conceptual Entity]

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "of the Western world."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376556:Western World [Idea or Concept]
   861   C2700280:World [Population Group]
Processing 00000000.tx.14: In the United States alone over 180,000new cases are diagnosed annually and more than 40,000women die from this disease each year (1). 

Phrase: "In the United States"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0041703:United States [Geographic Area]
   861   C1301808:states [Geographic Area]
   827   C0166872:unite [Biomedical or Dental Material]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "alone over 180,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205171:Alone [Quantitative Concept]
   790   C0439044:alone [Finding]
   790   C0679994:alone [Group Attribute]

Phrase: "000new cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "are"

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "annually"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332181:Annually [Temporal Concept]

Phrase: "and"

Phrase: "more than 40,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205172:More [Functional Concept]
   790   C0439509:/40 [Temporal Concept]

Phrase: "000women"

Phrase: "die from this disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0012634:Disease [Disease or Syndrome]
   715   C0011065:Expired [Organism Function]
   715   C0231800:Expired [Organ or Tissue Function]
   715   C1704631:Expire [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "each year"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439234:year [Temporal Concept]
  1000   C0439508:/year [Temporal Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: Epithelial ovarian cancer continues to be the leading cause of death from gynecologic malignancies in the United States (1, 2). 

Phrase: "Epithelial ovarian cancer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0677886:Epithelial ovarian cancer [Neoplastic Process]
   901   C0029925:ovarian cancer [Neoplastic Process]
   901   C1140680:Ovarian Cancer [Neoplastic Process]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   827   C0221908:Epithelial [Qualitative Concept]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]

Phrase: "continues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continue [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the leading cause of death"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0007465:Cause of Death [Finding]
           Death Cause
   862   C0804771:Cause of death [Clinical Attribute]
   760   C0015127:cause [Functional Concept]
   760   C1524003:Cause [Conceptual Entity]

Phrase: "from gynecologic malignancies"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0006826:MALIGNANCIES [Neoplastic Process]
   827 E C1306459:Malignancy [Finding]
   777 E C0205282:Malignant [Qualitative Concept]
   777 E C0334590:MALIGNANT [Neoplastic Process]
   777 E C1533592:MALIGNANT [Neoplastic Process]

Phrase: "in the United States"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0041703:United States [Geographic Area]
   861   C1301808:states [Geographic Area]
   827   C0166872:unite [Biomedical or Dental Material]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: One woman in 70in the U.S. will develop ovarian cancer in her lifetime, and one woman in 100will die of this disease. 

Phrase: "One woman in 70in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043210:Woman [Population Group]

Phrase: "the U.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:U S [Geographic Area]

Phrase: "will"

Phrase: "develop"

Phrase: "ovarian cancer in her lifetime,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0029925:ovarian cancer [Neoplastic Process]
   806   C1140680:Ovarian Cancer [Neoplastic Process]
   760   C0006826:Cancer [Neoplastic Process]
   760   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   760   C0998265:Cancer [Eukaryote]
   760   C1306459:Cancer [Finding]

Phrase: "and"

Phrase: "one woman in 100will"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043210:Woman [Population Group]

Phrase: "die of this disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0012634:Disease [Disease or Syndrome]
   715   C0011065:Expired [Organism Function]
   715   C0231800:Expired [Organ or Tissue Function]
   715   C1704631:Expire [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.17: Breast and ovarian cancer etiology are multifactorial, involving environmental factors, hormones, genetic susceptibility, and genetic changes during progression. 

Phrase: "Breast"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0006141:Breast [Body Part, Organ, or Organ Component]
  1000   C1268990:Breast [Body Part, Organ, or Organ Component]
   944 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   944 E C1521735:Pectoral [Qualitative Concept]
   916 E C0817096:Chest [Body Location or Region]
   916 E C1527391:Chest [Body Location or Region]

Phrase: "and"

Phrase: "ovarian cancer etiology"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1516195:Cancer Etiology [Biomedical Occupation or Discipline]
   827   C0015127:aetiology [Functional Concept]
   827   C1314792:Aetiology [Functional Concept]
   827   C1524003:Etiology [Conceptual Entity]
   734   C0029925:ovarian cancer [Neoplastic Process]
   734   C1140680:Ovarian Cancer [Neoplastic Process]

Phrase: "are"

Phrase: "multifactorial,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1837655:Multifactorial [Finding]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "environmental factors,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "hormones,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormones [Hormone]
   916 E C0458083:Hormonal [Qualitative Concept]

Phrase: "genetic susceptibility,"
Meta Candidates (Total=23; Excluded=16; Pruned=0; Remaining=7)
  1000   C0314657:Genetic Susceptibility [Organism Attribute]
   861   C0012655:Susceptibility [Clinical Attribute]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0220898:Susceptibility [Organism Attribute]
   861   C0314603:Genetic [Functional Concept]
   861   C1264642:Susceptibility [Functional Concept]
   861   C1547045:*Susceptibility [Quantitative Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   789 E C0231204:Susceptible [Functional Concept]
   789 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "genetic changes during progression."
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
   799   C1705285:Genetic Change [Cell or Molecular Dysfunction]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]
Processing 00000000.tx.18: Both cancers are a heterogeneous group of tumors with no unifying molecular alteration yet identified. 

Phrase: "Both cancers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "are"

Phrase: "a heterogeneous group of tumors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0441835:Group A [Classification]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "with no unifying molecular alteration yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1515926:Alteration [Idea or Concept]

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.19: A certain number of breast and ovarian cancer cases (~5-10%) are attributed to inherited mutations in highly penetrant breast cancer susceptibility genes, such as BRCA1 and BRCA2 (reviewed in Ref. 3). 

Phrase: "A certain number of breast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "ovarian cancer cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0029925:ovarian cancer [Neoplastic Process]
   734   C1140680:Ovarian Cancer [Neoplastic Process]

Phrase: "(~5-10%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "attributed to inherited mutations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0026882:Mutations [Genetic Function]
   770   C0439660:Inherited [Functional Concept]
   737   C0449234:Attribute [Idea or Concept]
   737   C1704772:Attribute [Conceptual Entity]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]
   737   C1882133:Attribute [Qualitative Concept]

Phrase: "in highly penetrant breast cancer susceptibility genes,"
Meta Candidates (Total=23; Excluded=7; Pruned=0; Remaining=16)
   850   C0919453:Cancer Susceptibility Gene [Gene or Genome]
           Susceptibility Gene
   839   C0029016:cancer genes [Gene or Genome]
   839   C0919437:Cancer Genes [Gene or Genome]
   827   C0006142:Breast Cancer [Neoplastic Process]
   827   C0678222:Breast Cancer [Neoplastic Process]
   799   C0006141:Breast [Body Part, Organ, or Organ Component]
   799   C0006826:Cancer [Neoplastic Process]
   799   C0012655:Susceptibility [Clinical Attribute]
   799   C0017337:Genes [Gene or Genome]
   799   C0220898:Susceptibility [Organism Attribute]
   799   C0998265:Cancer [Eukaryote]
   799   C1264642:Susceptibility [Functional Concept]
   799   C1268990:Breast [Body Part, Organ, or Organ Component]
   799   C1306459:Cancer [Finding]
   799   C1547045:*Susceptibility [Quantitative Concept]
   777 E C0153661:thoracic cancer [Neoplastic Process]
   743 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   743 E C1521735:Pectoral [Qualitative Concept]
   727 E C0231204:Susceptible [Functional Concept]
   727 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]
   716 E C0817096:Chest [Body Location or Region]
   716 E C1527391:Chest [Body Location or Region]

Phrase: "such as BRCA1"

Phrase: "and"

Phrase: "BRCA2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0294028:BRCA2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0598034:BRCA2 [Gene or Genome]

Phrase: "("

Phrase: "reviewed in Ref. 3"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.20: However, the majority of the tumors occur in women with little or no family history, and the molecular basis of these sporadic cancers is still poorly defined. 

Phrase: "However,"

Phrase: "the majority of the tumors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "occur in women"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043210:Women [Population Group]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "with little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no family history,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
  1000   C0241889:Family history [Finding]
  1000   C1705495:Family History [Idea or Concept]
   861   C0015576:Family [Family Group]
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1704727:Family [Conceptual Entity]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C0241888:Familial [Functional Concept]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "and"

Phrase: "the molecular basis of these sporadic cancers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1853126:MOLECULAR BASIS [Idea or Concept]
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]

Phrase: "is"

Phrase: "still poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205169:Poorly [Qualitative Concept]

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.21: In an effort to identify other genes involved in the development and/or progression of breast and ovarian cancer, we and others used differential gene expression approaches and have found that -synuclein, initially termed breast cancer-specific gene 1(BCSG1),1 is up-regulated in the majority of late-stage breast (4, 5) and ovarian cancer (4).2 In addition, we showed that there was a correlation between -synuclein expression in breast ductal carcinomas and the staging of the cancer suggesting that -synuclein may be a potential marker for both late stage breast and ovarian cancer. 

Phrase: "In an effort to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015264:Effort [Organism Function]

Phrase: "identify"

Phrase: "other genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "involved in the development"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1314939:Involved [Functional Concept]
   770   C1527148:Development [Functional Concept]

Phrase: "and/or"

Phrase: "progression of breast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]

Phrase: "and"

Phrase: "ovarian cancer,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancer [Neoplastic Process]
  1000   C1140680:Ovarian Cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "we"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "differential gene expression approaches"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0449445:Approaches [Spatial Concept]
   812   C1292724:Approaches [Functional Concept]
   756   C1519516:Differential Gene Expression [Genetic Function]

Phrase: "and"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "initially termed breast cancer-specific gene 1"
Meta Candidates (Total=19; Excluded=5; Pruned=0; Remaining=14)
   913   C1335851:BREAST CANCER-SPECIFIC GENE 1 [Gene or Genome]
   913   C1709991:Breast Cancer-Specific Gene 1 [Gene or Genome]
   829   C0029016:cancer gene [Gene or Genome]
   829   C0919437:Cancer Gene [Gene or Genome]
   818   C0006142:Breast Cancer [Neoplastic Process]
   818   C0678222:Breast Cancer [Neoplastic Process]
   795   C0006141:Breast [Body Part, Organ, or Organ Component]
   795   C0006826:Cancer [Neoplastic Process]
   795   C0017337:Gene [Gene or Genome]
   795   C0205369:Specific [Qualitative Concept]
   795   C0998265:Cancer [Eukaryote]
   795   C1268990:Breast [Body Part, Organ, or Organ Component]
   795   C1306459:Cancer [Finding]
   795   C1552740:specific [Intellectual Product]
   768 E C0153661:thoracic cancer [Neoplastic Process]
   740 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   740 E C1521735:Pectoral [Qualitative Concept]
   712 E C0817096:Chest [Body Location or Region]
   712 E C1527391:Chest [Body Location or Region]

Phrase: "(BCSG1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335851:BCSG1 [Gene or Genome]
  1000   C1709991:BCSG1 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "is"

Phrase: "up-regulated in the majority of late-stage breast"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C1279941:Late stage [Temporal Concept]
   742   C0006141:Breast [Body Part, Organ, or Organ Component]
   742   C0205087:Late [Temporal Concept]
   742   C0205390:Stage [Temporal Concept]
   742   C0547043:Up [Spatial Concept]
   742   C0680220:majority [Social Behavior]
   742   C0851285:Regulated [Governmental or Regulatory Activity]
   742   C1268990:Breast [Body Part, Organ, or Organ Component]
   742   C1282911:Up [Spatial Concept]
   742   C1300072:Stage [Clinical Attribute]
   742   C1306673:Stage [Qualitative Concept]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "ovarian cancer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancer [Neoplastic Process]
  1000   C1140680:Ovarian Cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "(4"

Phrase: ").2 In addition,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0740116:+2 [Quantitative Concept]
   790   C1883712:Addition [Functional Concept]
   790   C2827735:2+ [Quantitative Concept]
   790   C2981700:2+ [Classification]
   718 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that there"

Phrase: "was"

Phrase: "a correlation between -synuclein expression in breast ductal carcinomas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "the staging of the cancer"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   797   C0027646:Cancer Staging [Diagnostic Procedure]
   797   C0441904:Cancer staging [Intellectual Product]
   797   C0804824:Staging Cancer [Clinical Attribute]
   760   C0332305:Staging [Functional Concept]
   726 E C0205390:Stage [Temporal Concept]
   726 E C1300072:Stage [Clinical Attribute]
   726 E C1306673:Stage [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "a potential marker for both late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0005516:Marker [Clinical Attribute]

Phrase: "stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "breast"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0006141:Breast [Body Part, Organ, or Organ Component]
  1000   C1268990:Breast [Body Part, Organ, or Organ Component]
   944 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   944 E C1521735:Pectoral [Qualitative Concept]
   916 E C0817096:Chest [Body Location or Region]
   916 E C1527391:Chest [Body Location or Region]

Phrase: "and"

Phrase: "ovarian cancer."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancer [Neoplastic Process]
  1000   C1140680:Ovarian Cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]
Processing 00000000.tx.22: Additional studies have revealed that -synuclein over-expression leads to increased invasiveness of breast tumor cells (6) and stimulated cell proliferation (7). 

Phrase: "Additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that -synuclein over-expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leads to increased invasiveness of breast tumor cells"
Meta Candidates (Total=27; Excluded=6; Pruned=0; Remaining=21)
   793   C1458155:Tumor of breast [Neoplastic Process]
           Breast tumor
   770   C0431085:Tumor cells [Cell]
   767   C0861064:increased lead [Finding]
   744   C0006141:Breast [Body Part, Organ, or Organ Component]
   744   C0007634:Cells [Cell]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0027651:Tumor [Neoplastic Process]
   744   C0181586:leads [Medical Device]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1268990:Breast [Body Part, Organ, or Organ Component]
   744   C1301757:Invasiveness [Qualitative Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1578706:Tumor [Intellectual Product]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3273930:Tumor [Finding]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   744   C3282337:Cells [Cell]
   743 E C0024667:mammary tumor [Neoplastic Process]
   737 E C0597032:Tumor Cell [Cell]
   725   C0441098:Chest lead [Medical Device]
   720 E C0039981:Thoracic Tumor [Neoplastic Process]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(6"

Phrase: ")"

Phrase: "and"

Phrase: "stimulated cell proliferation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0596290:Cell Proliferation [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0334094:Proliferation [Pathologic Function]
   827   C1269647:Cell [Cell]
   827   C1514485:Proliferation [Functional Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.23: Synucleins are a family of small, highly soluble proteins that are predominantly expressed in neurons. 

Phrase: "Synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "a family of small, highly soluble proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0015576:Family [Family Group]
   748   C1704727:Family [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "predominantly"

Phrase: "expressed in neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.24: The functions of the synucleins are not entirely understood. 

Phrase: "The functions of the synucleins"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0542341:Functions [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]

Phrase: "are"

Phrase: "not entirely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.25: There are four known members: -synuclein (also referred to as synelfin or non-A component of Alzheimer's disease (AD) amyloid precursor protein) and -synuclein (also referred to as phosphoneuroprotein 14) are neuronal proteins primarily expressed in brain and are predominantly found at axonal terminals. 

Phrase: "There"

Phrase: "are"

Phrase: "four known members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680022:members [Population Group]
   793 E C2698041:Member [Professional or Occupational Group]

Phrase: ": -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(also"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "synelfin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0380919:synelfin [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "non-A component of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "(AD) amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(also"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "phosphoneuroprotein 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0245467:Phosphoneuroprotein 14 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "are"

Phrase: "neuronal proteins primarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "expressed in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "are"

Phrase: "predominantly"

Phrase: "found at axonal terminals."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0206181:Axon Terminals [Cell Component]
   770   C0150312:Found [Quantitative Concept]
   737   C0205088:Terminal [Temporal Concept]
   737 E C0243095:Find [Finding]
   737   C1705314:Terminal [Manufactured Object]
   737   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.26: -Synuclein (also known as persyn) is predominantly expressed in certain regions of the peripheral nervous system such as dorsal root ganglia and trigeminal ganglia. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(also"

Phrase: "known as persyn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205309:Known [Qualitative Concept]
   790   C0753208:Persyn [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1335851:PERSYN [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "predominantly"

Phrase: "expressed in certain regions of the peripheral nervous system"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   790   C0206417:Peripheral Nervous System [Body System]
   781 E C0869552:nervous peripheral system [Therapeutic or Preventive Procedure]
   764   C0027763:Nervous System [Body System]
   764   C0422837:NERVOUS SYSTEM [Finding]
   764   C1269560:Nervous system [Body System]
   742   C0027769:Nervous [Sign or Symptom]
   742   C0205100:Peripheral [Spatial Concept]
   742   C0449913:System [Functional Concept]
   742   C0599851:Nervous [Functional Concept]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]
   718   C1283933:Regional peripheral nerve [Body Part, Organ, or Organ Component]
   709 E C0205494:Neurologic [Qualitative Concept]
   708   C0017446:Region [Geographic Area]
   708   C0205147:Region [Spatial Concept]
   707   C0031119:Peripheral Nerves [Body Part, Organ, or Organ Component]
   707   C1280200:Peripheral nerve [Body Part, Organ, or Organ Component]

Phrase: "such as dorsal root ganglia"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0017070:Dorsal Root Ganglia [Body Part, Organ, or Organ Component]
           Dorsal Root
   966 E C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   901   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   884   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   827   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   827   C0040452:Root [Body Part, Organ, or Organ Component]
   827   C0205095:Dorsal [Spatial Concept]
   827   C0242726:Root [Plant]
   827   C1318154:Root [Body Part, Organ, or Organ Component]
   827   C1705917:Root [Idea or Concept]
   793 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "and"

Phrase: "trigeminal ganglia."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0040995:Trigeminal Ganglia [Body Part, Organ, or Organ Component]
   966 E C1280198:Trigeminal ganglion [Body Part, Organ, or Organ Component]
   861   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   827 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
Processing 00000000.tx.27: Synoretin, the newest member of the synuclein family, is expressed at high levels in the retina and at lower levels in the brain (8, 9). 

Phrase: "Synoretin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0753208:Synoretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335851:synoretin [Gene or Genome]

Phrase: "the newest member of the synuclein family,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0086282:Family member [Family Group]
   774   C1611821:Family Member [Intellectual Product]
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]

Phrase: "is"

Phrase: "expressed at high levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205250:High [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "and at lower levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0441889:Levels [Qualitative Concept]
   770   C0441994:Lower [Spatial Concept]
   770   C1515981:And [Idea or Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.28: The synuclein proteins contain several repeated domains that display variations of a KTKEGV consensus sequence. 

Phrase: "The synuclein proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "several repeated domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "variations of a KTKEGV consensus sequence."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0042333:Sequence Variation [Natural Phenomenon or Process]
   753   C0205419:variations [Qualitative Concept]
Processing 00000000.tx.29: The -synuclein protein contains five of these domains, whereas the - and -synucleins have six. 

Phrase: "The -synuclein protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "five of these domains,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205451:Five [Quantitative Concept]
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]

Phrase: "whereas"

Phrase: "the -"

Phrase: "and -"

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "six."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205452:Six [Quantitative Concept]
Processing 00000000.tx.30: Interestingly, the third domain of each protein is completely conserved, and this same type of domain is present in proteins of the Rho family (10). 

Phrase: "Interestingly,"

Phrase: "the third domain of each protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0162808:Protein Domain [Spatial Concept]
   783   C1514562:Protein Domain [Amino Acid Sequence]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "conserved"

Phrase: ","

Phrase: "and"

Phrase: "this same type of domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "present in proteins of the Rho family"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.31: Another type of organization of the synuclein proteins that has been noted is an 11-residue repeat. 

Phrase: "Another type of organization of the synuclein proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332307:Type [Qualitative Concept]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "is"

Phrase: "an 11-residue repeat."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]
Processing 00000000.tx.32: This motif, repeated six to seven times in the N-terminal portion of the protein, is reminiscent of the amphipathic -helical domains of the apolipoproteins and suggests possible lipid binding properties (11). 

Phrase: "This motif,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514562:Motif [Amino Acid Sequence]

Phrase: "repeated six to seven times"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0040223:times [Temporal Concept]
   760   C0205341:Repeated [Functional Concept]
   760   C0205452:Six [Quantitative Concept]
   760   C0205453:Seven [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "in the N-terminal portion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449719:Portion [Spatial Concept]

Phrase: "of the protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "reminiscent of the amphipathic -helical domains of the apolipoproteins"

Phrase: "and"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "possible lipid binding properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0871161:properties [Qualitative Concept]
   812   C1292721:properties [Functional Concept]
   779 E C1882134:Property [Conceptual Entity]
   779 E C2347695:Property [Entity]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.33: The -synuclein gene maps to 10q23, is composed of five coding exons, and is transcribed into an mRNA of ~1 kb (8). 

Phrase: "The -synuclein gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "maps to 10q23,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0024779:Map [Manufactured Object]
   790   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1706473:Map [Conceptual Entity]

Phrase: "is"

Phrase: "composed of five coding exons,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0009219:Coding [Occupational Activity]
   760   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205451:Five [Quantitative Concept]
   726 E C0805701:Code [Intellectual Product]

Phrase: "and"

Phrase: "is"

Phrase: "transcribed into an mRNA of ~1 kb (8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.34: The human -synuclein is 127amino acids long and is 87.7% and 83.3% identical to the mouse and rat proteins, respectively. 

Phrase: "The human -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "127amino acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "long"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "87.7%"

Phrase: "and"

Phrase: "83.3% identical to the mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205280:Identical [Qualitative Concept]

Phrase: "and"

Phrase: "rat proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "respectively."
Processing 00000000.tx.35: In addition, comparison of the amino acid sequences indicates that -synuclein is highly homologous to -synuclein and -synuclein except for the last 27amino acids of -synuclein. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "comparison of the amino acid sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "indicates"

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "highly homologous to -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "synuclein except for the last 27amino acids of -synuclein."
Processing 00000000.tx.36: Overall, -synuclein shares 54%, 56%, and 84% amino acid sequence identity with -synuclein, -synuclein, and synoretin, respectively (8, 9). 

Phrase: "Overall, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "54%,"

Phrase: "56%,"

Phrase: "and"

Phrase: "84% amino acid sequence identity with -synuclein, -"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0424215:Identity [Mental Process]
   748   C1519249:Sequence [Functional Concept]
   748   C2003939:Identity [Finding]

Phrase: "synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "synoretin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0753208:Synoretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335851:synoretin [Gene or Genome]

Phrase: "respectively"

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.37: Among the synucleins, -synuclein is the best characterized because of its significant role implicated in neurodegenerative diseases (12). 

Phrase: "Among the synucleins, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "the best"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "characterized because of its significant role"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0035820:Role [Social Behavior]
   753   C0237881:significant [Quantitative Concept]
   753   C0750502:Significant [Idea or Concept]
   753   C1546944:Significant [Qualitative Concept]
   753   C1705810:Role [Conceptual Entity]
   753   C1880022:Characterized [Activity]

Phrase: "implicated in neurodegenerative diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   770   C0012634:Diseases [Disease or Syndrome]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.38: Mutations in the -synuclein gene have been identified in rare kindreds with Parkinson's disease (PD) (12-14), and intracytoplasmic aggregates comprised of -synuclein fibrils are characteristic of several neurodegenerative diseases as exemplified by the intraneuronal Lewy bodies (LBs), neuroaxonal spheroids, and dystrophic neurites (i.e. Lewy neurites) that are prominent in PD, LB variant of Alzheimer's disease (AD), and dementia with LBs (14-19). 

Phrase: "Mutations in the -synuclein gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "identified in rare kindreds"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205396:Identified [Qualitative Concept]
   770   C0521114:Rare [Temporal Concept]
   770   C0522498:Rare [Qualitative Concept]
   770   C0598429:kindreds [Qualitative Concept]
   770   C1514917:RARE [Gene or Genome]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "with Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD) (12-14"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "intracytoplasmic aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "comprised"

Phrase: "of -synuclein fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "are"

Phrase: "characteristic of several neurodegenerative diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0599878:disease characteristic [Pathologic Function]
   760   C1521970:Characteristic [Qualitative Concept]

Phrase: "as"

Phrase: "exemplified by the intraneuronal Lewy bodies (LBs),"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0085200:Lewy Bodies [Cell Component]
   753   C0242821:bodies [Human]
   753   C1995017:Bodies [Cell Component]
   719 E C0460148:Body [Anatomical Structure]
   719 E C1268086:Body [Anatomical Structure]

Phrase: "neuroaxonal spheroids,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3148985:Neuroaxonal spheroids [Finding]
   861   C1844596:Spheroids [Finding]

Phrase: "and"

Phrase: "dystrophic neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2674684:Dystrophic neurites [Finding]
   861   C0085103:Neurites [Cell Component]

Phrase: "(i.e. Lewy neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3548404:Lewy neurite [Cell Component]
   812   C0085103:Neurites [Cell Component]

Phrase: ")"

Phrase: "that"

Phrase: "are"

Phrase: "prominent in PD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205402:Prominent [Qualitative Concept]

Phrase: "LB variant of Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variant [Qualitative Concept]

Phrase: "(AD"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "dementia with LBs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(14-19"

Phrase: ")."
Processing 00000000.tx.39: The normal physiological functions of synucleins are not well characterized. 

Phrase: "The normal physiological functions of synucleins"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "are"

Phrase: "not well characterized."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205170:Well [Qualitative Concept]
   827   C1880022:Characterized [Activity]
   827   C3146287:Well [Manufactured Object]
Processing 00000000.tx.40: The N-terminal portion of -synuclein (residues 1-61) shares 40% amino acid homology with members of the 14-3-3protein family (20). 

Phrase: "The N-terminal portion of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(residues 1-61"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "40% amino acid homology with members"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1334043:Homology [Gene or Genome]
   753   C2697616:Homology [Qualitative Concept]

Phrase: "of the 14-3-3protein family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0015576:Family [Family Group]
   812   C1704727:Family [Conceptual Entity]
   741 E C0241888:Familial [Functional Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.41: The 14-3-3family of proteins helps regulate many different signal transduction pathways and is thought to act by directly binding to various protein kinases and bringing them into close proximity with substrate and regulatory proteins. 

Phrase: "The 14-3-3family of proteins"

Phrase: "helps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "regulate"

Phrase: "many different signal transduction pathways"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0086982:Signal Transduction Pathways [Molecular Function]
   875   C0037080:Signal Pathways [Molecular Function]
   861   C0037083:Signal Transduction [Cell Function]
   812   C1160185:transduction [Organism Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act by directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0079613:ACT [Therapeutic or Preventive Procedure]
   790   C1947931:Directly [Qualitative Concept]

Phrase: "binding to various protein kinases"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   827   C1149290:protein kinase binding [Molecular Function]
   806   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0033618:Protein Binding [Molecular Function]
   797   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1149289:kinase binding [Molecular Function]
   760   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243122:binding [Functional Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "bringing"

Phrase: "them into close proximity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0587267:Close [Functional Concept]
   770   C1514583:Proximity [Spatial Concept]

Phrase: "with substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "regulatory proteins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0815047:regulatory proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
Processing 00000000.tx.42: 14-3-3proteins bind to phospho-serine residues critical for the functions of many kinases and phosphatases that are involved in diverse cell functions (21-24). 

Phrase: "14-3-3proteins"

Phrase: "bind to phospho-serine residues"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "critical for the functions of many kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511545:Critical [Qualitative Concept]

Phrase: "and"

Phrase: "phosphatases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031678:Phosphatases [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1149880:phosphatase [Molecular Function]

Phrase: "that"

Phrase: "are"

Phrase: "involved in diverse cell functions"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0007613:cell functions [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0542341:Functions [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1314939:Involved [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1880371:Diverse [Qualitative Concept]
   760   C1948049:Cell [Spatial Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]

Phrase: "(21-24"

Phrase: ")."
Processing 00000000.tx.43: Like the synucleins, 14-3-3proteins are ubiquitously expressed in the brain and have been shown to associate in a chaperone-like manner with PKC, BAD, ERK, and RAF-1 (16, 21). 

Phrase: "Like the synucleins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "14-3-3proteins"

Phrase: "are"

Phrase: "ubiquitously"

Phrase: "expressed in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "associate in a chaperone-like manner"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0750490:Associate [Idea or Concept]
   753   C1706221:Associate [Professional or Occupational Group]

Phrase: "with PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "BAD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Bad [Qualitative Concept]

Phrase: "ERK,"

Phrase: "and"

Phrase: "RAF-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0812215:Raf-1 [Gene or Genome]
  1000   C1706586:RAF-1 [Gene or Genome]
           RAF
  1000   C2746015:Raf-1 [Molecular Function]
   861   C1425569:RAF [Gene or Genome]

Phrase: "(16,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.44: -Synuclein binds 14-3-3as well as to PKC, BAD, ERK, and the microtubule-associated protein tau (25). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "14-3-3as well as to PKC,"

Phrase: "BAD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Bad [Qualitative Concept]

Phrase: "ERK,"

Phrase: "and"

Phrase: "the microtubule-associated protein tau"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1446659:MICROTUBULE-ASSOCIATED PROTEIN TAU [Gene or Genome]
  1000   C2700455:Microtubule-Associated Protein Tau [Amino Acid, Peptide, or Protein]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0085401:Microtubule protein tau [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1421563:protein tau [Gene or Genome]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.45: In addition to shared regions of homology to 14-3-3,-synuclein as well as - and -synuclein also appear to act as a protein chaperone, at least in vitro, by disrupting protein aggregation (26). 

Phrase: "In addition to shared regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of homology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334043:Homology [Gene or Genome]
  1000   C2697616:Homology [Qualitative Concept]

Phrase: "to 14-3-3,-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0090388:14-3-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421563:14-3-3 [Gene or Genome]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as well as"

Phrase: "-"

Phrase: "and -"

Phrase: "synuclein also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act as a protein chaperone,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at least in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]

Phrase: "by disrupting protein aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.46: To help further unravel the function of -synuclein and establish its role in the oncogenesis of breast and ovarian cancer, we searched for proteins that could interact with -synuclein and identified the MAPKs ERK1/2 and JNK1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "unravel"

Phrase: "the function of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "its role in the oncogenesis of breast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "ovarian cancer,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancer [Neoplastic Process]
  1000   C1140680:Ovarian Cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "we"

Phrase: "searched for proteins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1706202:Searched [Activity]
   756 E C1552603:search [Intellectual Product]

Phrase: "that"

Phrase: "could"

Phrase: "interact with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the MAPKs ERK1/2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "JNK1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]
Processing 00000000.tx.47: In this study we provide evidence that -synuclein contributes to tumor development by protecting cancer cells under adverse conditions through modulating the ERK and JNK pathways. 

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contributes to tumor development"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0027651:Tumor [Neoplastic Process]
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C1880177:Contribute [Activity]
   770   C3273930:Tumor [Finding]

Phrase: "by protecting cancer cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0334227:cancer cells [Cell]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0007634:Cells [Cell]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "under adverse conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "through modulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulating [Spatial Concept]

Phrase: "the ERK"

Phrase: "and"

Phrase: "JNK pathways."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1621396:Pathways, JNK [Molecular Function]
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.48: In addition, we observed that paclitaxel- or vinblastine-induced cell death is protected by -synuclein, indicating that chemotherapeutic drugs that take effect through activating the JNK apoptosis pathway may not be effective for cancer with high -synuclein expression.  

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that paclitaxel-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0144576:Paclitaxel [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "vinblastine-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "protected by -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "indicating"

Phrase: "that chemotherapeutic drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "that"

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "effect through activating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "the JNK apoptosis pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1621396:JNK Pathway [Molecular Function]
   901   C0162638:Apoptosis Pathway [Cell Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "effective for cancer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280519:effective [Qualitative Concept]
   790   C1704419:Effective [Qualitative Concept]

Phrase: "with high -synuclein expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.49: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Reagents and Antibodies-- Paclitaxel, vinblastine, and etoposide were purchased from Sigma (St. Louis, MO). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "--"

Phrase: "Paclitaxel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0144576:Paclitaxel [Organic Chemical,Pharmacologic Substance]

Phrase: "vinblastine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "etoposide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from Sigma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.50: The MEK1/2 inhibitor U0126 was purchased from Promega (Madison, WI). 

Phrase: "The MEK1/2 inhibitor U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "purchased from Promega"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0072149:Promega [Lipid]
   790   C0869011:purchased [Activity]

Phrase: "(Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.51: Anti-ERK1, anti-ERK2, and anti-JNK1 antibodies and normal IgG were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). 

Phrase: "Anti-ERK1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "anti-ERK2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1150579:ERK2 [Molecular Function]

Phrase: "and"

Phrase: "anti-JNK1 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "normal IgG"

Phrase: "were"

Phrase: "obtained from Santa Cruz Biotechnology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "(Santa Cruz,"

Phrase: "CA)."
Processing 00000000.tx.52: Anti-phospho-ERK1/2 and anti-PARP antibodies were obtained from Cell Signaling (Beverly, MA). 

Phrase: "Anti-phospho-ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "anti-PARP antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from Cell Signaling"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   851   C1371607:Increased Cell Signaling [Cell Function]
   833   C0037083:Cell Signaling [Cell Function]
           Signaling
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1301820:Obtained [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C3537152:signaling [Biologic Function]
   737 E C1706701:Obtain [Activity]

Phrase: "(Beverly,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.53: The mouse antibody Syn303 was raised to recombinant human -synuclein but recognizes -, -, and -synuclein. 

Phrase: "The mouse antibody Syn303"

Phrase: "was"

Phrase: "raised to recombinant human -synuclein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086418:Human [Human]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0442818:Raised [Quantitative Concept]
   760   C1514798:recombinant [Organism]

Phrase: "but"

Phrase: "recognizes -"

Phrase: ", -"

Phrase: ","

Phrase: "and -"

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.54: -2 is a rabbit polyclonal antibody raised to recombinant human -synuclein that specifically recognizes human -synuclein (27). 

Phrase: "-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "is"

Phrase: "a rabbit polyclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "raised to recombinant human -synuclein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086418:Human [Human]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0442818:Raised [Quantitative Concept]
   760   C1514798:recombinant [Organism]

Phrase: "that specifically"

Phrase: "recognizes"

Phrase: "human -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.55: Mouse monoclonal antibodies Syn204 and Syn207 were raised against human - and -synucleins, respectively. 

Phrase: "Mouse monoclonal antibodies Syn204"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   740   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "Syn207"

Phrase: "were"

Phrase: "raised against human -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086418:Human [Human]
   790   C0442818:Raised [Quantitative Concept]

Phrase: "and -"

Phrase: "synucleins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "respectively."
Processing 00000000.tx.56: Cell Culture and Transfection-- Ovarian cancer cell lines A2780 and OVCAR5 were maintained in 10% FBS Dulbecco's modified Eagle's medium and 10% FBS RPMI 1640,respectively. 

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "--"

Phrase: "Ovarian cancer cell lines A2780"

Phrase: "and"

Phrase: "OVCAR5"

Phrase: "were"

Phrase: "maintained in 10% FBS Dulbecco's modified Eagle's medium"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   744   C0009458:Medium [Intellectual Product]
   744   C0325564:Eagle [Bird]
   744   C0392747:Modified [Functional Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C1314677:Maintained [Functional Concept]
   744   C1551720:Eagle [Population Group]
   744   C1705217:Medium [Substance]
   744   C3244283:medium [Intellectual Product]
   711 E C0024501:Maintain [Activity]

Phrase: "and"

Phrase: "10% FBS RPMI 1640,"

Phrase: "respectively."
Processing 00000000.tx.57: HEK293, human embryonic kidney cells, were maintained in 10% FBS Dulbecco's modified Eagle's medium supplemented with sodium pyruvate and non-essential amino acids. 

Phrase: "HEK293,"

Phrase: "human embryonic kidney cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   844   C0553257:kidney cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in 10% FBS Dulbecco's modified Eagle's medium"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   744   C0009458:Medium [Intellectual Product]
   744   C0325564:Eagle [Bird]
   744   C0392747:Modified [Functional Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C1314677:Maintained [Functional Concept]
   744   C1551720:Eagle [Population Group]
   744   C1705217:Medium [Substance]
   744   C3244283:medium [Intellectual Product]
   711 E C0024501:Maintain [Activity]

Phrase: "supplemented with sodium pyruvate"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1576824:Sodium Pyruvate [Organic Chemical,Pharmacologic Substance]
   802   C3661596:Sodium supplement [Food]
   770   C0034354:pyruvate [Organic Chemical]
   770   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   770   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   770   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "non-essential amino acids."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   983   C0311461:Non-Essential Amino Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   923   C0002525:Amino Acids, Essential [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   890 E C2348468:Essential_Amino_Acid [Conceptual Entity]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0205224:Essential [Qualitative Concept]
   812   C1518422:Non [Functional Concept]
   779 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.58: To create the CMV plasmid for establishing stable cell lines over-expressing human -, -, or -synuclein, human cDNAs were amplified by PCR and subcloned into pcDNA3 (Invitrogen). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "the CMV plasmid for establishing stable cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "over-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "human -, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: ","

Phrase: "or -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "human cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "subcloned into pcDNA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C1883178:Subclone [Cell]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.59: GenePorter Transfection Reagent (GTS Inc., San Diego, CA) was used for transfection, and stable cell lines were selected by G418 (Invitrogen). 

Phrase: "GenePorter Transfection Reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(GTS Inc.,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "was"

Phrase: "used for transfection,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "stable cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   983   C0598091:stable cell line [Cell]
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "selected by G418"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0052009:G418 [Antibiotic,Organic Chemical]
   756   C1707391:Select [Activity]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.60: Expression of human -, -, or -synuclein was confirmed by immunoblotting with Syn204, Syn207, or -2 antibody, respectively. 

Phrase: "Expression of human -, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "or -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "confirmed by immunoblotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "with Syn204,"

Phrase: "Syn207,"

Phrase: "or -2 antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.61: Cell Treatment with UV and Other Stress Signals or Chemotherapeutic Drugs-- For UV treatment, cells at 70-80% confluence were washed once with PBS before UV irradiation (254nm, 20J/m2). 

Phrase: "Cell Treatment with UV"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "Other Stress Signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "or"

Phrase: "Chemotherapeutic Drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "-"

Phrase: "-"

Phrase: "For UV treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "cells at 70-80% confluence"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720092:Once [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948045:Once [Temporal Concept]

Phrase: "before UV irradiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1282930:Irradiation [Natural Phenomenon or Process]
   861   C1522449:irradiation [Therapeutic or Preventive Procedure]

Phrase: "(254nm,"

Phrase: "20J/m2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457242:m2 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.62: Complete medium was added to the plates after treatment. 

Phrase: "Complete medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "added to the plates"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1139930:plates [Medical Device]
   770   C1524062:Added [Functional Concept]
   737 E C0005971:Plate [Medical Device]
   737 E C1883712:Add [Functional Concept]
   737 E C3537155:Plate [Manufactured Object]

Phrase: "after treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.63: The intensity of the UV light source was measured with a BLAK-RAY meter (UVP, Inc., San Gabriel, CA) prior to each experiment. 

Phrase: "The intensity of the UV light source"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0596836:Light intensity [Natural Phenomenon or Process]
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "measured with a BLAK-RAY meter"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0086894:ray [Fish]
   753   C0444706:Measured [Qualitative Concept]
   753   C0475209:Meter [Quantitative Concept]
   753   C0851346:ray [Natural Phenomenon or Process]
   753   C1706378:METER [Manufactured Object]
   753   C2314876:ray [Fish]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "(UVP,"

Phrase: "Inc.,"

Phrase: "San Gabriel,"

Phrase: "CA) prior to each experiment."
Processing 00000000.tx.64: Heat-shock was carried at 42C for 15min. 

Phrase: "Heat-shock"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282498:Heat Shock [Physiologic Function]
   861   C0018837:Heat [Natural Phenomenon or Process]
   861   C0036974:Shock [Pathologic Function]

Phrase: "was"

Phrase: "carried at 42C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0206243:carried [Activity]
   790   C0699809:carried [Finding]
   790   C1419782:42C [Gene or Genome]
   790   C3538774:42C [Gene or Genome]

Phrase: "for 15min."
Processing 00000000.tx.65: 50M sodium arsenite was used to treat the cells for 6h. 

Phrase: "50M sodium arsenite"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0074719:sodium arsenite [Inorganic Chemical,Pharmacologic Substance]
   827   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0052418:arsenite [Inorganic Chemical,Pharmacologic Substance]
   827   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "treat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292734:TREAT [Functional Concept]
  1000   C1522326:Treat [Functional Concept]

Phrase: "the cells for 6h."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   816   C0007634:THE CELL [Cell]
           Cells
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.66: Paclitaxel, vinblastine, etoposide, and U0126 were dissolved in Me2SO, and cells were treated with various concentrations of the drugs as indicated in each experiment. 

Phrase: "Paclitaxel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0144576:Paclitaxel [Organic Chemical,Pharmacologic Substance]

Phrase: "vinblastine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "etoposide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "dissolved in Me2SO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with various concentrations of the drugs"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   757   C0678756:concentrations drug [Quantitative Concept]
   748   C0013227:Drugs [Pharmacologic Substance]
   748   C0086045:Concentrations [Mental Process]
   748   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   748   C1522326:Treated [Functional Concept]
   714 E C1254351:Drug [Pharmacologic Substance]
   714 E C1292734:TREAT [Functional Concept]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "as"

Phrase: "indicated in each experiment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0681814:Experiment [Research Activity]
   770   C1444656:Indicated [Finding]
   770   C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.67: Co-immunoprecipitation-- Cells at 70-80% confluence were washed twice with ice-cold D-PBS before scraping on ice with lysis buffer (20mM Tris-HCl, pH 7.5; 150mM NaCl; 2.5mM sodium pyrophosphate; 1mM sodium -glycerophosphate; 5mM NaF, 1mM Na3VO4, 1mM phenylmethylsulfonyl fluoride, 1% Triton X-100, and 1tablet of protease inhibitor mixture (Roche Molecular Biochemicals, Indianapolis, IN) per 40ml of lysis buffer). 

Phrase: "Co-immunoprecipitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "--"

Phrase: "Cells at 70-80% confluence"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with ice-cold"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0456963:Ice cold [Qualitative Concept]
   770   C0009264:Cold [Natural Phenomenon or Process]
   770   C0009443:Cold [Disease or Syndrome]
   770   C0020746:Ice [Inorganic Chemical]
   770   C0234192:Cold [Physiologic Function]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "D-"

Phrase: "PBS before scraping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]

Phrase: "on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "with lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(20mM Tris-HCl,"

Phrase: "pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "; 150mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "; 2.5mM sodium pyrophosphate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0074764:sodium pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0034320:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C3252566:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "; 1mM sodium -glycerophosphate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0377349:Sodium glycerophosphate [Biologically Active Substance,Organophosphorus Compound]
   827   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "; 5mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   861   C1366571:NAF [Gene or Genome]
   861   C1705592:NAF [Gene or Genome]

Phrase: "1mM Na3VO4,"

Phrase: "1mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "1tablet of protease inhibitor mixture"

Phrase: "(Roche Molecular Biochemicals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: "Indianapolis,"

Phrase: "IN) per 40ml of lysis buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:In [Quantitative Concept]
   753   C0332285:In [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.68: Cellular debris was removed by centrifugation (14,000g for 15min at 4C) and precleared with protein G-agarose (Invitrogen, Rockville, MD). 

Phrase: "Cellular debris"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0440266:Debris [Substance]

Phrase: "was"

Phrase: "removed by centrifugation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "(14,"

Phrase: "000g for 15min"

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "precleared with protein G-agarose"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Agarose [Carbohydrate]
   760   C0439267:g% [Quantitative Concept]

Phrase: "(Invitrogen,"

Phrase: "Rockville,"

Phrase: "MD)."
Processing 00000000.tx.69: Protein concentrations were determined with Bio-Rad DC protein assay reagents. 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined with Bio-Rad DC protein assay reagents."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0249069:RAD Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   744   C0243073:assay [Qualitative Concept]
   744   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.70: Syn303 (3l of ascites) or control IgG (3g) were preincubated in 500l of PBS with 50l of protein-G-agarose overnight at 4C, and washed twice with PBS before incubation with 300g of total cellular lysate for 4h at 4C. 

Phrase: "Syn303"

Phrase: "(3l of ascites"

Phrase: ")"

Phrase: "or"

Phrase: "control IgG (3g"

Phrase: ")"

Phrase: "were"

Phrase: "preincubated in 500l of PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]

Phrase: "with 50l"

Phrase: "of protein-G-agarose overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036681:Agarose [Carbohydrate]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720725:Twice [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "before incubation"

Phrase: "with 300g"

Phrase: "of total cellular lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "for 4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.71: The beads were washed four times with the lysis buffer, resuspended in 50l of 2 SDS sample buffer before boiling for 5min. 

Phrase: "The beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "four times with the lysis buffer,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "resuspended in 50l of 2 SDS sample buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0370003:Sample [Substance]
   744   C2347026:Sample [Conceptual Entity]

Phrase: "before boiling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0242301:Boil [Disease or Syndrome]
   966   C1546559:Boil [Intellectual Product]

Phrase: "for 5min."
Processing 00000000.tx.72: 10l of immunoprecipitates was separated by SDS-PAGE electrophoresis on 4-20% linear gradient Tris-HCl ready gels (Bio-Rad). 

Phrase: "10l of immunoprecipitates"

Phrase: "was"

Phrase: "separated by SDS-PAGE electrophoresis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1704732:Page [Intellectual Product]

Phrase: "on 4-20% linear gradient Tris-HCl ready gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0017243:Gels [Biomedical or Dental Material]
   760 E C1382104:Gel [Substance]

Phrase: "(Bio-Rad"

Phrase: ")."
Processing 00000000.tx.73: Immunoblotting and Data Quantification-- Proteins separated on SDS-PAGE gels were transferred onto an Immobilon-P polyvinylidene difluoride membrane (Millipore, Bedford, MA). 

Phrase: "Immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "and"

Phrase: "Data Quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709793:Quantification [Quantitative Concept]

Phrase: "--"

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "separated on SDS-PAGE gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1704732:Page [Intellectual Product]
   726 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "transferred onto an Immobilon-P polyvinylidene difluoride membrane"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0071710:polyvinylidene difluoride [Organic Chemical]
   770   C0123400:Immobilon P [Organic Chemical]
   744   C0025255:Membrane [Tissue]
   744   C0063412:Immobilon [Organic Chemical,Pharmacologic Substance]
   744   C0348011:transferred [Functional Concept]
   744   C0596901:Membrane [Cell Component]
   744   C1706182:Membrane [Manufactured Object]
   711 E C0040671:Transfer [Mental Process]
   711 E C1705822:Transfer [Activity]

Phrase: "(Millipore,"

Phrase: "Bedford,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.74: The primary antibodies were diluted 1:1000, and the horseradish peroxidase-conjugated second antibodies were diluted 1:10,000 (Amersham Biosciences, Piscataway, NJ). 

Phrase: "The primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000,"

Phrase: "and"

Phrase: "the horseradish peroxidase-conjugated second antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10,000"

Phrase: "(Amersham Biosciences,"

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.75: PerkinElmer Life Sciences Renaissance Enhanced Luminol Reagents (Boston, MA) were used as substrates for detection. 

Phrase: "PerkinElmer Life Sciences Renaissance Enhanced Luminol Reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA)"

Phrase: "were"

Phrase: "used as substrates"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1710236:Substrate [Manufactured Object]
   756 E C1947944:Use [Intellectual Product]

Phrase: "for detection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.76: For re-use of the same membrane with another primary antibody, Restore Western blot Stripping buffer (Pierce, Rockford, IL) was used to strip the membrane. 

Phrase: "For"

Phrase: "re-use of the same membrane"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1524063:Use of [Functional Concept]
   753   C0025255:Membrane [Tissue]
   753   C0042153:use [Functional Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C0457083:Use [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   753   C1947944:Use [Intellectual Product]
   753   C2986904:RE [Idea or Concept]

Phrase: "with another primary antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Restore"

Phrase: "Western blot Stripping buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(Pierce,"

Phrase: "Rockford,"

Phrase: "IL)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "strip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1321564:Strip [Medical Device]

Phrase: "the membrane."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.77: The results of immunoblotting were quantitated using the program IMAGE (National Institutes of Health) for the integrated density of each band. 

Phrase: "The results of immunoblotting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "were"

Phrase: "quantitated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the program IMAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1704254:Image [Intellectual Product]
   861   C1704922:Image [Entity]
   861   C3542466:Image [Intellectual Product]

Phrase: "(National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: ")"

Phrase: "for the integrated density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0178587:density [Quantitative Concept]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "of each band."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]
Processing 00000000.tx.78: JNK Kinase Activity Assay-- The kinase activity of JNK was measured using the SAPK/JNK assay kit (Cell Signaling Technologies). 

Phrase: "JNK Kinase Activity Assay"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0291988:JNK Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1150423:kinase activity [Molecular Function]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0205177:Activity [Functional Concept]
   812   C0243073:assay [Qualitative Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1510438:Assay [Laboratory Procedure]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The kinase activity of JNK"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1150423:kinase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the SAPK/JNK assay kit (Cell Signaling Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0039421:technologies [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.79: Briefly, 250l of cell lysate (1g/l protein) was incubated with 2g of c-JUN fusion protein beads (in 20l) overnight at 4C. 

Phrase: "Briefly,"

Phrase: "250l of cell lysate"

Phrase: "(1g/l protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "was"

Phrase: "incubated with 2g of c-JUN fusion protein beads"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   764   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   762   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1168438:Protein C [Laboratory Procedure]
   762   C1418943:PROTEIN C [Gene or Genome]
   762   C3536909:JUN Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           JUN
   762   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0332466:Fusion [Functional Concept]
   742   C0991566:Beads [Biomedical or Dental Material]
   742   C1293131:Fusion [Therapeutic or Preventive Procedure]
   742   C1439852:Incubated [Laboratory Procedure]
   708 E C2346972:Bead [Spatial Concept]

Phrase: "("

Phrase: "in 20l"

Phrase: ")"

Phrase: "overnight at 4C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]
Processing 00000000.tx.80: After washing, the proteins on the beads were incubated in the kinase reaction buffer supplemented with 100M ATP for 30min at 30C. 

Phrase: "After washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "the proteins on the beads"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "incubated in the kinase reaction buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "supplemented with 100M ATP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "for 30min"

Phrase: "at 30C."
Processing 00000000.tx.81: To measure the JNK activity, the phosphorylated c-JUN was detected by SDS-PAGE and immunoblotting with the specific antibody (Cell Signaling Technologies). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the JNK activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "the phosphorylated c-JUN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected by SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotting with the specific antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "(Cell Signaling Technologies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039421:technologies [Occupation or Discipline]
   734   C0037083:Cell Signaling [Cell Function]

Phrase: ")."
Processing 00000000.tx.82: Cell Viability Assay-- Cell viability was determined by Trypan blue exclusion assay and/or WST-1 assay. 

Phrase: "Cell Viability Assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0007620:Cell Viability [Cell Function]

Phrase: "--"

Phrase: "Cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined by Trypan blue exclusion assay"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0680251:EXCLUSION [Functional Concept]
   753   C1260957:Blue [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1565627:Trypan [Organic Chemical]
   753   C2828389:Exclusion [Activity]

Phrase: "and/or"

Phrase: "WST-1 assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.83: For Trypan blue assay, cells were stained with 0.2% Trypan blue for 2-5 min. 

Phrase: "For Trypan blue assay,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with 0.2% Trypan blue"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   804   C0041213:Trypan blue stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Trypan Blue
   753   C1260957:Blue [Qualitative Concept]
   753   C1565627:Trypan [Organic Chemical]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "for 2-5 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0702093:/min [Temporal Concept]
   734   C0450346:2 5 [Quantitative Concept]
Processing 00000000.tx.84: The number of viable cells (non-stained) and dead cells (stained) were counted under a microscope using a cell hemacytometer. 

Phrase: "The number of viable cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "(non-stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2986582:Stained [Qualitative Concept]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "and"

Phrase: "dead cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "were"

Phrase: "counted under a microscope"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0181839:Microscope [Medical Device]
   770   C1706379:Microscope [Medical Device]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cell hemacytometer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0181168:hemacytometer [Medical Device]
Processing 00000000.tx.85: For the WST-1 assay, cells under different culture conditions were incubated with WST-1 (Roche Molecular Biochemicals) for 4h. 

Phrase: "For the WST-1 assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "cells under different culture conditions"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C0007585:cells culture [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with WST-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: "for 4h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]
Processing 00000000.tx.86: Cleavage of WST-1 to formazan was monitored at 450nm using a microplate reader. 

Phrase: "Cleavage of WST-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "to formazan"

Phrase: "was"

Phrase: "monitored at 450nm"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a microplate reader."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0182258:Microplate Reader [Medical Device]
   861   C1514743:Reader [Professional or Occupational Group]
   861   C1706461:Reader [Manufactured Object]
Processing 00000000.tx.87: Caspase Activity Assay-- Colorimetric CaspACE assay (Promega) was used to detect the caspase-3 activity. 

Phrase: "Caspase Activity Assay"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C1150130:caspase activity [Molecular Function]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0205177:Activity [Functional Concept]
   827   C0243073:assay [Qualitative Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1510438:Assay [Laboratory Procedure]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "--"

Phrase: "Colorimetric CaspACE assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the caspase-3 activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.88: Briefly, pNA released from the substrate Ac-DEVD-pNA by caspase-3 in the cell lysate was monitored at 405nm using a microplate reader. 

Phrase: "Briefly,"

Phrase: "pNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600500:PNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "released from the substrate Ac-DEVD-pNA"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   814   C0967499:Ac-DEVD-pNA [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   778   C1259541:DEVD-pNA [Amino Acid, Peptide, or Protein]
   748   C0391871:Released [Functional Concept]
   748   C0600500:PNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1283071:Released [Functional Concept]
   748   C1412573:AC [Gene or Genome]
   748   C1710236:Substrate [Manufactured Object]
   748   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   748   C3539770:AC [Gene or Genome]
   714 E C0030685:Release [Health Care Activity]
   714 E C0439180:% release [Quantitative Concept]
   714 E C0680255:release [Health Care Activity]
   714 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "by caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "monitored at 405nm"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a microplate reader."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0182258:Microplate Reader [Medical Device]
   861   C1514743:Reader [Professional or Occupational Group]
   861   C1706461:Reader [Manufactured Object]
Processing 00000000.tx.89: Statistical Analysis-- Where indicated, a two-tailed Student t test was used to test for significance.  

Phrase: "Statistical Analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "--"

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "a two-tailed Student t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0022885:Test [Laboratory Procedure]
   804   C0038492:student [Professional or Occupational Group]
   804   C0039593:Test [Functional Concept]
   804   C0392366:test [Intellectual Product]
   804   C1551041:student [Idea or Concept]
   804   C1552573:student [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test for significance."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0237881:Significance [Quantitative Concept]
   790   C0392366:test [Intellectual Product]
   790   C0750502:Significance [Idea or Concept]
   718 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.90: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Expression of Synuclein in Tumor Cell Lines-- We have previously reported that -synuclein is highly expressed in the vast majority of late-stage breast and ovarian tumors (4), suggesting a potentially important role for -synuclein in the development of these diseases. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Expression of Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in Tumor Cell Lines"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0085983:Tumor Cell Lines [Cell]
   901   C0007600:Cell lines [Cell]
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
   734   C0431085:Tumor cell [Cell]
   734   C0597032:Tumor Cell [Cell]

Phrase: "-"

Phrase: "-"

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "expressed in the vast majority of late-stage breast"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C1279941:Late stage [Temporal Concept]
   742   C0006141:Breast [Body Part, Organ, or Organ Component]
   742   C0205087:Late [Temporal Concept]
   742   C0205390:Stage [Temporal Concept]
   742   C0680220:majority [Social Behavior]
   742   C0814230:VAST [Intellectual Product]
   742   C1268990:Breast [Body Part, Organ, or Organ Component]
   742   C1300072:Stage [Clinical Attribute]
   742   C1306673:Stage [Qualitative Concept]

Phrase: "and"

Phrase: "ovarian tumors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0919267:Ovarian Tumors [Neoplastic Process]
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a potentially important role for -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of these diseases."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.91: To help unravel the function of -synuclein, we established several in vitro models. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "unravel"

Phrase: "the function of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "several in vitro models."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   906   C1515654:In Vitro Model [Research Activity]
   812   C3161035:Models [Intellectual Product]
Processing 00000000.tx.92: The ovarian tumor cell lines A2780 and OVCAR5, which express low levels of -synuclein, as well as kidney HEK293 cells, which do not express detectable levels of -synuclein, were transfected with CMV--synuclein or with vector alone and were selected with G418. 

Phrase: "The ovarian tumor cell lines A2780"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0085983:Tumor Cell Lines [Cell]

Phrase: "and"

Phrase: "OVCAR5,"

Phrase: "which"

Phrase: "express"

Phrase: "low levels of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as well as"

Phrase: "kidney HEK293 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C2936239:HEK293 Cells [Cell]
   896   C0553257:kidney cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "detectable levels of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transfected with CMV--synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or with vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0442335:Vector [Spatial Concept]
   790   C1705099:Vector [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and"

Phrase: "were"

Phrase: "selected with G418."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0052009:G418 [Antibiotic,Organic Chemical]
   756   C1707391:Select [Activity]
Processing 00000000.tx.93: Resistant colonies were screened by Western blotting for stable expression of -synuclein protein, and positive colonies were pooled into A2780gam, OVCAR5gam, and 293gam cell lines (Fig. 1). 

Phrase: "Resistant colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "screened by Western blotting"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737   C0220908:screen [Health Care Activity]
   737   C1305399:screen [Functional Concept]
   737   C1705053:Screen [Medical Device]

Phrase: "for stable expression of -synuclein protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1171362:expression protein [Genetic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "positive colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "pooled into A2780gam,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1709595:Pooled [Conceptual Entity]
   790   C2349200:Pooled [Functional Concept]
   756 E C0337051:Pool [Geographic Area]
   756 E C1509144:pool [Clinical Attribute]

Phrase: "OVCAR5gam,"

Phrase: "and"

Phrase: "293gam cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.94: Cell lines stably expressing -synuclein and -synuclein were also derived from A2780 cells as described for the -synuclein expressing lines (Fig. 1). 

Phrase: "Cell lines stably"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "expressing -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "also"

Phrase: "derived from A2780 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "described for the -synuclein expressing lines"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205132:lines [Spatial Concept]
   753   C1552738:described [Idea or Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.95: Like A2780gam, OVCAR5gam, and 293gam cells, there were no obvious alterations in cell doubling time of the A2780alpha or A2780beta cell lines (data not shown). 

Phrase: "Like A2780gam,"

Phrase: "OVCAR5gam,"

Phrase: "and"

Phrase: "293gam cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "there"

Phrase: "were"

Phrase: "no obvious alterations in cell doubling time of the A2780alpha"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C2986483:Doubling Time [Temporal Concept]
   739   C0040223:Time [Temporal Concept]
   739   C0205173:doubling [Functional Concept]
   739   C1705764:Doubling [Activity]
   739   C3541383:Time [Temporal Concept]
   706 E C1705765:Double [Qualitative Concept]

Phrase: "or"

Phrase: "A2780beta cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.96: View larger version (45K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(45K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.97: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.98: Establishment of cell lines that ectopically over-express -synuclein. 

Phrase: "Establishment of cell lines"

Phrase: "that ectopically"

Phrase: "over-express -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.99: Whole cell lysates from the parental cells or stably transfected cells were analyzed by SDS-PAGE and immunoblotting. 

Phrase: "Whole cell lysates from the parental cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C1881488:Cell Lysate [Physical Object]
           Lysate
   748   C0007634:Cell [Cell]
   748   C0444667:Whole [Quantitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "stably transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "analyzed by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.100: Protein levels of -synuclein were determined by Western blotting with -2, a polyclonal antibody specific for -synuclein. 

Phrase: "Protein levels of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "determined by Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "with -2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "a polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for -synuclein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]
Processing 00000000.tx.101: Protein loading levels were evaluated by immunoblotting with anti--actin antibody. 

Phrase: "Protein loading levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   896   C0428479:Protein level [Laboratory or Test Result]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "evaluated by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0220825:Evaluated [Functional Concept]

Phrase: "with anti--actin antibody."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   755 E C0439681:Actinic [Qualitative Concept]
Processing 00000000.tx.102: The numbers beneath each band represent the densitometry units (A2780 was assigned the arbitrary unit 1.0in the -actin blot). 

Phrase: "The numbers beneath each band"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the densitometry units"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0439148:Units [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: "(A2780"

Phrase: "was"

Phrase: "assigned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516050:Assigned [Functional Concept]
  1000   C1552601:assigned [Intellectual Product]

Phrase: "the arbitrary unit 1.0in"

Phrase: "the -actin blot"

Phrase: ")."
Processing 00000000.tx.103: -Synuclein protein levels were normalized to the protein levels of -actin. 

Phrase: "-Synuclein protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C0428479:Protein level [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "normalized to the protein levels of -actin."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0441889:Levels [Qualitative Concept]
   748   C1882115:Normalized [Research Activity]
   745   C0428479:Protein level [Laboratory or Test Result]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.104: The graph represents the averageS.E. of at least three independent experiments, and representative blots are shown here. 

Phrase: "The graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the averageS.E."

Phrase: "of"

Phrase: "at least three independent experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "representative blots"

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here."
Processing 00000000.tx.105: Molecular mass standards (in kilodaltons) are indicated to the left of each blot. 

Phrase: "Molecular mass standards"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0038137:standards [Intellectual Product]
   827   C0175675:Standards [Qualitative Concept]
   793 E C1442989:Standard [Qualitative Concept]
   793 E C2828392:Standard [Intellectual Product]
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "("

Phrase: "in kilodaltons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532717:Kilodalton [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "indicated to the left of each blot."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205091:Left [Spatial Concept]
   748   C1444656:Indicated [Finding]
   748   C1552822:left [Functional Concept]
Processing 00000000.tx.106: -Synuclein Interacts with ERK and JNK MAPKs in Cancer Cells-- -Synuclein has recently been reported to bind directly to the ERK2 kinase (28). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Interacts with ERK"

Phrase: "and"

Phrase: "JNK MAPKs in Cancer Cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0291988:JNK Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "-- -"

Phrase: "Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "directly to the ERK2 kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1150579:ERK2 [Molecular Function]
   760   C1947931:Directly [Qualitative Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.107: Therefore, we evaluated whether -synuclein could also interact with the ERK kinases as well as other MAPKs. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "whether -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "also"

Phrase: "interact with the ERK kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as well as"

Phrase: "other MAPKs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.108: By co-immunoprecipitation approaches, we were able to demonstrate a novel association of -synucleins with ERK1/2 and JNK1 kinase but not with the p38 kinase (Fig. 2). 

Phrase: "By co-immunoprecipitation approaches,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]
   734   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "demonstrate"

Phrase: "a novel association of -synucleins with ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "JNK1 kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0380051:JNK1 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "not with the p38 kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1518422:Not [Functional Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.109: We also confirmed that -synuclein is associated with ERK1/2 as well with JNK1 (Fig. 2), which is consistent with the recent studies using neuro2a, a neuronal cell line (29). 

Phrase: "We also"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "associated with ERK1/2"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "as well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "with JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "consistent with the recent studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "neuro2a,"

Phrase: "a neuronal cell line"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.110: These data indicate that - and -synuclein can interact with ERK1/2 and JNK1 in cancer cells that over-express these proteins. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that -"

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "interact with ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "JNK1 in cancer cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1367731:JNK1 [Gene or Genome]
   770   C1705632:JNK1 [Gene or Genome]

Phrase: "that"

Phrase: "over-express"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "these proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.111: View larger version (55K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(55K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.112: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.113: Interaction between - and -synucleins with ERK1/2 and JNK. 

Phrase: "Interaction between -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1704675:Interaction [Functional Concept]

Phrase: "and -"

Phrase: "synucleins with ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "JNK."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]
Processing 00000000.tx.114: Cell lysate from A2780, A2780/gam, or A2780/alpha were immunoprecipitated with Syn303, normal IgG (NIg), or irrelevant antibodies (not shown) as described under "Experimental Procedures." 

Phrase: "Cell lysate from A2780,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "A2780/gam,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0061057:gam [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "A2780/alpha"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated with Syn303,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "normal IgG (NIg),"

Phrase: "or"

Phrase: "irrelevant antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.115: The proteins in the immunoprecipitates were identified by immunoblotting with antibodies against ERK1/2, JNK1, p38, and -2 (a polyclonal antibody specific for -synuclein). 

Phrase: "The proteins in the immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "identified by immunoblotting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against ERK1/2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "JNK1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "p38,"

Phrase: "and -"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "("

Phrase: "a polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.116: Molecular mass standards (in kilodaltons) are indicated on the left. 

Phrase: "Molecular mass standards"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0038137:standards [Intellectual Product]
   827   C0175675:Standards [Qualitative Concept]
   793 E C1442989:Standard [Qualitative Concept]
   793 E C2828392:Standard [Intellectual Product]
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "("

Phrase: "in kilodaltons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532717:Kilodalton [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "indicated on the left."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C1444656:Indicated [Finding]
   770   C1552822:left [Functional Concept]
Processing 00000000.tx.117: Nonspecific bands around the IgG heavy (**) and light (*) chains are indicated by asterisks. 

Phrase: "Nonspecific bands around the IgG"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0175723:Bands [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: "heavy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439539:Heavy [Qualitative Concept]

Phrase: "("

Phrase: "*"

Phrase: "*"

Phrase: ")"

Phrase: "and"

Phrase: "light (*) chains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C0337112:chains [Manufactured Object]
   861   C1306462:Light [Functional Concept]
   861   C1524075:Chains [Idea or Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "are"

Phrase: "indicated by asterisks."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1444656:Indicated [Finding]
   790   C2945706:asterisks [Conceptual Entity]
Processing 00000000.tx.118: Elevated Activity of ERK in Cells Over-expressing -Synuclein-- We next evaluated whether these protein interactions would affect the activity of ERK1/2 and/or JNK1 (see below). 

Phrase: "Elevated Activity of ERK"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "in Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Over-expressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "-"

Phrase: "-"

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "whether"

Phrase: "these protein interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0872079:protein interaction [Molecular Function]
   827   C1704675:Interaction [Functional Concept]

Phrase: "would"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the activity of ERK1/2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "and/or"

Phrase: "JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.119: In A2780 and OVCAR5 cancer cells over-expressing -synuclein, the activated ERK1/2 was increased 2-to 3-fold as evidenced by immunoblotting with an anti-phospho-ERK specific antibody (Fig. 3). 

Phrase: "In A2780"

Phrase: "and"

Phrase: "OVCAR5 cancer cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0334227:cancer cells [Cell]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0007634:Cells [Cell]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "over-expressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the activated ERK1/2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1879547:Activated [Activity]
   793 E C1515877:Activate [Functional Concept]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "to 3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "as"

Phrase: "evidenced by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0332120:Evidence [Functional Concept]

Phrase: "with an anti-phospho-ERK specific antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.120: In contrast, - and -synucleins appeared to have little or no effect on the activity of ERK1/2 (Fig. 3A), although -synuclein was also found to be associated with ERK (as described above and shown in Fig. 2) in A2780 cells. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "-"

Phrase: "and -"

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no effect on the activity of ERK1/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 3A"

Phrase: ")"

Phrase: ","

Phrase: "although -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with ERK ("
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "as"

Phrase: "described above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "shown in Fig. 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "in A2780 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.121: In HEK293 cells, the basal level of ERK activation is undetectable and -synuclein over-expression does not increase its activation level (Fig. 3B). 

Phrase: "In HEK293 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the basal level of ERK activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "undetectable"

Phrase: "and -"

Phrase: "synuclein over-expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "its activation level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.122: Structural analysis indicated that -synuclein does not contain any kinase domain, suggesting that the activation of ERK is mediated by other kinase. 

Phrase: "Structural analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0204514:Structural analysis [Therapeutic or Preventive Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "any kinase domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the activation of ERK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "mediated by other kinase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.123: Because MEK1/2 is required for the activation of ERK1/2 in response to many mitogens, we determined whether MEK1/2 is still required for -synuclein-mediated activation of ERK1/2. 

Phrase: "Because"

Phrase: "MEK1/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1150604:MEK1 [Molecular Function]
   861   C1334474:MEK1 [Gene or Genome]
   861   C1708799:MEK1 [Gene or Genome]

Phrase: "is"

Phrase: "required for the activation of ERK1/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1514873:Required [Functional Concept]
   748   C1879547:Activation [Activity]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to many mitogens,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026249:Mitogens [Pharmacologic Substance]
   966 E C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "determined"

Phrase: "whether"

Phrase: "MEK1/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1150604:MEK1 [Molecular Function]
   861   C1334474:MEK1 [Gene or Genome]
   861   C1708799:MEK1 [Gene or Genome]

Phrase: "is"

Phrase: "still"

Phrase: "required for -synuclein-mediated activation of ERK1/2."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1514873:Required [Functional Concept]
   744   C1879547:Activation [Activity]
Processing 00000000.tx.124: When cells over-expressing -synuclein were treated with the MEK1/2 inhibitor U0126, the activation of ERK1/2 was suppressed (Fig. 4A). 

Phrase: "When"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "over-expressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "treated with the MEK1/2 inhibitor U0126,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]
   748   C1150604:MEK1 [Molecular Function]
   748   C1334474:MEK1 [Gene or Genome]
   748   C1522326:Treated [Functional Concept]
   748   C1708799:MEK1 [Gene or Genome]
   748   C1999216:Inhibitor [Qualitative Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "the activation of ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.125: We further studied the relation of -synuclein-ERK interaction and the activation status of ERK1/2. 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the relation of -synuclein-ERK interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the activation status of ERK1/2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449438:Status [Qualitative Concept]
Processing 00000000.tx.126: In cells treated with U0126 or serum-starved, the association of -synuclein and ERK1/2 was still present (Fig. 4B). 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with U0126"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "serum-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "starved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348531:Starve [Activity]

Phrase: ","

Phrase: "the association of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "still"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.127: These data indicate that -synuclein may be constitutively associated with ERK1/2, which could facilitate the activation of ERK by MEK1/2 and lead to the constitutive activation of ERK1/2 in cells over-expressing -synuclein. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "constitutively"

Phrase: "associated with ERK1/2,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "which"

Phrase: "could"

Phrase: "facilitate"

Phrase: "the activation of ERK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "by MEK1/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1150604:MEK1 [Molecular Function]
   861   C1334474:MEK1 [Gene or Genome]
   861   C1708799:MEK1 [Gene or Genome]

Phrase: "and"

Phrase: "lead to the constitutive activation of ERK1/2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C2346661:Lead 2+ [Element, Ion, or Isotope]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1879547:Activation [Activity]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "over-expressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.128: View larger version (41K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.129: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.130: Activation of ERK in cells over-expressing -synuclein. 

Phrase: "Activation of ERK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "over-expressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.131: A, ERK1/2 activation is enhanced in -synuclein over-expressing A2780 cells. 

Phrase: "A,"

Phrase: "ERK1/2 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "in -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "over-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "A2780 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.132: Whole cell lysates (40g/lane) from A2780 cells (parent) or A2780 cells transfected with -, -, or -synuclein were separated by SDS-PAGE and blotted with appropriate antibodies. 

Phrase: "Whole cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(40g/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "from A2780 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(parent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030551:parent [Family Group]
  1000   C2699423:Parent [Conceptual Entity]

Phrase: ")"

Phrase: "or"

Phrase: "A2780 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with -, -"

Phrase: ","

Phrase: "or -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "blotted with appropriate antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C1548787:Appropriate [Qualitative Concept]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.133: The levels of activated ERK or total ERK1/2 were determined using an anti-phospho-ERK specific antibody or ERK1/2 antibodies, respectively. 

Phrase: "The levels of activated ERK"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "total ERK1/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an anti-phospho-ERK specific antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "ERK1/2 antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.134: The number beneath each band represents the arbitrary densitometry units of the corresponding band (the integrated densitometry reading number of A2780 or OVCAR5 was assigned to an arbitrary unit 1.0,and the other readings were normalized thereafter). 

Phrase: "The number beneath each band"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the arbitrary densitometry units of the corresponding band"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   750   C0439183:Arbitrary unit [Quantitative Concept]
   744   C0439148:Units [Quantitative Concept]
   744   C1519795:Units [Quantitative Concept]
   711 E C1704753:Unit [Manufactured Object]
   711 E C1880519:Unit [Quantitative Concept]

Phrase: "("

Phrase: "the integrated densitometry reading number of A2780"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "or"

Phrase: "OVCAR5"

Phrase: "was"

Phrase: "assigned to an arbitrary unit 1.0,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0439183:Arbitrary unit [Quantitative Concept]
   748   C0439148:Unit [Quantitative Concept]
   748   C1264693:*Arbitrary [Quantitative Concept]
   748   C1516050:Assigned [Functional Concept]
   748   C1519795:Unit [Quantitative Concept]
   748   C1552601:assigned [Intellectual Product]
   748   C1704753:Unit [Manufactured Object]
   748   C1880519:Unit [Quantitative Concept]

Phrase: "and"

Phrase: "the other readings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0034754:Readings [Daily or Recreational Activity]
   966 E C1705179:Reading [Finding]

Phrase: "were"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "thereafter"

Phrase: ")."
Processing 00000000.tx.135: The synucleins were evaluated by blotting with specific antibodies, i.e. 

Phrase: "The synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "evaluated by blotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0220825:Evaluated [Functional Concept]

Phrase: "with specific antibodies,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.136: -2 for -synuclein, Syn207 for -synuclein, and Syn204 for -synuclein, respectively. 

Phrase: "-2 for -synuclein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0740116:+2 [Quantitative Concept]
   790   C2827735:2+ [Quantitative Concept]
   790   C2981700:2+ [Classification]

Phrase: "Syn207 for -synuclein,"

Phrase: "and"

Phrase: "Syn204 for -synuclein,"

Phrase: "respectively."
Processing 00000000.tx.137: B, activation of ERK by -synuclein in OVCAR5 cells but not HEK293 cells. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "activation of ERK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "by -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in OVCAR5 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "not HEK293 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.138: Whole cell lysate (40g/lane) from parental or -synuclein over-expressing cells were separated and blotted as in A.A and B are representative of at least three independent experiments with comparable results. 

Phrase: "Whole cell lysate"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(40g/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "from parental or -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "over-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "and"

Phrase: "blotted"

Phrase: "as in A."

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "with comparable results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.139: C, -fold increase of ERK activation. 

Phrase: "C, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "fold increase of ERK activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]
Processing 00000000.tx.140: The data shown are the averageS.E. of three independent experiments. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "the averageS.E."

Phrase: "of three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.141: Phosphorylated ERK was normalized to the protein level of total ERK. 

Phrase: "Phosphorylated ERK"

Phrase: "was"

Phrase: "normalized to the protein level of total ERK."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0428479:Protein level [Laboratory or Test Result]
   767   C0439177:Protein.total [Quantitative Concept]
   767   C0555903:Total protein [Laboratory Procedure]
   767   C1261360:total protein [Laboratory or Test Result]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C1882115:Normalized [Research Activity]
   744   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.142: The basal levels of ERK phosphorylation in the parental A2780 or OVCAR5 cells were set as 1.0.*, significant difference compared with the parental cells (p<0.05). 

Phrase: "The basal levels of ERK phosphorylation"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the parental A2780"

Phrase: "or"

Phrase: "OVCAR5 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "set as 1.0."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "*,"

Phrase: "significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "compared with the parental cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0030551:Parental [Family Group]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.143: View larger version (52K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(52K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.144: 4.  

Phrase: "4."
Processing 00000000.tx.145: Requirement of MEK1/2 for -synuclein enhanced ERK1/2 activation. 

Phrase: "Requirement of MEK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514873:Requirement [Functional Concept]

Phrase: "for -synuclein enhanced ERK1/2 activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]
Processing 00000000.tx.146: A, A2780 and A2780/gam cells untreated or treated with the MEK1/2 inhibitor, U0126 (10M), were lysed, and 30g of proteins was loaded into each lane. 

Phrase: "A,"

Phrase: "A2780"

Phrase: "and"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "or"

Phrase: "treated with the MEK1/2 inhibitor,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C1150604:MEK1 [Molecular Function]
   753   C1334474:MEK1 [Gene or Genome]
   753   C1522326:Treated [Functional Concept]
   753   C1708799:MEK1 [Gene or Genome]
   753   C1999216:Inhibitor [Qualitative Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "30g of proteins"

Phrase: "was"

Phrase: "loaded into each lane."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1708639:Lane [Spatial Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.147: As in Fig. 

Phrase: "As in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.148: 3, anti-phospho-ERK1/2-specific antibody was used to detect activated ERK1/2; 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "anti-phospho-ERK1/2-specific antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "activated ERK1/2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1879547:Activated [Activity]
   793 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.149: the antibody against ERK1/2 was used to detect the protein level of total ERK1/2. 

Phrase: "the antibody against ERK1/2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the protein level of total ERK1/2."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0428479:Protein level [Laboratory or Test Result]
   774   C0439177:Protein.total [Quantitative Concept]
   774   C0456948:Level 2 [Intellectual Product]
   774   C0555903:Total protein [Laboratory Procedure]
   774   C1261360:total protein [Laboratory or Test Result]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.150: B, the interaction between ERK and -synuclein is independent of the activation status of ERK1/2. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the interaction between ERK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is independent of the activation status of ERK1/2."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0332291:Independent of [Functional Concept]
   742   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0085862:Independent [Idea or Concept]
   742   C0449438:Status [Qualitative Concept]
   742   C1299583:Independent [Finding]
   742   C1879547:Activation [Activity]
Processing 00000000.tx.151: A2780/gam cells in normal 10% FBS medium, 10% FBS medium with U0126 (10M), or serum-free medium were lysed and immunoprecipitated with Syn303 or control IgG. 

Phrase: "A2780/gam cells in normal 10% FBS medium,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   750   C0007634:Normal cell [Cell]
           Cells
   750   C1268443:Normal cell [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "10% FBS medium with U0126"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "serum-free medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0009458:Medium [Intellectual Product]
   827   C0229671:Serum [Body Substance]
   827   C0332296:free [Functional Concept]
   827   C0439536:Medium [Quantitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1705217:Medium [Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   827   C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "immunoprecipitated with Syn303"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "or"

Phrase: "control IgG."
Processing 00000000.tx.152: The proteins in the immunoprecipitates were detected with the antibodies against ERK1/2 or against human -synuclein (-2). 

Phrase: "The proteins in the immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "detected with the antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or against human -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086418:Human [Human]
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.153: The autoradiogram shown is representative of three independent experiments with comparable results. 

Phrase: "The autoradiogram"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "is"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with comparable results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.154: Down-regulation of JNK Activation by -Synuclein in Response to Different Stress Signals-- JNK is activated by stress signals, including UV, which leads to mitochondria-mediated apoptosis (30). 

Phrase: "Down-regulation of JNK Activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0013081:Down-Regulation [Cell Function,Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "by -Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in Response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to Different Stress Signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "--"

Phrase: "JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "is"

Phrase: "activated by stress signals,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0038435:Stress [Finding]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "UV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041625:UV [Natural Phenomenon or Process]
  1000   C1961129:uV [Quantitative Concept]

Phrase: "which"

Phrase: "leads to mitochondria-mediated apoptosis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0026237:Mitochondria [Cell Component]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0162638:Apoptosis [Cell Function]
   760   C0181586:leads [Medical Device]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.155: The basal level of JNK activity in A2780 and OVCAR5 ovarian cancer cells is very low in untreated cells whether -synuclein was over-expressed or not (Fig. 5). 

Phrase: "The basal level of JNK activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0683317:Activity level [Finding]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "in A2780"

Phrase: "and"

Phrase: "OVCAR5 ovarian cancer cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0334227:cancer cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "very low in untreated cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0442811:Very low [Finding]
   760   C0205251:low [Qualitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]

Phrase: "whether -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "over-expressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "or"

Phrase: "not (Fig. 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]
   827   C1518422:Not [Functional Concept]

Phrase: ")."
Processing 00000000.tx.156: JNK was highly activated in the parental cells when treated with UV (Fig. 5). 

Phrase: "JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "was"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "activated in the parental cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0030551:Parental [Family Group]
   760   C1879547:Activated [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1515877:Activate [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "when"

Phrase: "treated with UV (Fig. 5"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0041625:UV [Natural Phenomenon or Process]
   760   C0349966:Fig [Food]
   760   C1337208:FIG [Food]
   760   C1522326:Treated [Functional Concept]
   760   C1961129:uV [Quantitative Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: ")."
Processing 00000000.tx.157: In cells over-expressing -synuclein, the activation of JNK was almost completely blocked in A2780/gam cells (p<0.05) and was down-regulated by ~50% in OVCAR5/gam cells when treated with UV (Fig. 5) or heat-shock (data not shown). 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "over-expressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "almost completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205197:Completely [Qualitative Concept]

Phrase: "blocked in A2780/gam cells"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0028778:Blocked [Pathologic Function]
   760   C0061057:gam [Amino Acid, Peptide, or Protein]
   760   C0332206:Blocked [Functional Concept]
   760   C2983591:BLOCKED [Research Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1533157:Block [Substance]
   726 E C1704653:Cell [Medical Device]
   726 E C1706084:Block [Geographic Area]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "(p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "down-regulated by ~50%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]

Phrase: "in OVCAR5/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "when"

Phrase: "treated with UV (Fig. 5"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0041625:UV [Natural Phenomenon or Process]
   760   C0349966:Fig [Food]
   760   C1337208:FIG [Food]
   760   C1522326:Treated [Functional Concept]
   760   C1961129:uV [Quantitative Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "heat-shock"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282498:Heat Shock [Physiologic Function]
   861   C0018837:Heat [Natural Phenomenon or Process]
   861   C0036974:Shock [Pathologic Function]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.158: The blockage of JNK activation by UV appears to be -synuclein-specific, because over-expression of - and -synucleins appeared to have little or no effect on the activation of JNK by UV (Fig. 5 and data not shown). 

Phrase: "The blockage of JNK activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1706968:Blockage [Finding]
   760   C1879887:Blockage [Phenomenon or Process]

Phrase: "by UV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041625:UV [Natural Phenomenon or Process]
  1000   C1961129:uV [Quantitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be -"

Phrase: "synuclein-specific,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205369:Specific [Qualitative Concept]
   861   C1552740:specific [Intellectual Product]

Phrase: "because"

Phrase: "over-expression of -"

Phrase: "and -"

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no effect on the activation of JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "by UV (Fig. 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041625:UV [Natural Phenomenon or Process]
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]
   827   C1961129:uV [Quantitative Concept]

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.159: The inhibition of JNK activation in OVCAR5/gam cells is much less than that in A2780/gam cells. 

Phrase: "The inhibition of JNK activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "in OVCAR5/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "much less than that"

Phrase: "in A2780/gam cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.160: The cause of this difference could either be cell-type specific or it could be the high endogenous -synuclein expression in OVCAR5 cells. 

Phrase: "The cause of this difference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015127:cause [Functional Concept]
   760   C1524003:Cause [Conceptual Entity]

Phrase: "could"

Phrase: "either"

Phrase: "be"

Phrase: "cell-type specific"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0007634:Cell Type [Cell]
           Cell
   901   C0449475:cell type [Intellectual Product]
   827   C0205369:Specific [Qualitative Concept]
   827   C0332307:Type [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1547052:*Type [Quantitative Concept]
   827   C1552740:specific [Intellectual Product]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "it"

Phrase: "could"

Phrase: "be"

Phrase: "the high endogenous -synuclein expression in OVCAR5 cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.161: Similarly, the activation of JNK by sodium arsenate was blocked to different extents by -synuclein in 293/gam, OVCAR5/gam, and A2780/gam cells (Fig. 6). 

Phrase: "Similarly,"

Phrase: "the activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "by sodium arsenate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0074718:sodium arsenate [Inorganic Chemical,Pharmacologic Substance]
   861   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0104238:arsenate [Inorganic Chemical,Pharmacologic Substance]
   861   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "blocked to different extents"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C0439792:Extents [Spatial Concept]
   770   C1705242:Different [Qualitative Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "by -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in 293/gam,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0061057:gam [Amino Acid, Peptide, or Protein]

Phrase: "OVCAR5/gam,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0061057:gam [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.162: Collectively, these data indicate that stress-induced activation of JNK can be blocked by -synuclein over-expression in a variety of cell lines. 

Phrase: "Collectively,"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that stress-induced activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "can"

Phrase: "be"

Phrase: "blocked by -synuclein over-expression"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0028778:Blocked [Pathologic Function]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0332206:Blocked [Functional Concept]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "in a variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883525:Variety [Conceptual Entity]
  1000   C2346866:Variety [Conceptual Entity]

Phrase: "of cell lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.163: View larger version (52K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(52K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.164: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.165: Inhibition of JNK activation by -synuclein in response to UV treatment. 

Phrase: "Inhibition of JNK activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to UV treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.166: A2780, A2780/gam, A2780/beta, OVCAR5, and OVCAR5/gam cells were un-treated or treated with UV (20J/M2), and cells were lysed at 30min. 

Phrase: "A2780,"

Phrase: "A2780/gam,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0061057:gam [Amino Acid, Peptide, or Protein]

Phrase: "A2780/beta,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "OVCAR5,"

Phrase: "and"

Phrase: "OVCAR5/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "un-treated"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0041701:UN [Organization]
   861   C0332293:treated [Therapeutic or Preventive Procedure]
   861   C1522326:Treated [Functional Concept]
   861   C1704620:UN [Organism Attribute]
   827 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "treated with UV (20J/M2"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0041625:UV [Natural Phenomenon or Process]
   760   C0457242:m2 [Quantitative Concept]
   760   C1522326:Treated [Functional Concept]
   760   C1961129:uV [Quantitative Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed at 30min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0024348:lysed [Pathologic Function]
Processing 00000000.tx.167: JNK activities were analyzed by an immunocomplex kinase assay using GST-c-JUN as substrate. 

Phrase: "JNK activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "analyzed by an immunocomplex kinase assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0243073:assay [Qualitative Concept]
   753   C0936012:Analyzed [Research Activity]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GST-c-JUN as substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.168: The phosphorylated GST-c-JUN by activated JNK was evaluated by immunoblotting with anti-phospho-c-JUN specific antibody (see "Experimental Procedures" for details). 

Phrase: "The phosphorylated GST-c-JUN by activated JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "evaluated by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0220825:Evaluated [Functional Concept]

Phrase: "with anti-phospho-c-JUN specific antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   898   C0051967:anti-c antibody [Immunologic Factor]
   895   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: "for details"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Details [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: ")."
Processing 00000000.tx.169: The protein levels of JNK and -synuclein were determined by immunoblotting with anti-JNK and -2 antibody, respectively. 

Phrase: "The protein levels of JNK"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0428479:Protein level [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "determined by immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "with anti-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1150587:JNK [Molecular Function]
   861   C1367731:JNK [Gene or Genome]
   861   C1705632:JNK [Gene or Genome]

Phrase: "and -"

Phrase: "2 antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.170: The number beneath each band represents the arbitrary densitometry units of the corresponding band. 

Phrase: "The number beneath each band"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the arbitrary densitometry units of the corresponding band."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   750   C0439183:Arbitrary unit [Quantitative Concept]
   744   C0439148:Units [Quantitative Concept]
   744   C1519795:Units [Quantitative Concept]
   711 E C1704753:Unit [Manufactured Object]
   711 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.171: The blots shown here are representative of three independent experiments with comparable results. 

Phrase: "The blots"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with comparable results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.172: JNK activities were measured by levels of phosphorylated c-JUN and normalized to levels of total JNK proteins. 

Phrase: "JNK activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "measured by levels of phosphorylated c-JUN"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   748   C0441889:Levels [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "normalized to levels of total JNK proteins."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   757   C0439177:Protein.total [Quantitative Concept]
   757   C0555903:Total protein [Laboratory Procedure]
   757   C1261360:total protein [Laboratory or Test Result]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1150587:JNK [Molecular Function]
   748   C1367731:JNK [Gene or Genome]
   748   C1705632:JNK [Gene or Genome]
   748   C1882115:Normalized [Research Activity]
   741   C0428479:Protein level [Laboratory or Test Result]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.173: The graph above the blots is the averageS.E. of three independent experiments. 

Phrase: "The graph above the blots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0681493:Graph [Intellectual Product]
   760   C2698021:Graph [Conceptual Entity]

Phrase: "is"

Phrase: "the averageS.E."

Phrase: "of three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.174: *, significant inhibition of JNK activation compared with that in the parental cells (p<0.05). 

Phrase: "*,"

Phrase: "significant inhibition of JNK activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in the parental cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.175: View larger version (25K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.176: 6.  

Phrase: "6."
Processing 00000000.tx.177: JNK activation is down-regulated by over-expression of -synuclein in response to sodium arsenate. 

Phrase: "JNK activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "down-regulated by over-expression of -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to sodium arsenate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0074718:sodium arsenate [Inorganic Chemical,Pharmacologic Substance]
   861   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0104238:arsenate [Inorganic Chemical,Pharmacologic Substance]
   861   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.178: HEK293, OVCAR5, and A2780 cells and their -synuclein over-expressing counterparts were treated with sodium arsenite (50M) for 6h. 

Phrase: "HEK293,"

Phrase: "OVCAR5,"

Phrase: "and"

Phrase: "A2780 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "their -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "over-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "counterparts"

Phrase: "were"

Phrase: "treated with sodium arsenite"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0074719:sodium arsenite [Inorganic Chemical,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   770   C0052418:arsenite [Inorganic Chemical,Pharmacologic Substance]
   770   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(50M"

Phrase: ")"

Phrase: "for 6h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292428:6H [Temporal Concept]
Processing 00000000.tx.179: Cells were lysed, and the extracts were assayed for JNK activity as described in the legends for Fig. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "the extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "assayed for JNK activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1150587:JNK [Molecular Function]
   770   C1367731:JNK [Gene or Genome]
   770   C1561536:*Activity [Idea or Concept]
   770   C1705632:JNK [Gene or Genome]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "described in the legends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   737   C2729544:Legend [Pharmacologic Substance]

Phrase: "for Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.180: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.181: The number beneath each band represents the arbitrary densitometry units of the corresponding band. 

Phrase: "The number beneath each band"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the arbitrary densitometry units of the corresponding band."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   750   C0439183:Arbitrary unit [Quantitative Concept]
   744   C0439148:Units [Quantitative Concept]
   744   C1519795:Units [Quantitative Concept]
   711 E C1704753:Unit [Manufactured Object]
   711 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.182: The blots shown here are representative of three independent experiments with comparable results. 

Phrase: "The blots"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with comparable results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.183: -Synuclein May Protect Paclitaxel (Taxol)-induced Cell Death by Regulating JNK and ERK Activities-- Based on the data presented above, we hypothesized that -synuclein may contribute to cancer cell survival by up-regulating the ERK cell survival pathway and by suppressing the JNK apoptosis pathway under adverse conditions. 

Phrase: "-Synuclein May"

Phrase: "Protect"

Phrase: "Paclitaxel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0144576:Paclitaxel [Organic Chemical,Pharmacologic Substance]

Phrase: "(Taxol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: ")-"

Phrase: "induced Cell Death by"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0007587:Cell Death [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0011065:Death [Organism Function]
   770   C1269647:Cell [Cell]
   770   C1306577:Death, NOS [Finding]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "Regulating"

Phrase: "JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "and"

Phrase: "ERK Activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "-"

Phrase: "-"

Phrase: "Based on the data"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   802   C0242356:data base [Intellectual Product]
   802   C0993637:Data Base [Intellectual Product]
   770   C1511726:Data [Idea or Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C3245479:data [Medical Device]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "above,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "contribute to cancer cell survival"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0007620:Cell Survival [Cell Function]
   806   C0334227:Cancer Cell [Cell]
   760   C0006826:Cancer [Neoplastic Process]
   760   C0007634:Cell [Cell]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
   760   C0998265:Cancer [Eukaryote]
   760   C1269647:Cell [Cell]
   760   C1306459:Cancer [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1880177:Contribute [Activity]
   760   C1948049:Cell [Spatial Concept]

Phrase: "by"

Phrase: "up-regulating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "the ERK cell survival pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C3179234:ERK Pathway [Cell Function,Molecular Function]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]

Phrase: "and by suppressing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1260953:suppressing [Functional Concept]
   790   C1515981:And [Idea or Concept]
   790   C2003921:Suppressing [Phenomenon or Process]

Phrase: "the JNK apoptosis pathway under adverse conditions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0162638:Apoptosis Pathway [Cell Function]
   774   C1621396:JNK Pathway [Molecular Function]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.184: However, when we treated -synuclein over-expressing cells with UV, significant differences in cell survival between A2780 and A2780/gam cells were not observed (data not shown). 

Phrase: "However,"

Phrase: "when"

Phrase: "we"

Phrase: "treated -"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "over-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "cells with UV,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "significant differences in cell survival between A2780"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0007620:Cell Survival [Cell Function]
   748   C0038952:Survival [Activity]
   748   C0220921:survival [Functional Concept]

Phrase: "and"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.185: The reason for this lack of difference is not readily apparent. 

Phrase: "The reason for this lack of difference"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392360:Reason [Idea or Concept]

Phrase: "is"

Phrase: "not readily apparent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.186: However, cell survival and cell death are regulated by the counterbalance between the survival factors and the apoptotic signaling pathways. 

Phrase: "However,"

Phrase: "cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "regulated by the counterbalance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1707527:Counterbalance [Manufactured Object]

Phrase: "between the survival factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "the apoptotic signaling pathways."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   988   C3269135:apoptotic signaling pathway [Cell Function]
   884   C0037080:Signal Pathways [Molecular Function]
   884   C0037083:signaling pathway [Cell Function]
   884   C0086982:Signaling Pathway [Molecular Function]
   861   C0162638:Apoptosis Pathway [Cell Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.187: Because UV treatment also activates the cell survival pathways ERK (Ref. 31 and data not shown) and PI3K-AKT (32, 33), the initiation of the mitochondria-associated caspase pathway may be blocked by the activation of ERK or AKT in A2780 cells. 

Phrase: "Because"

Phrase: "UV treatment also"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the cell survival pathways ERK (Ref. 31"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   827   C0007620:Cell Survival [Cell Function]
   799   C0007634:Cell [Cell]
   799   C0038952:Survival [Activity]
   799   C0220921:survival [Functional Concept]
   799   C0450355:31 [Intellectual Product]
   799   C1269647:Cell [Cell]
   799   C1425988:REF [Gene or Genome]
   799   C1704259:Pathways [Molecular Function]
   799   C1704653:Cell [Medical Device]
   799   C1705987:Pathways [Conceptual Entity]
   799   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "PI3K-AKT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "(32,"

Phrase: "33"

Phrase: ")"

Phrase: ","

Phrase: "the initiation of the mitochondria-associated caspase pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0589507:Initiation [Mental Process]
   744   C1158830:Initiation [Genetic Function]
   744   C1704686:Initiation [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "blocked by the activation of ERK"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0028778:Blocked [Pathologic Function]
   753   C0332206:Blocked [Functional Concept]
   753   C1879547:Activation [Activity]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "or"

Phrase: "AKT in A2780 cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0812228:AKT [Gene or Genome]
Processing 00000000.tx.188: In support of these findings we did not observe the cleavage of the caspase-3 substrate PARP in A2780 cells when treated with UV (data not shown). 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "the cleavage of the caspase-3 substrate PARP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "in A2780 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "when"

Phrase: "treated with UV (data"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0041625:UV [Natural Phenomenon or Process]
   770   C1511726:Data [Idea or Concept]
   770   C1522326:Treated [Functional Concept]
   770   C1961129:uV [Quantitative Concept]
   770   C3245479:data [Medical Device]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.189: We next evaluated the survival of -synuclein over-expressing cells in response to Taxol, a commonly used chemotherapeutic drug. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the survival of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "over-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "cells in response"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "to Taxol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "a commonly"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "chemotherapeutic drug."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C1254351:Drug [Pharmacologic Substance]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.190: In addition to its role in affecting microtubule assembly, Taxol is known to lead to apoptosis via the mitochondria by activating the JNK signaling pathway and Taxol-induced apoptosis can be enhanced by MEK inhibition (34-36). 

Phrase: "In addition to its role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "in affecting microtubule assembly,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "Taxol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lead to apoptosis"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0162638:Apoptosis [Cell Function]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "via the mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "by activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "the JNK signaling pathway"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1621396:JNK Signaling Pathway [Molecular Function]
           JNK Pathway
   901   C0037083:signaling pathway [Cell Function]
   901   C0086982:Signaling Pathway [Molecular Function]
   884 E C0037080:Signal Pathway [Molecular Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "Taxol-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "enhanced by MEK inhibition"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C0752313:mek [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C2349975:Enhanced [Activity]
   770   C3463820:Inhibition [Activity]

Phrase: "(34-36"

Phrase: ")."
Processing 00000000.tx.191: In A2780 cells, Taxol did not affect the basal level activity of ERK or the activation of ERK by -synuclein (Fig. 7A). 

Phrase: "In A2780 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Taxol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the basal level activity of ERK"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0683317:level activity [Finding]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "or"

Phrase: "the activation of ERK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "by -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.192: To test the effect of -synuclein on cell survival, cells were treated with Taxol for varying lengths of time. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the effect of -synuclein on cell survival,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with Taxol"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "for varying lengths"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C1444754:Lengths [Quantitative Concept]
   827 E C1706316:LENGTH [Research Activity]
   777 E C0205166:Long [Qualitative Concept]
   777 E C1522425:Longest [Qualitative Concept]
   777 E C1706317:Long [Qualitative Concept]

Phrase: "of time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.193: At 48h after treatment, 45-60% of A2780 cells had died, whereas only about 7-15% of A2780/gam cells were dead indicating that Taxol-induced cell death can be rescued by -synuclein over-expression (Fig. 7B). 

Phrase: "At 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "after treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "45-60% of A2780 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "died"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0011065:Died [Organism Function]
  1000   C1546956:Died [Finding]
   928 E C0231800:Expired [Organ or Tissue Function]
   928 E C1704631:Expire [Idea or Concept]
   907 E C0184532:dying [Organism Function]
   907 E C1553404:terminated [Idea or Concept]
   907 E C2348570:Terminated [Functional Concept]

Phrase: ","

Phrase: "whereas"

Phrase: "only about 7-15% of A2780/gam cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0007634:Cells [Cell]
   744   C0061057:gam [Amino Acid, Peptide, or Protein]
   744   C0205171:Only [Quantitative Concept]
   744   C1720467:Only [Intellectual Product]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "dead"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011065:Dead [Organism Function]

Phrase: "indicating"

Phrase: "that Taxol-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "rescued by -synuclein over-expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.194: When ERK activation was inhibited using the MEK1/2 inhibitor U0126, the cell death was reduced by ~25% in A2780 cells but was nearly doubled in A2780/gam cells (Fig. 7B). 

Phrase: "When"

Phrase: "ERK activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the MEK1/2 inhibitor U0126,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "the cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "reduced by ~25%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "in A2780 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "was"

Phrase: "nearly"

Phrase: "doubled in A2780/gam cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0061057:gam [Amino Acid, Peptide, or Protein]
   760   C0205173:doubled [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1705764:Double [Activity]
   726 E C1705765:Double [Qualitative Concept]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.195: These data suggest that enhanced cell survival in -synuclein over-expressing cells is partially mediated by activation of ERK. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that enhanced cell survival in -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "over-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "partially"

Phrase: "mediated by activation of ERK."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C1879547:Activation [Activity]
Processing 00000000.tx.196: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.197: 7.  

Phrase: "7."
Processing 00000000.tx.198: -Synuclein protects cells from paclitaxel (Taxol)-induced cell death and is partially mediated by ERK activation. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protects"

Phrase: "cells from paclitaxel"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "(Taxol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: ")-"

Phrase: "induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "is"

Phrase: "partially"

Phrase: "mediated by ERK activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C1879547:Activation [Activity]
Processing 00000000.tx.199: A, Taxol does not affect ERK activity or -synuclein-mediated ERK activation. 

Phrase: "A,"

Phrase: "Taxol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "ERK activity or -synuclein-mediated ERK activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1879547:Activation [Activity]
Processing 00000000.tx.200: A2780 or A2780/gam cells pre-treated with or without U0126 (10M) were treated with Taxol (30M) in the absence or presence of U0126 for 30min. 

Phrase: "A2780"

Phrase: "or"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "pre-treated with"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0332152:Pre [Temporal Concept]
   790   C0740175:Pre [Qualitative Concept]
   790   C1522326:Treated [Functional Concept]
   790   C2257086:PRE [Genetic Function]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "or without U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "were"

Phrase: "treated with Taxol"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(30M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1442458:30M [Temporal Concept]
  1000   C1552109:30m [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of U0126"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "for 30min."
Processing 00000000.tx.201: Whole cell lysate were separated by SDS-PAGE and blotted with phospho-ERK to determine the level of active ERK, or with ERK1/2 antibodies for the level of total ERK1/2. 

Phrase: "Whole cell lysate"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "blotted with phospho-ERK to"

Phrase: "determine"

Phrase: "the level of active ERK,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "or with ERK1/2 antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of total ERK1/2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
Processing 00000000.tx.202: The number beneath each band represents the arbitrary densitometry units of the corresponding band. 

Phrase: "The number beneath each band"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the arbitrary densitometry units of the corresponding band."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   750   C0439183:Arbitrary unit [Quantitative Concept]
   744   C0439148:Units [Quantitative Concept]
   744   C1519795:Units [Quantitative Concept]
   711 E C1704753:Unit [Manufactured Object]
   711 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.203: The blots shown here are representative of three independent experiments with comparable results. 

Phrase: "The blots"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with comparable results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.204: B, cell death induced by Taxol was significantly reduced in cells over-expressing -synuclein. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "induced by Taxol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induced [Functional Concept]
   790   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0392756:Reduced [Qualitative Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "over-expressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.205: A2780 and A2780/gam cells treated with Taxol for 48h in the presence or absence of the MEK1/2 inhibitor, U0126. 

Phrase: "A2780"

Phrase: "and"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with Taxol"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "for 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of the MEK1/2 inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "U0126."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.206: Cell death was determined by trypan blue staining (shown) and WST-1 assays (not shown). 

Phrase: "Cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined by trypan blue staining"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1260957:Blue [Qualitative Concept]
   760   C1565627:Trypan [Organic Chemical]
   760   C1704680:Staining [Finding]

Phrase: "("

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "WST-1 assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.207: The graph represents the averageS.E. of three independent experiments. 

Phrase: "The graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the averageS.E."

Phrase: "of three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.208: *, significant difference in cell death between A2780 and A2780/gam cells (p<0.05). 

Phrase: "*,"

Phrase: "significant difference in cell death between A2780"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0007587:Cell Death [Cell Function]
   748   C0011065:Death [Organism Function]
   748   C1306577:Death, NOS [Finding]

Phrase: "and"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.209: To determine whether the protective role of -synuclein on cell survival is also mediated through down-regulating JNK-associated apoptotic pathway(s), caspase-3 activity was monitored at different time points after Taxol treatment. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the protective role of -synuclein on cell survival"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "also"

Phrase: "mediated through"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0086597:mediated [Social Behavior]
   833   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "down-regulating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "JNK-associated apoptotic pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1621396:JNK Pathway [Molecular Function]
   825   C0162638:Apoptosis Pathway [Cell Function]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]

Phrase: "("

Phrase: "s)"

Phrase: ","

Phrase: "caspase-3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "monitored at different time points"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   773   C2348792:Time Point [Temporal Concept]
   762   C1442103:Time Difference [Temporal Concept]
   762   C1547049:*Time Difference [Quantitative Concept]
   760   C0040223:Time [Temporal Concept]
   760   C1705242:Different [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726   C1521743:Monitor [Professional or Occupational Group]
   726   C1552961:Point [Quantitative Concept]
   726   C1704646:Monitor [Manufactured Object]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "after Taxol treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.210: Consistent with the data in other ovarian and breast cancer cell lines (34, 36), JNK was activated in A2780 cells when treated with 30M Taxol. 

Phrase: "Consistent with the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in other ovarian"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205065:Ovarian [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "breast cancer cell lines"
Meta Candidates (Total=23; Excluded=7; Pruned=0; Remaining=16)
   923   C1512505:Breast Cancer Cell [Cell]
   861   C0006142:Breast Cancer [Neoplastic Process]
   861   C0007600:Cell lines [Cell]
   861   C0334227:Cancer Cell [Cell]
   861   C0678222:Breast Cancer [Neoplastic Process]
   858   C0230087:Mammary line [Body Location or Region]
   812   C0006141:Breast [Body Part, Organ, or Organ Component]
   812   C0006826:Cancer [Neoplastic Process]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C0998265:Cancer [Eukaryote]
   812   C1268990:Breast [Body Part, Organ, or Organ Component]
   812   C1269647:Cell [Cell]
   812   C1306459:Cancer [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   811 E C0153661:thoracic cancer [Neoplastic Process]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
   756 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   756 E C1521735:Pectoral [Qualitative Concept]
   729 E C0817096:Chest [Body Location or Region]
   729 E C1527391:Chest [Body Location or Region]

Phrase: "(34,"

Phrase: "36"

Phrase: ")"

Phrase: ","

Phrase: "JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "was"

Phrase: "activated in A2780 cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1879547:Activated [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1515877:Activate [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "when"

Phrase: "treated with 30M Taxol."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]
   770   C1442458:30M [Temporal Concept]
   770   C1522326:Treated [Functional Concept]
   770   C1552109:30m [Body Part, Organ, or Organ Component]
   737 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.211: The caspase-3 substrate PARP was found cleaved in cells treated with Taxol (data not shown). 

Phrase: "The caspase-3 substrate PARP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1538577:PARP [Gene or Genome]
   812   C1709384:PARP [Gene or Genome]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "cleaved in cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   841   C0333853:Cleaved cell [Cell]
           Cleaved
   790   C0007634:Cells [Cell]
   790   C0205242:Cleaved [Spatial Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "treated with Taxol"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.212: In A2780/gam cells, the activity of JNK was significantly inhibited following treatment with Taxol (p<0.05) (Fig. 8A). 

Phrase: "In A2780/gam cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "the activity of JNK"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment with Taxol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "(p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.213: In the parental A2780 cells, caspase-3 was highly activated following drug treatment. 

Phrase: "In the parental A2780 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "drug treatment."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1254351:Drug [Pharmacologic Substance]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.214: By contrast, the activation of caspase-3 by Taxol treatment was significantly reduced in -synuclein over-expressing ovarian cancer cells (p<0.05) (Fig. 8B). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the activation of caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1159825:Caspase Activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "by Taxol treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "in -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "over-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "ovarian cancer cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0334227:cancer cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0029925:ovarian cancer [Neoplastic Process]
   734   C1140680:Ovarian Cancer [Neoplastic Process]

Phrase: "(p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.215: These data indicate that the Taxol-activated JNK-mediated caspase apoptotic pathway was significantly attenuated in cells over-expressing -synuclein. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the Taxol-activated JNK-mediated caspase apoptotic pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1621396:JNK Pathway [Molecular Function]
   795   C1704259:Pathway [Molecular Function]
   795   C1705987:Pathway [Conceptual Entity]
   782   C0162638:Apoptosis Pathway [Cell Function]

Phrase: "was"

Phrase: "significantly"

Phrase: "attenuated in cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0332161:Attenuated [Qualitative Concept]
   790   C0599946:Attenuated [Activity]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "over-expressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.216: Taken together, our results indicate that the cell death in ovarian cancer cells induced by Taxol may be protected by -synuclein and that this may be mediated by regulating the JNK and ERK signaling pathways. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the cell death in ovarian cancer cells"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0007587:Cell Death [Cell Function]
           cells death
   778   C0007634:THE CELL [Cell]
           Cell
   748   C0011065:Death [Organism Function]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   732   C0334227:cancers cell [Cell]

Phrase: "induced by Taxol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induced [Functional Concept]
   790   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "protected by -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "that"

Phrase: "this"

Phrase: "may"

Phrase: "be"

Phrase: "mediated by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0086597:mediated [Social Behavior]
   833   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "regulating"

Phrase: "the JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "and"

Phrase: "ERK signaling pathways."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C3179234:Pathways, ERK [Cell Function,Molecular Function]
   884   C0037080:Signal Pathways [Molecular Function]
   884   C0037083:signaling pathway [Cell Function]
   884   C0086982:Signaling Pathway [Molecular Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.217: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.218: 8.  

Phrase: "8."
Processing 00000000.tx.219: Taxol-activated JNK and caspase-3 apoptotic pathway is blocked by -synuclein. 

Phrase: "Taxol-activated JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1150587:JNK [Molecular Function]
   827   C1367731:JNK [Gene or Genome]
   827   C1705632:JNK [Gene or Genome]

Phrase: "and"

Phrase: "caspase-3 apoptotic pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   825   C0162638:Apoptosis Pathway [Cell Function]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "blocked by -synuclein."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0028778:Blocked [Pathologic Function]
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.220: A, down-regulation of JNK activation by Taxol in cells over-expressing -synuclein. 

Phrase: "A,"

Phrase: "down-regulation of JNK activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0013081:Down-Regulation [Cell Function,Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "by Taxol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "over-expressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.221: Cell lysates from A2780 and A2780/gam cells treated with or without Taxol (30M) for 60min were assayed for JNK activity (see the legend for Fig. 5 for experimental details). 

Phrase: "Cell lysates from A2780"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "and"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "or without Taxol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "(30M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1442458:30M [Temporal Concept]
  1000   C1552109:30m [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "for 60min"

Phrase: "were"

Phrase: "assayed for JNK activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1150587:JNK [Molecular Function]
   770   C1367731:JNK [Gene or Genome]
   770   C1561536:*Activity [Idea or Concept]
   770   C1705632:JNK [Gene or Genome]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "the legend for Fig. 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2729544:Legend [Pharmacologic Substance]

Phrase: "for experimental details"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1522508:Details [Qualitative Concept]
   827 E C1561567:detail [Functional Concept]

Phrase: ")."
Processing 00000000.tx.222: The number beneath each band represents the arbitrary densitometry units of the corresponding band. 

Phrase: "The number beneath each band"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the arbitrary densitometry units of the corresponding band."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   750   C0439183:Arbitrary unit [Quantitative Concept]
   744   C0439148:Units [Quantitative Concept]
   744   C1519795:Units [Quantitative Concept]
   711 E C1704753:Unit [Manufactured Object]
   711 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.223: The blots shown here are representative of three independent experiments with comparable results. 

Phrase: "The blots"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with comparable results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.224: JNK activities were measured by levels of phosphorylated c-JUN and normalized to levels of total JNK proteins. 

Phrase: "JNK activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "measured by levels of phosphorylated c-JUN"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   748   C0441889:Levels [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "normalized to levels of total JNK proteins."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   757   C0439177:Protein.total [Quantitative Concept]
   757   C0555903:Total protein [Laboratory Procedure]
   757   C1261360:total protein [Laboratory or Test Result]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1150587:JNK [Molecular Function]
   748   C1367731:JNK [Gene or Genome]
   748   C1705632:JNK [Gene or Genome]
   748   C1882115:Normalized [Research Activity]
   741   C0428479:Protein level [Laboratory or Test Result]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.225: The graph above the blots is the averageS.E. of three independent experiments. 

Phrase: "The graph above the blots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0681493:Graph [Intellectual Product]
   760   C2698021:Graph [Conceptual Entity]

Phrase: "is"

Phrase: "the averageS.E."

Phrase: "of three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.226: B, down-regulation of caspase-3 activity activated by Taxol in A2780/gam cells. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "down-regulation of caspase-3 activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C3272110:down-regulation of caspase activity [Molecular Function]
   864   C1752742:regulation of caspase activity [Molecular Function]
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "activated by Taxol"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "in A2780/gam cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.227: A2780 and A2780/gam cells treated with Taxol (30M) for different time lengths were lysed, and ~20 g of protein were incubated with the caspase-3 substrate Ac-DEVD-pNA for 4h at 37C. 

Phrase: "A2780"

Phrase: "and"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with Taxol"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(30M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1442458:30M [Temporal Concept]
  1000   C1552109:30m [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "for different time lengths"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C1444754:Lengths [Quantitative Concept]
   793 E C1706316:LENGTH [Research Activity]
   743 E C0205166:Long [Qualitative Concept]
   743 E C1522425:Longest [Qualitative Concept]
   743 E C1706317:Long [Qualitative Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and ~"

Phrase: "20 g of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0060916:protein g [Amino Acid, Peptide, or Protein]
   819   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with the caspase-3 substrate Ac-DEVD-pNA"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0967499:Ac-DEVD-pNA [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   764   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1259541:DEVD-pNA [Amino Acid, Peptide, or Protein]
   742   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0600500:PNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C1412573:AC [Gene or Genome]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C1710236:Substrate [Manufactured Object]
   742   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   742   C3539770:AC [Gene or Genome]

Phrase: "for 4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.228: Cleavage of the substrate to release pNA was monitored at 405nm using a microplate reader. 

Phrase: "Cleavage of the substrate to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "pNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600500:PNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "monitored at 405nm"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a microplate reader."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0182258:Microplate Reader [Medical Device]
   861   C1514743:Reader [Professional or Occupational Group]
   861   C1706461:Reader [Manufactured Object]
Processing 00000000.tx.229: The graph represents the averageS.E. of three independent experiments. 

Phrase: "The graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the averageS.E."

Phrase: "of three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.230: In A and B, the asterisk represents significant difference compared with that in the parental cells (p<0.05). 

Phrase: "In A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in the parental cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.231: -Synuclein Overexpression Leads to Protection from Vinblastine but Not Etoposide-induced Cell Death-- To demonstrate whether the effects of -synuclein on cell survival were specific to Taxol or were a general mechanism of drug resistance, we evaluated two additional chemotherapeutic agents, i.e. vinblastine and etoposide. 

Phrase: "-Synuclein Overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "Leads to Protection"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C1545588:Protection [Finding]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "from Vinblastine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "but"

Phrase: "Not Etoposide-induced Cell Death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0007587:Cell Death [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0011065:Death [Organism Function]
   804   C1269647:Cell [Cell]
   804   C1306577:Death, NOS [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "whether"

Phrase: "the effects of -synuclein on cell survival"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "specific to Taxol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "or"

Phrase: "were"

Phrase: "a general mechanism of drug resistance,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0920474:drug mechanism [Pathologic Function]
   783   C1522618:resistance mechanism [Clinical Attribute]
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "two additional chemotherapeutic agents,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0003392:chemotherapeutic agent [Organic Chemical,Pharmacologic Substance]
   827   C0729502:Chemotherapeutic agent [Pharmacologic Substance]
   779   C0450442:Agent [Chemical Viewed Functionally]
   779   C1254351:Agent [Pharmacologic Substance]
   779   C1521826:Agent [Intellectual Product]

Phrase: "i.e. vinblastine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "and"

Phrase: "etoposide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.232: Both Taxol and vinblastine are microtubule-interfering agents; 

Phrase: "Both Taxol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "vinblastine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "are"

Phrase: "microtubule-interfering agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.233: Taxol binds to microtubule polymers, whereas vinblastine binds to monomers and dimers. 

Phrase: "Taxol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "binds to microtubule polymers,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0026046:Micro-tubule [Cell Component]
   770   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "whereas"

Phrase: "vinblastine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "binds to monomers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0596973:monomers [Chemical Viewed Structurally]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "dimers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]
Processing 00000000.tx.234: When treated with vinblastine (0.1,1.0,or 10M for 30h), cell death in A2780/gam cells was significantly lower (p<0.05for all the three concentrations tested) as compared with the parental cells (Fig. 9A). 

Phrase: "When"

Phrase: "treated with vinblastine"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(0.1,"

Phrase: "1.0,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "or"

Phrase: "10M for 30h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "cell death in A2780/gam cells"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0007587:Cell Death [Cell Function]
           cells death
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "significantly lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441994:Lower [Spatial Concept]
   861   C1548802:Lower [Body Location or Region]
   861   C2003888:Lower [Activity]

Phrase: "(p<0.05for"

Phrase: "all the three concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ")"

Phrase: "as"

Phrase: "compared with the parental cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0030551:Parental [Family Group]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.235: Consistent with other studies using a variety of tumor cell lines (36-39), vinblastine strongly activated JNK in A2780 cells. 

Phrase: "Consistent with other studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a variety of tumor cell lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]

Phrase: "(36-39"

Phrase: ")"

Phrase: ","

Phrase: "vinblastine strongly activated JNK in A2780 cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1150587:JNK [Molecular Function]
   748   C1367731:JNK [Gene or Genome]
   748   C1705632:JNK [Gene or Genome]
Processing 00000000.tx.236: However, this activation of JNK by vinblastine was significantly inhibited by -synuclein over-expression (Fig. 9B). 

Phrase: "However,"

Phrase: "this activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "by vinblastine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "significantly"

Phrase: "inhibited by -synuclein over-expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0311403:Inhibited [Qualitative Concept]

Phrase: "(Fig. 9B"

Phrase: ")."
Processing 00000000.tx.237: Furthermore, we observe that treatment with vinblastine results in a 2-fold increase in phosphorylated ERK1/2 in A2780 cells. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "observe"

Phrase: "that treatment with vinblastine"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "results in a 2-fold increase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0332462:Fold [Spatial Concept]
   753   C0442805:Increase [Functional Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1880834:FOLD [Phenomenon or Process]
   753   C2825142:Result [Finding]

Phrase: "in phosphorylated ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in A2780 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.238: This enhancement in activated ERK levels was not observed in the A2780/gam cells (Fig. 9B). 

Phrase: "This enhancement in activated ERK levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in the A2780/gam cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0061057:gam [Amino Acid, Peptide, or Protein]
   753   C1441672:Observed [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 9B"

Phrase: ")."
Processing 00000000.tx.239: Unlike our results for Taxol, inhibition of ERK phosphorylation by U0126 did not significantly affect the cell death in the parental cells or A2780/gam cells (Fig. 9, A and C). 

Phrase: "Unlike our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "for Taxol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "inhibition of ERK phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   881   C1519062:inhibition of phosphorylation [Molecular Function]
           Phosphorylation Inhibition
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the cell death in the parental cells"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0007587:Cell Death [Cell Function]
           cells death
   778   C0007634:THE CELL [Cell]
           Cell
   774   C0524342:Parental Death [Event]
   748   C0011065:Death [Organism Function]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.240: These data indicate that suppression of vinblastine-induced cell death by -synuclein may be mediated by inhibition of JNK activation. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that suppression of vinblastine-induced cell death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0221103:Suppression [Pathologic Function]
   748   C0301625:Suppression [Organism Function]
   748   C0439181:% suppression [Quantitative Concept]
   748   C0728721:suppression [Mental Process]

Phrase: "by -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "mediated by inhibition of JNK activation."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C1150587:JNK [Molecular Function]
   753   C1367731:JNK [Gene or Genome]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C1705632:JNK [Gene or Genome]
   753   C1879547:Activation [Activity]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.241: View larger version (41K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.242: 9.  

Phrase: "9."
Processing 00000000.tx.243: Vinblastine-induced cell death and activation of the MAPK pathways in -synuclein over-expressing cells. 

Phrase: "Vinblastine-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "activation of the MAPK pathways in -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1155551:MAPK activation [Molecular Function]
   748   C1879547:Activation [Activity]

Phrase: "over-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.244: A, the cell death induced by vinblastine was significantly reduced in cells over-expressing -synuclein. 

Phrase: "A,"

Phrase: "the cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "induced by vinblastine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0392756:Reduced [Qualitative Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "over-expressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.245: A2780 and A2780/gam cells treated with vinblastine (0.1,1,or 10M) for 30h in the presence or absence of the MEK1/2 inhibitor, U0126. 

Phrase: "A2780"

Phrase: "and"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with vinblastine"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(0.1,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "or"

Phrase: "10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "for 30h"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of the MEK1/2 inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "U0126."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.246: Cell death was determined by trypan blue staining. 

Phrase: "Cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined by trypan blue staining."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1260957:Blue [Qualitative Concept]
   760   C1565627:Trypan [Organic Chemical]
   760   C1704680:Staining [Finding]
Processing 00000000.tx.247: The graph represents the averageS.E. of three independent experiments. 

Phrase: "The graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the averageS.E."

Phrase: "of three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.248: *, significant difference in cell death between A2780 and A2780/gam cells (p<0.05). 

Phrase: "*,"

Phrase: "significant difference in cell death between A2780"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0007587:Cell Death [Cell Function]
   748   C0011065:Death [Organism Function]
   748   C1306577:Death, NOS [Finding]

Phrase: "and"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.249: B, inhibition of JNK activation by -synuclein in response to vinblastine treatment. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "inhibition of JNK activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to vinblastine treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.250: A2780 and A2780/gam cells were un-treated or treated with vinblastine (1and 10M) for 30and 60min before lysis for JNK activity assay. 

Phrase: "A2780"

Phrase: "and"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "un-treated"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0041701:UN [Organization]
   861   C0332293:treated [Therapeutic or Preventive Procedure]
   861   C1522326:Treated [Functional Concept]
   861   C1704620:UN [Organism Attribute]
   827 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "treated with vinblastine"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(1and 10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "for 30and 60min"

Phrase: "before lysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0024348:Lysis [Pathologic Function]
  1000   C1536403:lysis [Cell Function]
   928 E C0439680:Lytic [Qualitative Concept]

Phrase: "for JNK activity assay."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0205177:Activity [Functional Concept]
   827   C0243073:assay [Qualitative Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1510438:Assay [Laboratory Procedure]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.251: JNK activities were analyzed as described in the legend for Fig. 

Phrase: "JNK activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "for Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.252: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.253: The number beneath each band represents the arbitrary densitometry units of the corresponding band. 

Phrase: "The number beneath each band"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the arbitrary densitometry units of the corresponding band."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   750   C0439183:Arbitrary unit [Quantitative Concept]
   744   C0439148:Units [Quantitative Concept]
   744   C1519795:Units [Quantitative Concept]
   711 E C1704753:Unit [Manufactured Object]
   711 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.254: The blots shown here are representative of three independent experiments with comparable results. 

Phrase: "The blots"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with comparable results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.255: C, the effect of vinblastine on ERK phosphorylation. 

Phrase: "C,"

Phrase: "the effect of vinblastine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on ERK phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.256: A2780 or A2780/gam cells pre-treated with or without U0126 were treated with vinblastine (1and 10M) in the absence or presence of U0126 (10M) for 30min. 

Phrase: "A2780"

Phrase: "or"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "pre-treated with"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0332152:Pre [Temporal Concept]
   790   C0740175:Pre [Qualitative Concept]
   790   C1522326:Treated [Functional Concept]
   790   C2257086:PRE [Genetic Function]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "or without U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "treated with vinblastine"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(1and 10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of U0126"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "for 30min."
Processing 00000000.tx.257: Whole cell lysates were separated by SDS-PAGE and blotted with phospho-ERK to determine the level of active ERK, or with ERK1/2 antibodies for the level of total ERK1/2. 

Phrase: "Whole cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "blotted with phospho-ERK to"

Phrase: "determine"

Phrase: "the level of active ERK,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "or with ERK1/2 antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of total ERK1/2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
Processing 00000000.tx.258: The number beneath each band represents the arbitrary densitometry units of the corresponding band. 

Phrase: "The number beneath each band"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the arbitrary densitometry units of the corresponding band."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   750   C0439183:Arbitrary unit [Quantitative Concept]
   744   C0439148:Units [Quantitative Concept]
   744   C1519795:Units [Quantitative Concept]
   711 E C1704753:Unit [Manufactured Object]
   711 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.259: The blots shown are representative of three independent experiments with comparable results. 

Phrase: "The blots"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with comparable results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.260: We also evaluated etoposide, a DNA damage agent that has also been shown to induce JNK activation in some cell lines (37, 40-42). 

Phrase: "We also evaluated etoposide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "a DNA damage agent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0450442:Agent [Chemical Viewed Functionally]
   812   C1254351:Agent [Pharmacologic Substance]
   812   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "JNK activation in some cell lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1326120:cell activation [Cell Function]
   753   C1879547:Activation [Activity]

Phrase: "(37,"

Phrase: "40-42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.261: When treated with 1,10,or 100M etoposide for 56h, there was no significant difference in cell survival between A2780 and A2780/gam cells (Fig. 10A). 

Phrase: "When"

Phrase: "treated with 1,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "10,"

Phrase: "or"

Phrase: "100M etoposide for 56h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "there"

Phrase: "was"

Phrase: "no significant difference in cell survival between A2780"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007620:Cell Survival [Cell Function]
   744   C0038952:Survival [Activity]
   744   C0220921:survival [Functional Concept]

Phrase: "and"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 10A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553642:10a [Medical Device]

Phrase: ")."
Processing 00000000.tx.262: As might be predicted, JNK was not activated in response to etoposide treatment (Fig. 10B). 

Phrase: "As"

Phrase: "might"

Phrase: "be"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: ","

Phrase: "JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "activated in response"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C1879547:Activated [Activity]
   790   C2911692:Response [Mental Process]
   756 E C1515877:Activate [Functional Concept]

Phrase: "to etoposide treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 10B"

Phrase: ")."
Processing 00000000.tx.263: Furthermore, etoposide treatment did not result in ERK activation in A2780 cells. 

Phrase: "Furthermore,"

Phrase: "etoposide treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result in ERK activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1879547:Activation [Activity]
   770   C2825142:Result [Finding]

Phrase: "in A2780 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.264: However, surprisingly the constitutive phosphorylated ERK levels observed in A2780/gam cells were significantly down-regulated within 30min of treatment with 10or 100M of etoposide (Fig. 10C). 

Phrase: "However,"

Phrase: "surprisingly"

Phrase: "the constitutive phosphorylated ERK levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "observed in A2780/gam cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0061057:gam [Amino Acid, Peptide, or Protein]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "significantly"

Phrase: "down-regulated within 30min of treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with 10or 100M"

Phrase: "of etoposide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "(Fig. 10C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422424:10C [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.265: In the presence of the MEK inhibitor U0126, cell death induced by etoposide was reduced in both the parental and -synuclein over-expression cells, but statistical analysis indicated these differences were not statistically significant. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the MEK inhibitor U0126,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]
   734   C2347168:MEK Inhibitor [Pharmacologic Substance]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "induced by etoposide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "was"

Phrase: "reduced in both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "the parental"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030551:Parental [Family Group]

Phrase: "and -"

Phrase: "synuclein over-expression cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "these differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "not statistically significant."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1273937:Not significant [Finding]
   901   C0237881:statistically significant [Quantitative Concept]
           significant
   829 E C1709380:Statistical Significance [Quantitative Concept]
   827   C0038215:Statistically [Occupation or Discipline]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.266: View larger version (44K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(44K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.267: 10.  

Phrase: "10."
Processing 00000000.tx.268: Effects of -synuclein over-expression on etoposide-induced cell death and activation of the MAPK pathways. 

Phrase: "Effects of -synuclein over-expression on etoposide-induced cell death"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "activation of the MAPK pathways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1155551:MAPK activation [Molecular Function]
   760   C1879547:Activation [Activity]
Processing 00000000.tx.269: A, cell death induced by etoposide was not significantly altered in cells that over-express -synuclein. 

Phrase: "A,"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "induced by etoposide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "was"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "altered in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0392747:Altered [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "over-express -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.270: A2780 and A2780/gam cells treated with etoposide (1,10,and 100M) for 56h in the presence or absence of the MEK1/2 inhibitor, U0126. 

Phrase: "A2780"

Phrase: "and"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with etoposide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10,"

Phrase: "and"

Phrase: "100M"

Phrase: ")"

Phrase: "for 56h"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of the MEK1/2 inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "U0126."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.271: Cell death was determined by trypan blue staining. 

Phrase: "Cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined by trypan blue staining."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1260957:Blue [Qualitative Concept]
   760   C1565627:Trypan [Organic Chemical]
   760   C1704680:Staining [Finding]
Processing 00000000.tx.272: The graph represents the averageS.E. of three independent experiments. 

Phrase: "The graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the averageS.E."

Phrase: "of three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.273: B, vinblastine treatment does not induce JNK activation. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "vinblastine treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "JNK activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]
Processing 00000000.tx.274: A2780 and A2780/gam cells treated with or without etoposide (10M, and 100M) for 30min and/or 60min before lysis for JNK activity assay. 

Phrase: "A2780"

Phrase: "and"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "or without etoposide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "(10M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: "and"

Phrase: "100M"

Phrase: ")"

Phrase: "for 30min"

Phrase: "and/or"

Phrase: "60min before lysis"

Phrase: "for JNK activity assay."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0205177:Activity [Functional Concept]
   827   C0243073:assay [Qualitative Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1510438:Assay [Laboratory Procedure]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.275: JNK activities were analyzed as described in Fig. 

Phrase: "JNK activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.276: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.277: The number beneath each band represents the arbitrary densitometry units of the corresponding band. 

Phrase: "The number beneath each band"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the arbitrary densitometry units of the corresponding band."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   750   C0439183:Arbitrary unit [Quantitative Concept]
   744   C0439148:Units [Quantitative Concept]
   744   C1519795:Units [Quantitative Concept]
   711 E C1704753:Unit [Manufactured Object]
   711 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.278: The blots shown here are representative of three independent experiments with comparable results. 

Phrase: "The blots"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with comparable results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.279: C, effect of etoposide on ERK phosphorylation. 

Phrase: "C,"

Phrase: "effect of etoposide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on ERK phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.280: A2780 or A2780/gam cells pre-treated with or without U0126 were treated with etoposide (10and 100M) in the absence or presence of U0126 (10M) for 30min. 

Phrase: "A2780"

Phrase: "or"

Phrase: "A2780/gam cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "pre-treated with"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0332152:Pre [Temporal Concept]
   790   C0740175:Pre [Qualitative Concept]
   790   C1522326:Treated [Functional Concept]
   790   C2257086:PRE [Genetic Function]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "or without U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "treated with etoposide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(10and 100M"

Phrase: ")"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of U0126"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "for 30min."
Processing 00000000.tx.281: Whole cell lysate were separated by SDS-PAGE and blotted with phospho-ERK to determine the level of active ERK, or with ERK1/2 antibodies for the level of total ERK1/2. 

Phrase: "Whole cell lysate"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "blotted with phospho-ERK to"

Phrase: "determine"

Phrase: "the level of active ERK,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "or with ERK1/2 antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of total ERK1/2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
Processing 00000000.tx.282: The number beneath each band represents the arbitrary densitometry units of the corresponding band. 

Phrase: "The number beneath each band"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the arbitrary densitometry units of the corresponding band."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   750   C0439183:Arbitrary unit [Quantitative Concept]
   744   C0439148:Units [Quantitative Concept]
   744   C1519795:Units [Quantitative Concept]
   711 E C1704753:Unit [Manufactured Object]
   711 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.283: The blots shown are representative of three independent experiments with comparable results.  

Phrase: "The blots"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with comparable results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.284: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Synucleins are highly soluble proteins, and their biological and biochemical functions are not entirely understood. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "highly soluble proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "their biological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005532:Biological [Biomedical Occupation or Discipline]
  1000   C0205460:biological [Qualitative Concept]

Phrase: "and"

Phrase: "biochemical functions"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0205474:Biochemical [Functional Concept]
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "are"

Phrase: "not entirely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.285: Previous studies have suggested that they may be involved in neuron development and function (43). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "may"

Phrase: "be"

Phrase: "involved in neuron development"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1657987:neuron development [Cell Function]
   770   C0027882:Neuron [Cell]
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1314939:Involved [Functional Concept]
   770   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.286: The involvement of -synuclein in human neoplastic diseases came to light when -synuclein was isolated from a human breast tumor cDNA library and was shown to be over-expressed in infiltrating ductal carcinomas (4, 5) and ovarian cancer (4). 

Phrase: "The involvement of -synuclein in human neoplastic diseases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "came to light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0023693:Light [Natural Phenomenon or Process]
   790   C1306462:Light [Functional Concept]
   790   C1881376:Light [Qualitative Concept]

Phrase: "when -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "isolated from a human breast tumor cDNA library"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   770   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   770   C1458155:Breast tumor [Neoplastic Process]
   744   C0006141:Breast [Body Part, Organ, or Organ Component]
   744   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0023621:Library [Manufactured Object,Organization]
   744   C0027651:Tumor [Neoplastic Process]
   744   C0086418:Human [Human]
   744   C0205409:Isolated [Functional Concept]
   744   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1268990:Breast [Body Part, Organ, or Organ Component]
   744   C1548221:Isolated [Idea or Concept]
   744   C1578706:Tumor [Intellectual Product]
   744   C3273930:Tumor [Finding]
   743 E C0024667:mammary tumor [Neoplastic Process]
   720 E C0039981:Thoracic Tumor [Neoplastic Process]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "over-expressed in infiltrating ductal carcinomas"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   814   C1134719:carcinomas ductal infiltrating [Neoplastic Process]
   798 E C1176475:infiltrating duct carcinoma [Neoplastic Process]
           Ductal Carcinomas
   798 E C1412014:Infiltrating duct carcinoma [Neoplastic Process]
   756 E C1527349:Ductal Carcinoma [Neoplastic Process]
   753   C0007097:Carcinomas [Neoplastic Process]
   753   C0205136:Over [Spatial Concept]
   753   C0332448:Infiltrating [Pathologic Function]
   753   C1512083:Ductal [Qualitative Concept]
   719 E C1546677:Infiltrate [Intellectual Product]
   719 E C1549537:Infiltrate [Functional Concept]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "ovarian cancer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancer [Neoplastic Process]
  1000   C1140680:Ovarian Cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.287: Additional studies have suggested that -synuclein may be involved in enhancing cell motility and metastasis, in breast (6) and ovarian3 cancer cells as analyzed both in vitro and in nude mouse models in vivo. 

Phrase: "Additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "involved in enhancing cell motility"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0007608:cell motility [Cell Function]
           Motility
   760   C0007634:Cell [Cell]
   760   C0678835:Motility [Laboratory or Test Result]
   760   C1269647:Cell [Cell]
   760   C1314939:Involved [Functional Concept]
   760   C1510470:Motility [Organism Function]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C2349975:Enhance [Activity]

Phrase: "and"

Phrase: "metastasis,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0027627:Metastasis [Neoplastic Process]
  1000   C2939420:metastasis [Neoplastic Process]
   928 E C0036525:Metastatic [Functional Concept]
   928 E C1522484:metastatic [Quantitative Concept]

Phrase: "in breast"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0006141:Breast [Body Part, Organ, or Organ Component]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1268990:Breast [Body Part, Organ, or Organ Component]
   805 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   805 E C1521735:Pectoral [Qualitative Concept]
   777 E C0817096:Chest [Body Location or Region]
   777 E C1527391:Chest [Body Location or Region]

Phrase: "(6"

Phrase: ")"

Phrase: "and"

Phrase: "ovarian3 cancer cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0334227:cancer cells [Cell]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0007634:Cells [Cell]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and in nude mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0025932:Mouse, Nude [Mammal]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C1425014:NUDE [Gene or Genome]
   770   C1515981:And [Idea or Concept]

Phrase: "models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.288: We have found that oncogenic activation of -synuclein is independent of gene mutations or gene amplification. 

Phrase: "We"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that oncogenic activation of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is independent of gene mutations"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332291:Independent of [Functional Concept]
   806   C0596611:gene mutations [Genetic Function]
   797   C0314622:Is gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
   760   C0026882:Mutations [Genetic Function]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "gene amplification."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017256:Gene Amplification [Genetic Function]
  1000   C1705759:Gene Amplification [Cell or Molecular Dysfunction]
           Amplification
   861   C0017337:Gene [Gene or Genome]
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
Processing 00000000.tx.289: Liu and colleagues have recently reported that hypomethylation of the -synuclein gene CpG island promotes its aberrant expression in breast (45) and ovarian carcinomas.4 In the present studies, we showed that -synuclein over-expression activates the survival factor ERK1/2 and blocks the activation of JNK. 

Phrase: "Liu"

Phrase: "and"

Phrase: "colleagues"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that hypomethylation of the -synuclein gene CpG island"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C2613368:hypomethylation of CpG island [Genetic Function]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "its aberrant expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in breast"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0006141:Breast [Body Part, Organ, or Organ Component]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1268990:Breast [Body Part, Organ, or Organ Component]
   805 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   805 E C1521735:Pectoral [Qualitative Concept]
   777 E C0817096:Chest [Body Location or Region]
   777 E C1527391:Chest [Body Location or Region]

Phrase: "(45"

Phrase: ")"

Phrase: "and"

Phrase: "ovarian carcinomas.4 In the present studies,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0029925:ovarian carcinomas [Neoplastic Process]
   748   C0007097:Carcinomas [Neoplastic Process]
   748   C0150312:Present [Quantitative Concept]
   748   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   748   C0449450:Present [Idea or Concept]
   748   C0947630:studies [Laboratory Procedure]
   745 E C0677886:carcinoma, ovarian [Neoplastic Process]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that -synuclein over-expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the survival factor ERK1/2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0038952:Survival [Activity]
   812   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0220921:survival [Functional Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the activation of JNK."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]
Processing 00000000.tx.290: Activation of JNK can initiate the mitochondria-involved caspase apoptosis pathway (30). 

Phrase: "Activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "can"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "the mitochondria-involved caspase apoptosis pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0162638:Apoptosis Pathway [Cell Function]
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.291: Therefore, we propose that -synuclein, in its oncogenic form (over-expressed) contributes to tumor development by protecting cancer cells under adverse conditions through modulating the ERK and JNK pathways (Fig. 11). 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "propose"

Phrase: "that -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in its oncogenic form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "("

Phrase: "over-expressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: ")"

Phrase: "contributes to tumor development"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0027651:Tumor [Neoplastic Process]
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C1880177:Contribute [Activity]
   770   C3273930:Tumor [Finding]

Phrase: "by protecting cancer cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0334227:cancer cells [Cell]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0007634:Cells [Cell]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "under adverse conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "through modulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulating [Spatial Concept]

Phrase: "the ERK"

Phrase: "and"

Phrase: "JNK pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1621396:Pathways, JNK [Molecular Function]
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "(Fig. 11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.292: In addition, we observed that Taxol- and vinblastine-induced cell death is protected by -synuclein indicating that anti-cancer drugs that take effect through activating the JNK/caspase apoptosis pathway may not be effective for cancers with high -synuclein protein levels. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that Taxol-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "vinblastine-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "protected by -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "indicating"

Phrase: "that anti-cancer drugs"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   884   C0003392:Cancer Drug [Organic Chemical,Pharmacologic Substance]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "that"

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "effect through activating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "the JNK/caspase apoptosis pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1621396:JNK Pathway [Molecular Function]
   861   C0162638:Apoptosis Pathway [Cell Function]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "effective for cancers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280519:effective [Qualitative Concept]
   790   C1704419:Effective [Qualitative Concept]

Phrase: "with high -synuclein protein levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.293: View larger version (23K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.294: 11.  

Phrase: "11."
Processing 00000000.tx.295: A proposed model illustrating how -synuclein promotes cell survival by modulating the ERK and JNK pathways. 

Phrase: "A proposed model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "illustrating"

Phrase: "how -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell survival by modulating"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0007620:Cell Survival [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "the ERK"

Phrase: "and"

Phrase: "JNK pathways."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1621396:Pathways, JNK [Molecular Function]
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.296: The effects of -synuclein on ERK1/2 and JNK signaling in ovarian cancer cells appear to be specific for -synuclein, because over-expression of the - and -synucleins in A2780 cells had little or no effect on these MAPKs (Figs. 3 and 5). 

Phrase: "The effects of -synuclein on ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "JNK signaling in ovarian cancer cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0037083:Cell Signaling [Cell Function]
           Signaling
   753   C3537152:signaling [Biologic Function]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "specific for -synuclein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "because"

Phrase: "over-expression of the -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0205136:Over [Spatial Concept]

Phrase: "and -"

Phrase: "synucleins in A2780 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "had"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no effect on these MAPKs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "(Figs. 3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.297: Even though - and -synucleins are expressed in a significant fraction of ovarian tumors (4), we did not observe a discernable phenotype associated with over-expression in cultured cells. 

Phrase: "Even"

Phrase: "though"

Phrase: "-"

Phrase: "and -"

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "expressed in a significant fraction of ovarian tumors"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0919267:Ovarian Tumors [Neoplastic Process]
   770   C1264633:Fraction of [Quantitative Concept]
           Fraction
   744   C0027651:Tumors [Neoplastic Process]
   744   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   744   C0237881:significant [Quantitative Concept]
   744   C0750502:Significant [Idea or Concept]
   744   C1546944:Significant [Qualitative Concept]
   744   C1554103:Fraction [Idea or Concept]
   711 E C1578706:Tumor [Intellectual Product]
   711 E C3273930:Tumor [Finding]

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "a discernable phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "associated with over-expression"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in cultured cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.298: The reasons for these differences are not readily apparent. 

Phrase: "The reasons for these differences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392360:reasons [Idea or Concept]

Phrase: "are"

Phrase: "not readily apparent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.299: However, we have recently observed that the subcellular localization of -synuclein in tumor cells may be altered. 

Phrase: "However,"

Phrase: "we"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "the subcellular localization of -synuclein in tumor cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "altered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]
Processing 00000000.tx.300: Previous studies have shown that -synuclein is diffusely distributed in the cytoplasm of peripheral neurons, although it is also expressed in the brain (46). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "diffusely"

Phrase: "distributed in the cytoplasm of peripheral neurons,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C1178979:Cytoplasm of neuron [Cell Component]
           Neuron cytoplasm
   774   C1621884:peripheral cytoplasm [Cell Component]
   762   C0682700:Peripheral neuron [Cell]
   748   C0010834:Cytoplasm [Cell Component]
   748   C0027882:Neurons [Cell]
   748   C0205100:Peripheral [Spatial Concept]
   748   C1704711:Distributed [Functional Concept]

Phrase: "although"

Phrase: "it"

Phrase: "is"

Phrase: "also"

Phrase: "expressed in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.301: We have found in tumor cells, which over-express the wild-type -synuclein, that the protein tends to accumulate in the nuclei.2 This may also help explain why only a portion of ERK1/2 and JNK co-immunoprecipitates with -synuclein (Fig. 2), because the cytoplasmic levels are low in A2780 cells. 

Phrase: "We"

Phrase: "have"

Phrase: "found in tumor cells,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   833   C0431085:Tumor cells [Cell]
   799 E C0597032:Tumor Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0027651:Tumor [Neoplastic Process]
   770   C0150312:Found [Quantitative Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]
   770   C3282337:Cells [Cell]
   737 E C0243095:Find [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "over-express"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "the wild-type -synuclein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "that"

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "tends"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accumulate in the nuclei.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0007610:Nucleus [Cell Component]

Phrase: "This"

Phrase: "may"

Phrase: "also"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "explain"

Phrase: "why only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "a portion of ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449719:Portion [Spatial Concept]

Phrase: "and"

Phrase: "JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "co-immunoprecipitates with -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "because"

Phrase: "the cytoplasmic levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "low in A2780 cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205251:low [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
Processing 00000000.tx.302: Furthermore, the amino acid sequences of - and -synucleins are more closely related to each other than -synuclein (8, 9), and the -synuclein protein is the least conserved of the synuclein proteins (8, 9). 

Phrase: "Furthermore,"

Phrase: "the amino acid sequences of -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0002518:Sequences, Amino Acid [Amino Acid Sequence]

Phrase: "and -"

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "more closely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "related to each other"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "than -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(8,"

Phrase: "9"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the -synuclein protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "the least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "conserved of the synuclein proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.303: Therefore, it is possible that the conserved sequences of , , and -synuclein may be involved in the interaction with ERK1/2 and that the non-conserved regions (predominantly the C terminus) may contribute to activation of ERK in a cell type-specific manner. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the conserved sequences of ,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   833   C0009802:Sequences, Conserved [Nucleotide Sequence]
   770   C0162326:Sequences [Nucleotide Sequence]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: ","

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "involved in the interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1314939:Involved [Functional Concept]
   770   C1704675:Interaction [Functional Concept]

Phrase: "with ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "that"

Phrase: "the non-conserved regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "(predominantly"

Phrase: "the C terminus"

Phrase: ")"

Phrase: "may"

Phrase: "contribute to activation of ERK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1879547:Activation [Activity]
   760   C1880177:Contribute [Activity]

Phrase: "in a cell type-specific manner."
Processing 00000000.tx.304: Therefore, the effects that we are observing may be both cell type- and isoform-specific. 

Phrase: "Therefore,"

Phrase: "the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "we"

Phrase: "are"

Phrase: "observing"

Phrase: "may"

Phrase: "be"

Phrase: "both cell type-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007634:Cell Type [Cell]
           Cell
  1000   C0449475:cell type [Intellectual Product]
   861   C0332307:Type [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1547052:*Type [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "isoform-specific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205369:Specific [Qualitative Concept]
   861   C1552740:specific [Intellectual Product]
Processing 00000000.tx.305: Additional studies will be needed to better resolve these differences. 

Phrase: "Additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "will"

Phrase: "be"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to better"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332272:Better [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205170:Well [Qualitative Concept]
   827 E C3146287:Well [Manufactured Object]

Phrase: "resolve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699488:Resolve [Conceptual Entity]

Phrase: "these differences."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.306: Even though we have made some significant observations in this study, the biochemical function of -synuclein remains largely unknown. 

Phrase: "Even"

Phrase: "though"

Phrase: "we"

Phrase: "have"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "some significant observations in this study,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   767   C0552617:Study observation [Functional Concept]
   753   C0302523:observations [Research Activity]
   753   C0700325:observations [Health Care Activity]
   753   C3244290:observations [Functional Concept]
   742 E C1518527:Observational Study [Research Activity]
   719 E C1964257:Observation [Diagnostic Procedure]

Phrase: "the biochemical function of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "remains"

Phrase: "largely unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.307: Many of our approaches have come from the study of -synuclein. 

Phrase: "Many of our approaches"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439064:Many [Quantitative Concept]
   770   C0449445:Approaches [Spatial Concept]
   770   C0747726:many [Conceptual Entity]
   770   C1292724:Approaches [Functional Concept]

Phrase: "have"

Phrase: "come from the study of -synuclein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]
Processing 00000000.tx.308: -Synuclein, the most extensively studied synuclein, is the major component of Lewy bodies in sporadic PD, dementia with LBs, and a subtype of Alzheimer's disease known as the LB variant of Alzheimer's disease (19, 47, 48). 

Phrase: "-Synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the most extensively studied synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "the major component of Lewy bodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "in sporadic PD,"

Phrase: "dementia with LBs,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "a subtype of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0872379:disease subtype [Classification]
   760   C0449560:Subtype [Classification]

Phrase: "known as the LB variant of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0205309:Known [Qualitative Concept]
   744   C0205419:Variant [Qualitative Concept]

Phrase: "(19,"

Phrase: "47,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.309: Mutations in the -synuclein gene have also been linked to familial Parkinson's disease (49-51). 

Phrase: "Mutations in the -synuclein gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "linked to familial Parkinson's disease"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C0030567:Parkinson Disease [Disease or Syndrome]
   806   C1521736:Parkinson's Disease [Functional Concept]
   806   C2681933:PARKINSON DISEASE [Gene or Genome]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(49-51"

Phrase: ")."
Processing 00000000.tx.310: Based on homology to 14-3-3protein and in vitro assay, synucleins are hypothesized to be proteins with chaperone properties (20, 26). 

Phrase: "Based on homology"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C1334043:Homology [Gene or Genome]
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   790   C2697616:Homology [Qualitative Concept]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]

Phrase: "to 14-3-3protein"

Phrase: "and"

Phrase: "in vitro assay,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1515653:In Vitro Assay [Research Activity]
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "hypothesized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "proteins with chaperone properties"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(20,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.311: -Synuclein has been shown to be associated with many of the proteins that interact with 14-3-3proteins, including PKC, BAD, and ERK (16, 21, 25). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with many of the proteins"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "interact with 14-3-3proteins,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "BAD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Bad [Qualitative Concept]

Phrase: "and"

Phrase: "ERK (16,"

Phrase: "21,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.312: -Synuclein has also been shown to associate with ERK2 (28) and may reduce the phosphorylation of MAPKs in neurons (29), whereas synoretin can activate the Elk1 pathway when transfected in HEK293 cells (9). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "associate with ERK2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0750490:Associate [Idea or Concept]
   790   C1150579:ERK2 [Molecular Function]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "(28"

Phrase: ")"

Phrase: "and"

Phrase: "may"

Phrase: "reduce"

Phrase: "the phosphorylation of MAPKs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "synoretin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0753208:Synoretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335851:synoretin [Gene or Genome]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the Elk1 pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "when"

Phrase: "transfected in HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C2936239:HEK293 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.313: We have demonstrated in ovarian cancer cells that both - and -synucleins can associate with ERK1/2 (Fig. 2). 

Phrase: "We"

Phrase: "have"

Phrase: "demonstrated in ovarian cancer cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0029925:ovarian cancer [Neoplastic Process]
   806   C0334227:cancer cells [Cell]
   806   C1140680:Ovarian Cancer [Neoplastic Process]
   760   C0006826:Cancer [Neoplastic Process]
   760   C0007634:Cells [Cell]
   760   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   760   C0998265:Cancer [Eukaryote]
   760   C1306459:Cancer [Finding]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "that both -"

Phrase: "and -"

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "associate with ERK1/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0750490:Associate [Idea or Concept]
   770   C1706221:Associate [Professional or Occupational Group]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.314: However, only -synuclein but not -synuclein lead to constitutive activation of ERK indicating that the function of -synuclein might be different in cancer cells versus neuronal cells. 

Phrase: "However,"

Phrase: "only -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "not -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "lead to constitutive activation of ERK"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1879547:Activation [Activity]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "indicating"

Phrase: "that"

Phrase: "the function of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "be"

Phrase: "different in cancer cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "versus"

Phrase: "neuronal cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.315: Studies are underway to determine whether this constitutive activation is dependent on the C-terminal sequences, which are unique to -synuclein. 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "underway to"

Phrase: "determine"

Phrase: "whether"

Phrase: "this constitutive activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "dependent on the C-terminal sequences,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "which"

Phrase: "are"

Phrase: "unique to -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.316: The second prominent observation we made in this study was that ectopic expression of -synuclein resulted in enhanced resistance to the chemotherapeutic drugs Taxol and vinblastine (Figs. 7-9). 

Phrase: "The second prominent observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0302523:Observation [Research Activity]
   827   C0700325:observation [Health Care Activity]
   827   C1964257:Observation [Diagnostic Procedure]
   755 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "we"

Phrase: "made in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737   C1881534:Make [Functional Concept]

Phrase: "was"

Phrase: "that ectopic expression of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resulted in enhanced resistance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C2349975:Enhanced [Activity]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "to the chemotherapeutic drugs Taxol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "vinblastine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(Figs. 7-9"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0349966:Figs [Food]
   793 E C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.317: In contrast, when these same cells were treated with etoposide, a DNA-damaging agent, -synuclein over-expression did not enhanced cell survival (Fig. 10). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "when"

Phrase: "these same cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with etoposide,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "a DNA-damaging agent, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0450442:Agent [Chemical Viewed Functionally]
   812   C1254351:Agent [Pharmacologic Substance]
   812   C1521826:Agent [Intellectual Product]

Phrase: "synuclein over-expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "did"

Phrase: "not enhanced cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007620:Cell Survival [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0038952:Survival [Activity]
   812   C0220921:survival [Functional Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.318: There are two main apoptosis pathways initiated from the cell surface membrane, one is initiated by Fas and other death receptors, while the other is initiated by stress signals (30). 

Phrase: "There"

Phrase: "are"

Phrase: "two main apoptosis pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0162638:Apoptosis Pathway [Cell Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "initiated from the cell surface membrane,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0699040:Cell surface [Cell Component]
   783   C0007603:Cell Membrane [Cell Component]
   783   C3161472:Cell Membrane [Cell Component]
   753   C0007634:Cell [Cell]
   753   C0025255:Membrane [Tissue]
   753   C0205148:Surface [Spatial Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1706182:Membrane [Manufactured Object]
   753   C1948049:Cell [Spatial Concept]
   719   C1548602:Initiate [Idea or Concept]
   719   C1704686:Initiate [Functional Concept]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "initiated by Fas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1548602:Initiate [Idea or Concept]
   756   C1704686:Initiate [Functional Concept]

Phrase: "and"

Phrase: "other death receptors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1720947:Death Receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C0011065:Death [Organism Function]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C1306577:Death, NOS [Finding]

Phrase: "while"

Phrase: "the other"

Phrase: "is"

Phrase: "initiated by stress signals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0038435:Stress [Finding]
   737   C1548602:Initiate [Idea or Concept]
   737   C1704686:Initiate [Functional Concept]
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.319: JNK activation is an essential component of the latter apoptotic signaling (30, 52). 

Phrase: "JNK activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "an essential component of the latter apoptotic signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449432:Component [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]

Phrase: "(30,"

Phrase: "52"

Phrase: ")."
Processing 00000000.tx.320: In addition, many chemotherapy drugs also take effect partly through activating the JNK signaling (34-36). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "many chemotherapy drugs also"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   901   C0812987:Chemotherapy Drugs [Therapeutic or Preventive Procedure]
   827   C0013227:Drugs [Pharmacologic Substance]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "effect partly through activating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "the JNK signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "(34-36"

Phrase: ")."
Processing 00000000.tx.321: Our data indicate that abnormal over-expression of -synuclein might be one such mechanism in breast and ovarian cancer that permits tumor cells to overcome the JNK-activated apoptotic signaling (30). 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that abnormal over-expression of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "be"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "such mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "in breast"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0006141:Breast [Body Part, Organ, or Organ Component]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1268990:Breast [Body Part, Organ, or Organ Component]
   805 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   805 E C1521735:Pectoral [Qualitative Concept]
   777 E C0817096:Chest [Body Location or Region]
   777 E C1527391:Chest [Body Location or Region]

Phrase: "and"

Phrase: "ovarian cancer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancer [Neoplastic Process]
  1000   C1140680:Ovarian Cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "that"

Phrase: "permits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "tumor cells to"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   901   C0431085:Tumor cells [Cell]
   867 E C0597032:Tumor Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "the JNK-activated apoptotic signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   825   C1622858:apoptosis signaling [Cell Function]
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.322: Both Taxol and vinblastine robustly induced JNK activity in A2780 cells, whereas the etoposide treatment induced such activity very little (Figs. 8-10). 

Phrase: "Both Taxol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "vinblastine robustly induced JNK activity in A2780 cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "whereas"

Phrase: "the etoposide treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "such activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "very little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   861   C0700321:Little [Quantitative Concept]
   861   C2700395:Little [Quantitative Concept]

Phrase: "(Figs. 8-10"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0349966:Figs [Food]
   793 E C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.323: In -synuclein over-expressing cells, this induction by Taxol and vinblastine was suppressed 2-to 3-fold and cell survival was dramatically enhanced. 

Phrase: "In -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "over-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "this induction by Taxol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "vinblastine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "to 3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "dramatically"

Phrase: "enhanced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]
Processing 00000000.tx.324: Taken together, these results indicate that the cell death in ovarian cancer cells induced by Taxol, vinblastine, or other drugs that induce JNK, may be protected by -synuclein. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the cell death in ovarian cancer cells"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0007587:Cell Death [Cell Function]
           cells death
   778   C0007634:THE CELL [Cell]
           Cell
   748   C0011065:Death [Organism Function]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   732   C0334227:cancers cell [Cell]

Phrase: "induced by Taxol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induced [Functional Concept]
   790   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "vinblastine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042670:Vinblastine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "other drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "that"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "may"

Phrase: "be"

Phrase: "protected by -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.325: Furthermore, it is interesting to note that only ~35% of breast tumors and ~50% of all epithelial ovarian tumors possess mutations in the TP53 gene (53, 54). 

Phrase: "Furthermore,"

Phrase: "it"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that only ~35% of breast tumors"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   809   C1458155:Tumor of breast [Neoplastic Process]
           Breast Tumors
   762 E C0024667:mammary tumors [Neoplastic Process]
   753   C0006141:Breast [Body Part, Organ, or Organ Component]
   753   C0027651:Tumors [Neoplastic Process]
   753   C0205171:Only [Quantitative Concept]
   753   C1268990:Breast [Body Part, Organ, or Organ Component]
   753   C1720467:Only [Intellectual Product]
   723 E C0039981:Thoracic Tumor [Neoplastic Process]
   719 E C1578706:Tumor [Intellectual Product]
   719 E C3273930:Tumor [Finding]

Phrase: "and ~"

Phrase: "50% of all epithelial ovarian tumors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   803   C0341823:Ovarian Epithelial Tumor [Neoplastic Process]
   790   C0919267:Ovarian Tumors [Neoplastic Process]
   783   C1368683:epithelial tumors [Neoplastic Process]
   753   C0027651:Tumors [Neoplastic Process]
   753   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   753   C0221908:Epithelial [Qualitative Concept]
   719 E C1578706:Tumor [Intellectual Product]
   719 E C3273930:Tumor [Finding]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "mutations in the TP53 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(53,"

Phrase: "54"

Phrase: ")."
Processing 00000000.tx.326: Because JNK activation in UV- or Taxol-treated cells is independent of DNA damage (31, 55-57), it is interesting to speculate that over-expression of -synuclein may promote tumor cell survival in the presence of p53 wild-type cells. 

Phrase: "Because"

Phrase: "JNK activation in UV-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "or"

Phrase: "Taxol-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "is independent of DNA damage"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   806   C0332291:Independent of [Functional Concept]
   760   C0010957:Damage [Injury or Poisoning]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
   760   C1883709:Damage [Functional Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "55-57"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "speculate"

Phrase: "that over-expression of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "tumor cell survival in the presence of p53 wild-type cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0007620:Cell Survival [Cell Function]
   738   C0038952:Survival [Activity]
   738   C0220921:survival [Functional Concept]
Processing 00000000.tx.327: Because -synuclein is not expressed in normal breast and ovarian epithelial cells but is expressed in the majority of late-stage breast and ovarian cancers (4, 5), it may be a very promising target to develop drugs for the therapies of these diseases. 

Phrase: "Because -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "expressed in normal breast"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0567498:Normal breast [Finding]
   770   C0006141:Breast [Body Part, Organ, or Organ Component]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1268990:Breast [Body Part, Organ, or Organ Component]
   770   C2347086:% Normal [Quantitative Concept]
   715 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   715 E C1521735:Pectoral [Qualitative Concept]

Phrase: "and"

Phrase: "ovarian epithelial cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0014597:Epithelial Cells [Cell]
   901   C1273342:Epithelial Cells [Laboratory Procedure]
   827   C0007634:Cells [Cell]
   827   C0221908:Epithelial [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "is"

Phrase: "expressed in the majority of late-stage breast"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1279941:Late stage [Temporal Concept]
   744   C0006141:Breast [Body Part, Organ, or Organ Component]
   744   C0205087:Late [Temporal Concept]
   744   C0205390:Stage [Temporal Concept]
   744   C0680220:majority [Social Behavior]
   744   C1268990:Breast [Body Part, Organ, or Organ Component]
   744   C1300072:Stage [Clinical Attribute]
   744   C1306673:Stage [Qualitative Concept]

Phrase: "and"

Phrase: "ovarian cancers"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancers [Neoplastic Process]
  1000   C1140680:Ovarian Cancers [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "a very"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442824:Very [Qualitative Concept]

Phrase: "promising"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555307:promise [Idea or Concept]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "drugs for the therapies of these diseases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   774   C0013216:drugs therapies [Therapeutic or Preventive Procedure]
   748   C0013227:Drugs [Pharmacologic Substance]
   741 E C0013217:drug therapy [Functional Concept]
   714 E C1254351:Drug [Pharmacologic Substance]
Processing 00000000.tx.328: Our results of -synuclein in cancer cells seem different from those of -synuclein in neuronal cells. 

Phrase: "Our results of -synuclein in cancer cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "seem"

Phrase: "different from those of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "in neuronal cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.329: It remains to be determined whether these differences are caused by the different cellular context between cancer and neuronal cells, by different subcellular localization of the proteins in various normal and tumor cell types, or by the innate difference in protein functions between - and - synucleins. 

Phrase: "It"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined"

Phrase: "whether"

Phrase: "these differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "are"

Phrase: "caused by the different cellular context"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0007634:Cellular [Cell]
   753   C0178539:Cellular [Functional Concept]
   753   C0449255:Context [Finding]
   753   C0542559:Context [Functional Concept]
   753   C1705242:Different [Qualitative Concept]
   719   C0015127:cause [Functional Concept]
   719   C1524003:Cause [Conceptual Entity]

Phrase: "between cancer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "and"

Phrase: "neuronal cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "by different subcellular localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "of the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in various normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "tumor cell types,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0449475:Cell types [Intellectual Product]
   867 E C0007634:Cell Type [Cell]
   827   C0332307:Types [Qualitative Concept]
   793 E C1547052:*Type [Quantitative Concept]
   734   C0431085:Tumor cell [Cell]
   734   C0597032:Tumor Cell [Cell]

Phrase: "or by the innate difference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "in protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "functions between -"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0031843:function [Physiologic Function]
   833   C0542341:Function [Functional Concept]
   833   C0700205:FUNCTION [Classification]
   833   C1705273:Function [Intellectual Product]

Phrase: "and -"

Phrase: "synucleins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.330: -Synuclein over-expression in HEK293 cells or A2780 cells does not induce apoptosis (29).2 In neurons, mutant -synuclein may accelerate apoptosis (58-61) while wild-type -synuclein may induce or block apoptosis, depending on the path of apoptosis induction (29, 58-60, 62). 

Phrase: "-Synuclein over-expression in HEK293 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "A2780 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(29"

Phrase: ").2 In neurons,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0027882:Neurons [Cell]
   790   C0740116:+2 [Quantitative Concept]
   790   C2827735:2+ [Quantitative Concept]
   790   C2981700:2+ [Classification]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "mutant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(58-61"

Phrase: ")"

Phrase: "while"

Phrase: "wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "may"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "or"

Phrase: "block apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "depending on the path of apoptosis induction"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C3266896:Induction of Apoptosis [Cell Function]
           Apoptosis Induction
   748   C0162638:Apoptosis [Cell Function]
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]
   748   C0919386:PATH [Laboratory Procedure]
   748   C1705483:Path [Intellectual Product]
   714   C0725813:depend [Medical Device]

Phrase: "(29,"

Phrase: "58-60,"

Phrase: "62"

Phrase: ")."
Processing 00000000.tx.331: In Parkinson's diseases, mitochondrial dysfunction and oxidative stress are believed to be the two main causes for neuronal death (63). 

Phrase: "In Parkinson's diseases,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0030567:Parkinson Disease [Disease or Syndrome]
   983   C1521736:Parkinson's Disease [Functional Concept]
   983   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "are"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the two main causes for neuronal death"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   774   C0007465:Death Causes [Finding]
   748   C0015127:causes [Functional Concept]
   748   C1314792:Causes [Functional Concept]
   714 E C1524003:Cause [Conceptual Entity]

Phrase: "(63"

Phrase: ")."
Processing 00000000.tx.332: The apoptotic role of wild-type -synuclein in neuronal apoptosis may be secondary by disrupting mitochondria and causing oxidative stress (64). 

Phrase: "The apoptotic role of wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in neuronal apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   964   C1660771:neuron apoptosis [Cell Function]
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "secondary by disrupting mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027627:secondary [Neoplastic Process]
   770   C0175668:Secondary [Temporal Concept]
   770   C0205436:Secondary [Quantitative Concept]

Phrase: "and"

Phrase: "causing oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "(64"

Phrase: ")."
Processing 00000000.tx.333: There is evidence that the roles of synuclein in neurodegenerative diseases appear to be quite different. 

Phrase: "There"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the roles of synuclein"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "in neurodegenerative diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "quite different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.334: In contrast to the role of -synuclein in neuronal degeneration, -synuclein does not cause neuronal apoptosis (65). 

Phrase: "In contrast to the role of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in neuronal degeneration, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neuronal apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   964   C1660771:neuron apoptosis [Cell Function]
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.335: - and -Synucleins are not detected in Lewy bodies or Lewy neurites (8, 14), and they are intrinsically less fibrillogenic than -synuclein and cannot form mixed fibrils with -synuclein (44). 

Phrase: "-"

Phrase: "and -"

Phrase: "Synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in Lewy bodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "or"

Phrase: "Lewy neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C3548404:Lewy neurite [Cell Component]
   861   C0085103:Neurites [Cell Component]

Phrase: "(8,"

Phrase: "14"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "they"

Phrase: "are"

Phrase: "intrinsically less fibrillogenic than -synuclein"

Phrase: "and"

Phrase: "cannot"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "mixed fibrils with -synuclein"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0225328:fibrils [Cell Component]
   737 E C1948066:Fibril [Physical Object]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.336: Therefore, it would be of interest to determine whether the normal protective role of -synuclein is lost in the neurons of PD and other neurodegenerative diseases. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "would"

Phrase: "be of interest to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543488:Interest [Mental Process]
   770   C2987476:Be [Conceptual Entity]

Phrase: "determine"

Phrase: "whether"

Phrase: "the normal protective role of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "lost in the neurons of PD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0027882:Neurons [Cell]
   753   C0745777:Lost [Functional Concept]

Phrase: "and"

Phrase: "other neurodegenerative diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.337: Overall, our studies provide new insight into the biological function of -synuclein and its role in the pathogenesis of the breast and ovary and offer a new therapeutic target for future treatment.  

Phrase: "Overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "new insight into the biological function of -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0233820:Insight, function [Mental Process]
           Insight

Phrase: "and"

Phrase: "its role in the pathogenesis of the breast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "ovary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029939:Ovary [Body Part, Organ, or Organ Component]
  1000   C0227898:ovary [Body Part, Organ, or Organ Component]
  1000   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "offer"

Phrase: "a new therapeutic target for future treatment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1521840:Target [Functional Concept]
   748   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.338: ACKNOWLEDGEMENTS We thank Drs. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.339: Alfred Knudson, Erica Golemis, Maureen Murphy, and Anthony Yeung and Eryn Godwin for valuable input and for support from various Fox Chase Cancer Center Core Facilities.  

Phrase: "Alfred Knudson,"

Phrase: "Erica Golemis,"

Phrase: "Maureen Murphy,"

Phrase: "and"

Phrase: "Anthony Yeung"

Phrase: "and"

Phrase: "Eryn Godwin for valuable input"

Phrase: "and for support"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0183683:Support [Medical Device]
   790   C1515981:And [Idea or Concept]
   790   C1521721:Support [Conceptual Entity]

Phrase: "from various Fox Chase Cancer Center Core Facilities."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   801   C1511521:Core Facility [Health Care Related Organization,Manufactured Object]
   762   C1547538:Facility [Idea or Concept]
   710   C1517306:Fox Chase Cancer Center [Health Care Related Organization]
Processing 00000000.tx.340: FOOTNOTES * This work was supported in part by the Eileen Stein-Jacoby Fund, the Ovarian Cancer Research Fund, a concept grant from the Department of Defense (DAMD17-01-1-0522), a grant from the National Institutes of Health (Ovarian Cancer SPORE P50 CA83638), and by an appropriation from the Commonwealth of Pennsylvania.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by the Eileen Stein-Jacoby Fund,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0016820:Fund [Quantitative Concept]

Phrase: "the Ovarian Cancer Research Fund,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0681805:research fund [Research Activity]
   812   C0016820:Fund [Quantitative Concept]

Phrase: "a concept grant from the Department of Defense"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0018173:Grant [Quantitative Concept]
   744   C1548284:Grant [Idea or Concept]

Phrase: "(DAMD17-01-1-0522"

Phrase: ")"

Phrase: ","

Phrase: "a grant from the National Institutes of Health"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0018173:Grant [Quantitative Concept]
   744   C1548284:Grant [Idea or Concept]

Phrase: "(Ovarian Cancer SPORE P50 CA83638"

Phrase: ")"

Phrase: ","

Phrase: "and by an appropriation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0680799:appropriation [Governmental or Regulatory Activity]
   770   C1515981:And [Idea or Concept]

Phrase: "from the Commonwealth"

Phrase: "of Pennsylvania."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030853:Pennsylvania [Geographic Area]
Processing 00000000.tx.341: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.342: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.343: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.344: Supported by a fellowship from the Department of Defense (Institutional Breast Cancer Training Program grant DAMD17-00-1-0249).  

Phrase: "Supported by a fellowship"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0015770:Fellowship [Educational Activity]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "from the Department of Defense"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1511775:Department of Defense [Organization]
  1000   C3496101:Department of Defense [Health Care Related Organization]
   827   C1704729:Department [Organization]
   827   C1880266:Defense [Conceptual Entity]

Phrase: "(Institutional Breast Cancer Training"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0040607:Training [Educational Activity]
   812   C0220931:Training [Educational Activity]
   812   C2673163:training [Qualitative Concept]

Phrase: "Program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "grant DAMD17-00-1-0249"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0018173:Grant [Quantitative Concept]
   804   C1548284:Grant [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.345: Present address: Health Technology Assessment Information Service, Plymouth Meeting, PA 19462. 

Phrase: "Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Health Technology Assessment Information Service,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   897   C0018747:Service, Health [Health Care Activity]
   875   C0850397:health information [Health Care Activity]
   853   C0587538:Assessment service [Health Care Related Organization]
   840   C0021425:information service [Occupational Activity]
   840   C2359826:Assessment information [Finding]
   804   C0557854:Service [Occupational Activity]
   804   C1533716:Information [Idea or Concept]
   804   C2825316:Service [Manufactured Object]
   804   C3245478:service [Idea or Concept]
   733 E C3242430:informational [Idea or Concept]

Phrase: "Plymouth Meeting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0556656:Meeting [Health Care Activity]

Phrase: "PA 19462."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]
Processing 00000000.tx.346: Supported by a fellowship from the National Institutes of Health. 

Phrase: "Supported by a fellowship"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0015770:Fellowship [Educational Activity]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "from the National Institutes of Health."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]
Processing 00000000.tx.347: Supported by a fellowship from the Human Frontiers Foundation.  

Phrase: "Supported by a fellowship"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0015770:Fellowship [Educational Activity]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "from the Human Frontiers Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.348: To whom correspondence should be addressed: Dept. of Medical Oncology, Fox Chase Cancer Center, 7701Burholme Ave., Rm. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Medical Oncology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025098:Medical Oncology [Biomedical Occupation or Discipline]
  1000   C1555767:Medical Oncology [Professional or Occupational Group]
   861   C0278627:Oncology [Biomedical Occupation or Discipline]
   789 E C0205478:Oncologic [Biomedical Occupation or Discipline]

Phrase: "Fox Chase Cancer Center,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517306:Fox Chase Cancer Center [Health Care Related Organization]
   861   C1513817:Cancer Center [Health Care Related Organization]
   812   C0205099:Center [Spatial Concept]

Phrase: "7701Burholme Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Rm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2951520:RM [Body Location or Region]
Processing 00000000.tx.349: W322, Philadelphia, PA 19111.Tel.: 

Phrase: "W322,"

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "PA 19111.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.350: 215-728-2205; 

Phrase: "215-728-2205"

Phrase: ";"
Processing 00000000.tx.351: Fax: 215-728-2741; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "215-728-2741"

Phrase: ";"
Processing 00000000.tx.352: E-mail: A_Godwin@fccc.edu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "A_Godwin@fccc.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.353: Published, JBC Papers in Press, July 16,2002,DOI 10.1074/jbc.M201650200 2 Z.-Z. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "July 16,"

Phrase: "2002,"

Phrase: "DOI 10.1074/jbc.M201650200 2 Z.-Z."
Processing 00000000.tx.354: Pan and A.K.Godwin, unpublished data. 

Phrase: "Pan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085999:Pan [Mammal]

Phrase: "and"

Phrase: "A.K.Godwin,"

Phrase: "unpublished data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.355: 3 W. 

Phrase: "3 W."
Processing 00000000.tx.356: Bruening and A.K.Godwin, unpublished data. 

Phrase: "Bruening"

Phrase: "and"

Phrase: "A.K.Godwin,"

Phrase: "unpublished data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.357: 4 A. 

Phrase: "4 A."
Processing 00000000.tx.358: Gupta, A.K.Godwin, L.

Phrase: "Gupta,"

Phrase: "A.K.Godwin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.359: Vanderveer, A.P.Lu, and J.Liu, submitted for publication.  

Phrase: "Vanderveer,"

Phrase: "A.P.Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0024171:LU [Body System]
   827   C0024176:LU [Geographic Area]
   827   C2697939:LU [Quantitative Concept]

Phrase: "and"

Phrase: "J.Liu,"

Phrase: "submitted for publication."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1515023:Submitted [Functional Concept]
   790   C1704324:Publication [Intellectual Product]
Processing 00000000.tx.360: ABBREVIATIONS The abbreviations used are: BCSG1, breast cancer-specific gene 1; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "BCSG1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335851:BCSG1 [Gene or Genome]
  1000   C1709991:BCSG1 [Gene or Genome]

Phrase: "breast cancer-specific gene 1"
Meta Candidates (Total=19; Excluded=5; Pruned=0; Remaining=14)
  1000   C1335851:BREAST CANCER-SPECIFIC GENE 1 [Gene or Genome]
  1000   C1709991:Breast Cancer-Specific Gene 1 [Gene or Genome]
   853   C0029016:cancer gene [Gene or Genome]
   853   C0919437:Cancer Gene [Gene or Genome]
   840   C0006142:Breast Cancer [Neoplastic Process]
   840   C0678222:Breast Cancer [Neoplastic Process]
   804   C0006141:Breast [Body Part, Organ, or Organ Component]
   804   C0006826:Cancer [Neoplastic Process]
   804   C0017337:Gene [Gene or Genome]
   804   C0205369:Specific [Qualitative Concept]
   804   C0998265:Cancer [Eukaryote]
   804   C1268990:Breast [Body Part, Organ, or Organ Component]
   804   C1306459:Cancer [Finding]
   804   C1552740:specific [Intellectual Product]
   790 E C0153661:thoracic cancer [Neoplastic Process]
   748 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   748 E C1521735:Pectoral [Qualitative Concept]
   721 E C0817096:Chest [Body Location or Region]
   721 E C1527391:Chest [Body Location or Region]

Phrase: ";"
Processing 00000000.tx.361: MAPK, mitogen-activated protein kinase; 

Phrase: "MAPK,"

Phrase: "mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.362: ERK, extracellular signal-regulated protein kinase; 

Phrase: "ERK,"

Phrase: "extracellular signal-regulated protein kinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   912   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   912   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.363: JNK, c-JUN N-terminal kinase; 

Phrase: "JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "c-JUN N-terminal kinase"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0248813:c-jun N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0380051:c-JUN N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1367731:JUN N-terminal kinase [Gene or Genome]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1707271:C-Terminal [Amino Acid Sequence]
   840   C0162508:c-Jun [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0205088:Terminal [Temporal Concept]
   804   C1553033:[c] [Quantitative Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.364: MEK, MAPK kinase; 

Phrase: "MEK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752313:mek [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "MAPK kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   958   C0169101:MAPK Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.365: LBs, Lewy bodies; 

Phrase: "LBs,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: ";"
Processing 00000000.tx.366: AD, Alzheimer's disease; 

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.367: pNA, p-nitroaniline; 

Phrase: "pNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600500:PNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "p-nitroaniline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0303838:p-Nitroaniline [Organic Chemical]
   861   C0068820:nitroaniline [Organic Chemical]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.368: PD, Parkinson's disease; 

Phrase: "PD,"

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: ";"
Processing 00000000.tx.369: PKC, protein kinase C; 

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.370: PARP, poly(ADP-ribose) polymerase; 

Phrase: "PARP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1538577:PARP [Gene or Genome]
  1000   C1709384:PARP [Gene or Genome]

Phrase: "poly(ADP-ribose) polymerase"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0032405:Poly ADP Ribose Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           poly ADP polymerase
  1000   C1538577:POLY(ADP-RIBOSE) POLYMERASE [Gene or Genome]
   923   C0032403:Poly ADP Ribose [Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0001461:ADP Ribose [Biologically Active Substance,Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035549:Ribose [Carbohydrate]
   812   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0523452:ADP [Laboratory Procedure]
   812   C0747726:POLY [Conceptual Entity]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.371: CMV, cytomegalovirus; 

Phrase: "CMV,"

Phrase: "cytomegalovirus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010825:Cytomegalovirus [Virus]

Phrase: ";"
Processing 00000000.tx.372: FBS, fetal bovine serum; 

Phrase: "FBS,"

Phrase: "fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.373: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.374: SAPK, stress-activated protein kinase; 

Phrase: "SAPK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0872265:SAPK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150586:SAPK [Molecular Function]
  1000   C1334482:SAPK [Gene or Genome]

Phrase: "stress-activated protein kinase"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0872280:stress activated protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0018850:stress protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0038435:Stress [Finding]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]
   741 E C0231297:Stressful [Functional Concept]

Phrase: ";"
Processing 00000000.tx.375: GST, glutathione S-transferase.  

Phrase: "GST,"

Phrase: "glutathione S-transferase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.376: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.377: Landis, S. 

Phrase: "Landis,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.378: H., Murray, T., Bolden, S., and Wingo, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Murray,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bolden,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Wingo,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.379: A. 

Phrase: "A."
Processing 00000000.tx.380: (1999) CA Cancer J.Clin. 

Phrase: "(1999"

Phrase: ")"

Phrase: "CA Cancer J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0006826:CA - Cancer [Neoplastic Process]

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.381: 49, 8-31[Abstract/Free FullText] 2. 

Phrase: "49,"

Phrase: "8-31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "[Abstract/Free FullText"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.382: Greenlee, R. 

Phrase: "Greenlee,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.383: T., Murray, T., Bolden, S., and Wingo, P. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Murray,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bolden,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Wingo,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.384: A. 

Phrase: "A."
Processing 00000000.tx.385: (2000) CA Cancer J.Clin 50, 7-33[Abstract/Free FullText] 3. 

Phrase: "(2000"

Phrase: ")"

Phrase: "CA Cancer J.Clin 50,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0006826:CA - Cancer [Neoplastic Process]
           Cancer
   804   C0998265:Cancer [Eukaryote]
   804   C1306459:Cancer [Finding]
   804   C1315013:CLIN [Intellectual Product]

Phrase: "7-33"

Phrase: "[Abstract/Free FullText"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.386: Bove, B., Dunbrack, R., and Godwin, A. 

Phrase: "Bove,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Dunbrack,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Godwin,"

Phrase: "A."
Processing 00000000.tx.387: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.388: (2002) in Breast Cancer: Prognosis, Treatment and Prevention (Pasqualini, J., ed) , Marcel Dekker Inc., New York, in press 4. 

Phrase: "(2002"

Phrase: ")"

Phrase: "in Breast Cancer"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0006142:Breast Cancer [Neoplastic Process]
   901   C0678222:Breast Cancer [Neoplastic Process]
   851 E C0153661:thoracic cancer [Neoplastic Process]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]

Phrase: ":"

Phrase: "Prognosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033325:Prognosis [Health Care Activity]

Phrase: "Treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "Prevention"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199176:Prevention [Therapeutic or Preventive Procedure]
  1000   C1706420:PREVENTION [Research Activity]
  1000   C2700409:prevention [Qualitative Concept]

Phrase: "(Pasqualini,"

Phrase: "J.,"

Phrase: "ed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Marcel Dekker Inc.,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "in press 4."
Processing 00000000.tx.389: Bruening, W., Giasson, B. 

Phrase: "Bruening,"

Phrase: "W.,"

Phrase: "Giasson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.390: I., Klein-Szanto, A. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Klein-Szanto,"

Phrase: "A."
Processing 00000000.tx.391: J., Lee, V. 

Phrase: "J.,"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.392: M., Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.393: Q., and Godwin, A. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Godwin,"

Phrase: "A."
Processing 00000000.tx.394: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.395: (2000) Cancer 88, 2154-2163[CrossRef][Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Cancer 88,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "2154-2163"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.396: Ji, H., Liu, Y. 

Phrase: "Ji,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Liu,"

Phrase: "Y."
Processing 00000000.tx.397: E., Jia, T., Wang, M., Liu, J., Xiao, G., Joseph, B. 

Phrase: "E.,"

Phrase: "Jia,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "M."

Phrase: ","

Phrase: "Liu,"

Phrase: "J.,"

Phrase: "Xiao,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Joseph,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.398: K., Rosen, C., and Shi, Y. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Rosen,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Shi,"

Phrase: "Y."
Processing 00000000.tx.399: E. 

Phrase: "E."
Processing 00000000.tx.400: (1997) Cancer Res. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.401: 57, 759-764[Abstract] 6. 

Phrase: "57,"

Phrase: "759-764"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 6."
Processing 00000000.tx.402: Jia, T., Liu, Y. 

Phrase: "Jia,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Liu,"

Phrase: "Y."
Processing 00000000.tx.403: E., Liu, J., and Shi, Y. 

Phrase: "E.,"

Phrase: "Liu,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Shi,"

Phrase: "Y."
Processing 00000000.tx.404: E. 

Phrase: "E."
Processing 00000000.tx.405: (1999) Cancer Res. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.406: 59, 742-747[Abstract/Free FullText] 7. 

Phrase: "59,"

Phrase: "742-747"

Phrase: "[Abstract/Free FullText"

Phrase: "] 7."
Processing 00000000.tx.407: Liu, J., Spence, M. 

Phrase: "Liu,"

Phrase: "J.,"

Phrase: "Spence,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.408: J., Zhang, Y. 

Phrase: "J.,"

Phrase: "Zhang,"

Phrase: "Y."
Processing 00000000.tx.409: L., Jiang, Y., Liu, Y. 

Phrase: "L., Jiang,"

Phrase: "Y.,"

Phrase: "Liu,"

Phrase: "Y."
Processing 00000000.tx.410: E., and Shi, Y. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Shi,"

Phrase: "Y."
Processing 00000000.tx.411: E. 

Phrase: "E."
Processing 00000000.tx.412: (2000) Breast Cancer Res. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Breast Cancer Res."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2347379:RES [Finding]
   734   C0006142:Breast Cancer [Neoplastic Process]
   734   C0678222:Breast Cancer [Neoplastic Process]
Processing 00000000.tx.413: Treat. 

Phrase: "Treat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292734:TREAT [Functional Concept]
  1000   C1522326:Treat [Functional Concept]
Processing 00000000.tx.414: 62, 99-107[CrossRef][Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "62,"

Phrase: "99-107"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.415: Lavedan, C. 

Phrase: "Lavedan,"

Phrase: "C."
Processing 00000000.tx.416: (1998) Genome Res. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Genome Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.417: 8, 871-880[Abstract/Free FullText] 9. 

Phrase: "8,"

Phrase: "871-880"

Phrase: "[Abstract/Free FullText"

Phrase: "] 9."
Processing 00000000.tx.418: Surguchov, A., Surgucheva, I., Solessio, E., and Baehr, W. 

Phrase: "Surguchov,"

Phrase: "A.,"

Phrase: "Surgucheva,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Solessio,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Baehr,"

Phrase: "W."
Processing 00000000.tx.419: (1999) Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.420: Cell Neurosci. 

Phrase: "Cell Neurosci."
Processing 00000000.tx.421: 13, 95-103[CrossRef][Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "13,"

Phrase: "95-103"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.422: Maroteaux, L., Campanelli, J. 

Phrase: "Maroteaux,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Campanelli,"

Phrase: "J."
Processing 00000000.tx.423: T., and Scheller, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Scheller,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.424: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.425: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.426: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.427: 8, 2804-2815[Abstract] 11. 

Phrase: "8,"

Phrase: "2804-2815"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 11."
Processing 00000000.tx.428: Clayton, D. 

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.429: F., and George, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.430: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.431: (1998) Trends Neurosci. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.432: 21, 249-254[CrossRef][Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "21,"

Phrase: "249-254"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.433: Mukaetova-Ladinska, E. 

Phrase: "Mukaetova-Ladinska,"

Phrase: "E."
Processing 00000000.tx.434: B., Hurt, J., Jakes, R., Xuereb, J., Honer, W. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hurt,"

Phrase: "J.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Xuereb,"

Phrase: "J.,"

Phrase: "Honer,"

Phrase: "W."
Processing 00000000.tx.435: G., and Wischik, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Wischik,"

Phrase: "C."
Processing 00000000.tx.436: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.437: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.438: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.439: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.440: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.441: 59, 408-417[Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "59,"

Phrase: "408-417"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.442: Arima, K., Hirai, S., Sunohara, N., Aoto, K., Izumiyama, Y., Ueda, K., Ikeda, K., and Kawai, M. 

Phrase: "Arima,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1563875:Arima [Organic Chemical,Pharmacologic Substance]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hirai,"

Phrase: "S."

Phrase: ","

Phrase: "Sunohara,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Aoto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Izumiyama,"

Phrase: "Y.,"

Phrase: "Ueda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kawai,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.443: (1999) Brain Res. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.444: 843, 53-61[CrossRef][Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "843,"

Phrase: "53-61"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.445: Baba, M., Nakajo, S., Tu, P.H., Tomita, T., Nakaya, K., Lee, V. 

Phrase: "Baba,"

Phrase: "M."

Phrase: ","

Phrase: "Nakajo,"

Phrase: "S."

Phrase: ","

Phrase: "Tu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532464:TU [Quantitative Concept]
  1000   C2700314:TU [Fish]

Phrase: "P.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakaya,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.446: M., Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.447: Q., and Iwatsubo, T. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.448: (1998) Am. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.449: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.450: 152, 879-884[Abstract] 15. 

Phrase: "152,"

Phrase: "879-884"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 15."
Processing 00000000.tx.451: Tu, P. 

Phrase: "Tu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532464:TU [Quantitative Concept]
  1000   C2700314:TU [Fish]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.452: H., Galvin, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Galvin,"

Phrase: "J."
Processing 00000000.tx.453: E., Baba, M., Giasson, B. 

Phrase: "E.,"

Phrase: "Baba,"

Phrase: "M."

Phrase: ","

Phrase: "Giasson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.454: I., Tomita, T., Leight, S., Nakajo, S., Iwatssubo, T., Trojanowski, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Leight,"

Phrase: "S."

Phrase: ","

Phrase: "Nakajo,"

Phrase: "S."

Phrase: ","

Phrase: "Iwatssubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.455: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.456: M.-Y. 

Phrase: "M.-"

Phrase: "Y."
Processing 00000000.tx.457: (1998) Ann. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.458: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.459: 44, 415-422[Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "44,"

Phrase: "415-422"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.460: Arawaka, S., Saito, Y., Murayama, S., and Mori, H. 

Phrase: "Arawaka,"

Phrase: "S."

Phrase: ","

Phrase: "Saito,"

Phrase: "Y.,"

Phrase: "Murayama,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Mori,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.461: (1998) Neurology 51, 887-889[Abstract] 17. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurology 51,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "887-889"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 17."
Processing 00000000.tx.462: Arima, K., Ueda, K., Sunohara, N., Hirai, S., Izumiyama, Y., Tonozuka-Uehara, H., and Kawai, M. 

Phrase: "Arima,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1563875:Arima [Organic Chemical,Pharmacologic Substance]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ueda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sunohara,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hirai,"

Phrase: "S."

Phrase: ","

Phrase: "Izumiyama,"

Phrase: "Y.,"

Phrase: "Tonozuka-Uehara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kawai,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.463: (1998) Brain Res. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.464: 808, 93-100[CrossRef][Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "808,"

Phrase: "93-100"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.465: Irizarry, M. 

Phrase: "Irizarry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.466: C., Growdon, W., Gomez-Isla, T., Newell, K., George, J. 

Phrase: "C., Growdon,"

Phrase: "W.,"

Phrase: "Gomez-Isla,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Newell,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.467: M., Clayton, D. 

Phrase: "M."

Phrase: ","

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.468: F., and Hyman, B. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.469: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.470: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.471: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.472: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.473: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.474: 57, 334-337[Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "57,"

Phrase: "334-337"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.475: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.476: G., Crowther, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.477: A., Jakes, R., Hasegawa, M., and G., M. 

Phrase: "A.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.478: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.479: Natl. 

Phrase: "Natl."
Processing 00000000.tx.480: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.481: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.482: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.483: 95, 6469-6473[Abstract/Free FullText] 20. 

Phrase: "95,"

Phrase: "6469-6473"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.484: Ostrerova, N., Petrucelli, L., Farrer, M., Mehta, N., Choi, P., Hardy, J., and Wolozin, B. 

Phrase: "Ostrerova,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Petrucelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Mehta,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Choi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Wolozin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.485: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.486: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.487: 19, 5782-5791[Abstract/Free FullText] 21. 

Phrase: "19,"

Phrase: "5782-5791"

Phrase: "[Abstract/Free FullText"

Phrase: "] 21."
Processing 00000000.tx.488: Fu, H., Subramanian, R. 

Phrase: "Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Subramanian,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.489: R., and Masters, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.490: C. 

Phrase: "C."
Processing 00000000.tx.491: (2000) Annu. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.492: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.493: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.494: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.495: 40, 617-647[CrossRef][Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "617-647"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.496: Muslin, A. 

Phrase: "Muslin,"

Phrase: "A."
Processing 00000000.tx.497: J., Tanner, J. 

Phrase: "J.,"

Phrase: "Tanner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335730:Tanner [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.498: W., Allen, P. 

Phrase: "W., Allen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.499: M., and Shaw, A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Shaw,"

Phrase: "A."
Processing 00000000.tx.500: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.501: (1996) Cell 84, 889-897[Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cell 84,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "889-897"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.502: Yaffe, M. 

Phrase: "Yaffe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.503: B., and Elia, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Elia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3623712:Elia [Eukaryote]

Phrase: "A."
Processing 00000000.tx.504: E. 

Phrase: "E."
Processing 00000000.tx.505: (2001) Curr. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.506: Opin. 

Phrase: "Opin."
Processing 00000000.tx.507: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.508: 13, 131-138[CrossRef][Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "13,"

Phrase: "131-138"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.509: Yaffe, M. 

Phrase: "Yaffe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.510: B., Rittinger, K., Volinia, S., Caron, P. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Rittinger,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Volinia,"

Phrase: "S."

Phrase: ","

Phrase: "Caron,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.511: R., Aitken, A., Leffers, H., Gamblin, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Aitken,"

Phrase: "A.,"

Phrase: "Leffers,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gamblin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.512: J., Smerdon, S. 

Phrase: "J.,"

Phrase: "Smerdon,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.513: J., and Cantley, L. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Cantley,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.514: C. 

Phrase: "C."
Processing 00000000.tx.515: (1997) Cell 91, 961-971[Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cell 91,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "961-971"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.516: Tzivion, G., Luo, Z., and Avruch, J. 

Phrase: "Tzivion,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "Z.,"

Phrase: "and"

Phrase: "Avruch,"

Phrase: "J."
Processing 00000000.tx.517: (1998) Nature 394, 88-92[CrossRef][Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 394,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "88-92"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.518: Souza, J. 

Phrase: "Souza,"

Phrase: "J."
Processing 00000000.tx.519: M., Giasson, B. 

Phrase: "M."

Phrase: ","

Phrase: "Giasson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.520: I., Lee, V. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.521: M., and Ischiropoulos, H. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ischiropoulos,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.522: (2000) FEBS Lett. 

Phrase: "(2000"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.523: 474, 116-119[CrossRef][Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "474,"

Phrase: "116-119"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.524: Giasson, B. 

Phrase: "Giasson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.525: I., Duda, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Duda,"

Phrase: "J."
Processing 00000000.tx.526: E., Forman, M. 

Phrase: "E.,"

Phrase: "Forman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.527: S., Lee, V. 

Phrase: "S."

Phrase: ","

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.528: M.-Y., and Trojanowski, J. 

Phrase: "M.-"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.529: Q. 

Phrase: "Q."
Processing 00000000.tx.530: (2001) Exp. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.531: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.532: 172, 354-362[CrossRef][Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "172,"

Phrase: "354-362"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.533: Iwata, A., Miura, S., Kanazawa, I., Sawada, M., and Nukina, N. 

Phrase: "Iwata,"

Phrase: "A.,"

Phrase: "Miura,"

Phrase: "S."

Phrase: ","

Phrase: "Kanazawa,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sawada,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Nukina,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.534: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.535: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.536: 77, 239-252[CrossRef][Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "77,"

Phrase: "239-252"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.537: Iwata, A., Maruyama, M., Kanazawa, I., and Nukina, N. 

Phrase: "Iwata,"

Phrase: "A.,"

Phrase: "Maruyama,"

Phrase: "M."

Phrase: ","

Phrase: "Kanazawa,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Nukina,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.538: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.539: Biol. 

Phrase: "Biol."
Processing 00000000.tx.540: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.541: 276, 45320-453229[Abstract/Free FullText] 30. 

Phrase: "276,"

Phrase: "45320-453229"

Phrase: "[Abstract/Free FullText"

Phrase: "] 30."
Processing 00000000.tx.542: Davis, R. 

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.543: J. 

Phrase: "J."
Processing 00000000.tx.544: (2000) Cell 103, 239-252[Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Cell 103,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "239-252"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.545: Rosette, C., and Karin, M. 

Phrase: "Rosette,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035863:Rosette [Finding]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Karin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.546: (1996) Science 274, 1194-1197[Abstract/Free FullText] 32. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Science 274,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1194-1197"

Phrase: "[Abstract/Free FullText"

Phrase: "] 32."
Processing 00000000.tx.547: Krasilnikov, M., Adler, V., Fuchs, S. 

Phrase: "Krasilnikov,"

Phrase: "M."

Phrase: ","

Phrase: "Adler,"

Phrase: "V.,"

Phrase: "Fuchs,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.548: Y., Dong, Z., Haimovitz-Friedman, A., Herlyn, M., and Ronai, Z. 

Phrase: "Y.,"

Phrase: "Dong,"

Phrase: "Z.,"

Phrase: "Haimovitz-Friedman,"

Phrase: "A.,"

Phrase: "Herlyn,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ronai,"

Phrase: "Z."
Processing 00000000.tx.549: (1999) Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.550: Carcinog. 

Phrase: "Carcinog."
Processing 00000000.tx.551: 24, 64-69[CrossRef][Medline] [OrderarticleviaInfotrieve] 33. 

Phrase: "24,"

Phrase: "64-69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450388:69 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 33."
Processing 00000000.tx.552: Nomura, M., Kaji, A., Ma, W.Y., Zhong, S., Liu, G., Bowden, G. 

Phrase: "Nomura,"

Phrase: "M."

Phrase: ","

Phrase: "Kaji,"

Phrase: "A.,"

Phrase: "Ma,"

Phrase: "W.Y.,"

Phrase: "Zhong,"

Phrase: "S."

Phrase: ","

Phrase: "Liu,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bowden,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.553: T., Miyamoto, K. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Miyamoto,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.554: I., and Dong, Z. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Dong,"

Phrase: "Z."
Processing 00000000.tx.555: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.556: Biol. 

Phrase: "Biol."
Processing 00000000.tx.557: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.558: 276, 25558-25567[Abstract/Free FullText] 34. 

Phrase: "276,"

Phrase: "25558-25567"

Phrase: "[Abstract/Free FullText"

Phrase: "] 34."
Processing 00000000.tx.559: Lee, L. 

Phrase: "Lee,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.560: F., Li, G., Templeton, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Templeton,"

Phrase: "D."
Processing 00000000.tx.561: J., and Ting, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Ting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0723760:Ting [Organic Chemical,Pharmacologic Substance]

Phrase: "J."
Processing 00000000.tx.562: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.563: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.564: Biol. 

Phrase: "Biol."
Processing 00000000.tx.565: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.566: 273, 28253-28260[Abstract/Free FullText] 35. 

Phrase: "273,"

Phrase: "28253-28260"

Phrase: "[Abstract/Free FullText"

Phrase: "] 35."
Processing 00000000.tx.567: Mandlekar, S., Yu, R., Tan, T. 

Phrase: "Mandlekar,"

Phrase: "S."

Phrase: ","

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.568: H., and Kong, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kong,"

Phrase: "A."
Processing 00000000.tx.569: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.570: (2000) Cancer Res. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.571: 60, 5995-6000[Abstract/Free FullText] 36. 

Phrase: "60,"

Phrase: "5995-6000"

Phrase: "[Abstract/Free FullText"

Phrase: "] 36."
Processing 00000000.tx.572: Wang, T. 

Phrase: "Wang,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.573: H., Popp, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Popp,"

Phrase: "D."
Processing 00000000.tx.574: M., Wang, H. 

Phrase: "M."

Phrase: ","

Phrase: "Wang,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.575: S., Saitoh, M., Mural, J. 

Phrase: "S."

Phrase: ","

Phrase: "Saitoh,"

Phrase: "M."

Phrase: ","

Phrase: "Mural,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441995:Mural [Spatial Concept]

Phrase: "J."
Processing 00000000.tx.576: G., Henley, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Henley,"

Phrase: "D."
Processing 00000000.tx.577: C., Ichijo, H., and Wimalasena, J. 

Phrase: "C., Ichijo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Wimalasena,"

Phrase: "J."
Processing 00000000.tx.578: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.579: Biol. 

Phrase: "Biol."
Processing 00000000.tx.580: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.581: 274, 8208-8216[Abstract/Free FullText] 37. 

Phrase: "274,"

Phrase: "8208-8216"

Phrase: "[Abstract/Free FullText"

Phrase: "] 37."
Processing 00000000.tx.582: Osborn, M. 

Phrase: "Osborn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.583: T., and Chambers, T. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Chambers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0179874:chambers [Medical Device]
   966 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.584: C. 

Phrase: "C."
Processing 00000000.tx.585: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.586: Biol. 

Phrase: "Biol."
Processing 00000000.tx.587: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.588: 271, 30950-30955[Abstract/Free FullText] 38. 

Phrase: "271,"

Phrase: "30950-30955"

Phrase: "[Abstract/Free FullText"

Phrase: "] 38."
Processing 00000000.tx.589: Stone, A. 

Phrase: "Stone,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006736:Stone [Body Substance]
   928 E C0443312:Stoney [Qualitative Concept]

Phrase: "A."
Processing 00000000.tx.590: A., and Chambers, T. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Chambers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0179874:chambers [Medical Device]
   966 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.591: C. 

Phrase: "C."
Processing 00000000.tx.592: (2000) Exp. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.593: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.594: 254, 110-119[CrossRef][Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "254,"

Phrase: "110-119"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.595: Fan, M., Goodwin, M., Vu, T., Brantley-Finley, C., Gaarde, W. 

Phrase: "Fan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441039:Fan [Manufactured Object]
  1000   C1705854:Fan [Manufactured Object]
  1000   C3540815:FAN [Gene or Genome]

Phrase: "M."

Phrase: ","

Phrase: "Goodwin,"

Phrase: "M."

Phrase: ","

Phrase: "Vu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042321:VU [Geographic Area]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Brantley-Finley,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Gaarde,"

Phrase: "W."
Processing 00000000.tx.596: A., and Chambers, T. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Chambers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0179874:chambers [Medical Device]
   966 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.597: C. 

Phrase: "C."
Processing 00000000.tx.598: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.599: Biol. 

Phrase: "Biol."
Processing 00000000.tx.600: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.601: 275, 29980-29985[Abstract/Free FullText] 40. 

Phrase: "275,"

Phrase: "29980-29985"

Phrase: "[Abstract/Free FullText"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.602: Anderson, S. 

Phrase: "Anderson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.603: M., Reyland, M. 

Phrase: "M."

Phrase: ","

Phrase: "Reyland,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.604: E., Hunter, S., Deisher, L. 

Phrase: "E.,"

Phrase: "Hunter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "S."

Phrase: ","

Phrase: "Deisher,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.605: M., Barzen, K. 

Phrase: "M."

Phrase: ","

Phrase: "Barzen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.606: A., and Quissell, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Quissell,"

Phrase: "D."
Processing 00000000.tx.607: O. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.608: (1999) Cell Death Differ 6, 454-462[CrossRef][Medline] [OrderarticleviaInfotrieve] 41. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Cell Death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "Differ"

Phrase: "6,"

Phrase: "454-462"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 41."
Processing 00000000.tx.609: Gibson, S., Widmann, C., and Johnson, G. 

Phrase: "Gibson,"

Phrase: "S."

Phrase: ","

Phrase: "Widmann,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Johnson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.610: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.611: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.612: Biol. 

Phrase: "Biol."
Processing 00000000.tx.613: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.614: 274, 10916-10922[Abstract/Free FullText] 42. 

Phrase: "274,"

Phrase: "10916-10922"

Phrase: "[Abstract/Free FullText"

Phrase: "] 42."
Processing 00000000.tx.615: Jarvis, W. 

Phrase: "Jarvis,"

Phrase: "W."
Processing 00000000.tx.616: D., Johnson, C. 

Phrase: "D."

Phrase: ","

Phrase: "Johnson,"

Phrase: "C."
Processing 00000000.tx.617: R., Fornari, F. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fornari,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.618: A., Park, J. 

Phrase: "A.,"

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "J."
Processing 00000000.tx.619: S., Dent, P., and Grant, S. 

Phrase: "S."

Phrase: ","

Phrase: "Dent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880278:DENT [Event]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Grant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.620: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.621: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.622: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.623: Ther. 

Phrase: "Ther."
Processing 00000000.tx.624: 290, 1384-1392[Abstract/Free FullText] 43. 

Phrase: "290,"

Phrase: "1384-1392"

Phrase: "[Abstract/Free FullText"

Phrase: "] 43."
Processing 00000000.tx.625: Galvin, J. 

Phrase: "Galvin,"

Phrase: "J."
Processing 00000000.tx.626: E., Lee, V. 

Phrase: "E.,"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.627: M., and Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.628: Q. 

Phrase: "Q."
Processing 00000000.tx.629: (2001) Arch. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.630: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.631: 58, 186-190[Abstract/Free FullText] 44. 

Phrase: "58,"

Phrase: "186-190"

Phrase: "[Abstract/Free FullText"

Phrase: "] 44."
Processing 00000000.tx.632: Biere, A. 

Phrase: "Biere,"

Phrase: "A."
Processing 00000000.tx.633: L., Wood, S. 

Phrase: "L., Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.634: J., Wypych, J., Steavenson, S., Jiang, Y., Anafi, D., Jacobsen, F. 

Phrase: "J.,"

Phrase: "Wypych,"

Phrase: "J.,"

Phrase: "Steavenson,"

Phrase: "S."

Phrase: ","

Phrase: "Jiang,"

Phrase: "Y.,"

Phrase: "Anafi,"

Phrase: "D."

Phrase: ","

Phrase: "Jacobsen,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.635: W., Jarosinski, M. 

Phrase: "W., Jarosinski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.636: A., Wu, G.M., Louis, J. 

Phrase: "A.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Louis,"

Phrase: "J."
Processing 00000000.tx.637: C., Martin, F., Narhi, L. 

Phrase: "C., Martin,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Narhi,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.638: O., and Citron, M. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.639: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.640: Biol. 

Phrase: "Biol."
Processing 00000000.tx.641: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.642: 275, 34574-34579[Abstract/Free FullText] 45. 

Phrase: "275,"

Phrase: "34574-34579"

Phrase: "[Abstract/Free FullText"

Phrase: "] 45."
Processing 00000000.tx.643: Lu, A., Gupta, A., Li, C., Ahlborn, T. 

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "A.,"

Phrase: "Gupta,"

Phrase: "A.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ahlborn,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.644: E., Ma, Y., Shi, E. 

Phrase: "E.,"

Phrase: "Ma,"

Phrase: "Y.,"

Phrase: "Shi,"

Phrase: "E."
Processing 00000000.tx.645: Y., and Liu, J. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Liu,"

Phrase: "J."
Processing 00000000.tx.646: (2001) Oncogene 20, 5173-5185[CrossRef][Medline] [OrderarticleviaInfotrieve] 46. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Oncogene 20,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "5173-5185"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 46."
Processing 00000000.tx.647: Buchman, V. 

Phrase: "Buchman,"

Phrase: "V."
Processing 00000000.tx.648: L., Hunter, H. 

Phrase: "L., Hunter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.649: J., Pinon, L. 

Phrase: "J.,"

Phrase: "Pinon,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.650: G., Thompson, J., Privalova, E. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Thompson,"

Phrase: "J.,"

Phrase: "Privalova,"

Phrase: "E."
Processing 00000000.tx.651: M., Ninkina, N. 

Phrase: "M."

Phrase: ","

Phrase: "Ninkina,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.652: N., and Davies, A. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Davies,"

Phrase: "A."
Processing 00000000.tx.653: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.654: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.655: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.656: 18, 9335-9341[Abstract/Free FullText] 47. 

Phrase: "18,"

Phrase: "9335-9341"

Phrase: "[Abstract/Free FullText"

Phrase: "] 47."
Processing 00000000.tx.657: Goedert, M., Jakes, R., Crowther, R. 

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.658: A., Hasegawa, M., Smith, M. 

Phrase: "A.,"

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.659: J., and Spillantini, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.660: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.661: (1998) Biochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.662: Soc. 

Phrase: "Soc."
Processing 00000000.tx.663: Trans. 

Phrase: "Trans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2826298:TRANS [Idea or Concept]
Processing 00000000.tx.664: 26, 463-471[Medline] [OrderarticleviaInfotrieve] 48. 

Phrase: "26,"

Phrase: "463-471"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 48."
Processing 00000000.tx.665: Trojanowski, J. 

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.666: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.667: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.668: (1998) Arch. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.669: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.670: 55, 151-152[Free FullText] 49. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "151-152"

Phrase: "[Free FullText"

Phrase: "] 49."
Processing 00000000.tx.671: Polymeropoulos, M. 

Phrase: "Polymeropoulos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.672: H., Lavedan, C., Leroy, E., Ide, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.673: E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. 

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stenroos,"

Phrase: "E."
Processing 00000000.tx.674: S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. 

Phrase: "S."

Phrase: ","

Phrase: "Chandrasekharappa,"

Phrase: "S."

Phrase: ","

Phrase: "Athanassiadou,"

Phrase: "A.,"

Phrase: "Papapetropoulos,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Johnson,"

Phrase: "W."
Processing 00000000.tx.675: G., Lazzarini, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lazzarini,"

Phrase: "A."
Processing 00000000.tx.676: M., Duvoisin, R. 

Phrase: "M."

Phrase: ","

Phrase: "Duvoisin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.677: C., Di, Iorio, G., Golbe, L. 

Phrase: "C., Di,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3538902:DI [Gene or Genome]
   861   C3541881:DI [Idea or Concept]

Phrase: "Iorio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Golbe,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.678: I., and Nussbaum, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.679: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.680: (1997) Science 276, 2045-2047[Abstract/Free FullText] 50. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 276,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "2045-2047"

Phrase: "[Abstract/Free FullText"

Phrase: "] 50."
Processing 00000000.tx.681: Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J. 

Phrase: "Kruger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Graeber,"

Phrase: "M."

Phrase: ","

Phrase: "Kosel,"

Phrase: "S."

Phrase: ","

Phrase: "Przuntek,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Epplen,"

Phrase: "J."
Processing 00000000.tx.682: T., Schols, L., and Riess, O. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schols,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riess,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.683: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.684: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.685: 18, 106-108[Medline] [OrderarticleviaInfotrieve] 51. 

Phrase: "18,"

Phrase: "106-108"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 51."
Processing 00000000.tx.686: Papadimitriou, A., Veletza, V., Hadjigeorgiou, G. 

Phrase: "Papadimitriou,"

Phrase: "A.,"

Phrase: "Veletza,"

Phrase: "V.,"

Phrase: "Hadjigeorgiou,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.687: M., Patrikiou, A., Hirano, M., and Anastasopoulos, I. 

Phrase: "M."

Phrase: ","

Phrase: "Patrikiou,"

Phrase: "A.,"

Phrase: "Hirano,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Anastasopoulos,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.688: (1999) Neurology 52, 651-654[Abstract/Free FullText] 52. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neurology 52,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "651-654"

Phrase: "[Abstract/Free FullText"

Phrase: "] 52."
Processing 00000000.tx.689: Tournier, C., Hess, P., Yang, D. 

Phrase: "Tournier,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hess,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "D."
Processing 00000000.tx.690: D., Xu, J., Turner, T. 

Phrase: "D."

Phrase: ","

Phrase: "Xu,"

Phrase: "J.,"

Phrase: "Turner,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.691: K., Nimnual, A., Bar-Sagi, D., Jones, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nimnual,"

Phrase: "A.,"

Phrase: "Bar-Sagi,"

Phrase: "D."

Phrase: ","

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.692: N., Flavell, R. 

Phrase: "N., Flavell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.693: A., and Davis, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.694: J. 

Phrase: "J."
Processing 00000000.tx.695: (2000) Science 288, 870-874[Abstract/Free FullText] 53. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Science 288,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "870-874"

Phrase: "[Abstract/Free FullText"

Phrase: "] 53."
Processing 00000000.tx.696: Shahin, M. 

Phrase: "Shahin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.697: S., Hughes, J. 

Phrase: "S."

Phrase: ","

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "J."
Processing 00000000.tx.698: H., Sood, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sood,"

Phrase: "A."
Processing 00000000.tx.699: K., and Buller, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Buller,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.700: E. 

Phrase: "E."
Processing 00000000.tx.701: (2000) Cancer 89, 2006-2017[CrossRef][Medline] [OrderarticleviaInfotrieve] 54. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Cancer 89,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "2006-2017"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 54."
Processing 00000000.tx.702: Thorlacius, S., Thorgilsson, B., Bjornsson, J., Tryggvadottir, L., Borresen, A. 

Phrase: "Thorlacius,"

Phrase: "S."

Phrase: ","

Phrase: "Thorgilsson,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bjornsson,"

Phrase: "J.,"

Phrase: "Tryggvadottir,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Borresen,"

Phrase: "A."
Processing 00000000.tx.703: L., Ogmundsdottir, H. 

Phrase: "L., Ogmundsdottir,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.704: M., and Eyfjord, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Eyfjord,"

Phrase: "J."
Processing 00000000.tx.705: E. 

Phrase: "E."
Processing 00000000.tx.706: (1995) Eur. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.707: J.

Phrase: "J."
Processing 00000000.tx.708: Cancer 31A, 1856-1861[CrossRef] 55. 

Phrase: "Cancer 31A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553671:31a [Medical Device]

Phrase: "1856-1861"

Phrase: "[CrossRef"

Phrase: "] 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.709: Devary, Y., Rosette, C., DiDonato, J. 

Phrase: "Devary,"

Phrase: "Y.,"

Phrase: "Rosette,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035863:Rosette [Finding]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "DiDonato,"

Phrase: "J."
Processing 00000000.tx.710: A., and Karin, M. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Karin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.711: (1993) Science 261, 1442-1445[Medline] [OrderarticleviaInfotrieve] 56. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Science 261,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1442-1445"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 56."
Processing 00000000.tx.712: Devary, Y., Gottlieb, R. 

Phrase: "Devary,"

Phrase: "Y.,"

Phrase: "Gottlieb,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.713: A., Smeal, T., and Karin, M. 

Phrase: "A.,"

Phrase: "Smeal,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Karin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.714: (1992) Cell 71, 1081-1091[Medline] [OrderarticleviaInfotrieve] 57. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Cell 71,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007634:Cell [Cell]
   861   C0450389:71 [Intellectual Product]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1081-1091"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 57."
Processing 00000000.tx.715: Wang, T. 

Phrase: "Wang,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.716: H., Wang, H. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.717: S., and Soong, Y. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Soong,"

Phrase: "Y."
Processing 00000000.tx.718: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.719: (2000) Cancer 88, 2619-2628[CrossRef][Medline] [OrderarticleviaInfotrieve] 58. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Cancer 88,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "2619-2628"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 58."
Processing 00000000.tx.720: Lee, M., Hyun, D., Halliwell, B., and Jenner, P. 

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Hyun,"

Phrase: "D."

Phrase: ","

Phrase: "Halliwell,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Jenner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.721: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.722: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.723: 76, 998-1009[CrossRef][Medline] [OrderarticleviaInfotrieve] 59. 

Phrase: "76,"

Phrase: "998-1009"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 59."
Processing 00000000.tx.724: Tanaka, Y., Engelender, S., Igarashi, S., Rao, R. 

Phrase: "Tanaka,"

Phrase: "Y.,"

Phrase: "Engelender,"

Phrase: "S."

Phrase: ","

Phrase: "Igarashi,"

Phrase: "S."

Phrase: ","

Phrase: "Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.725: K., Wanner, T., Tanzi, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wanner,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.726: E., Sawa, A. 

Phrase: "E.,"

Phrase: "Sawa,"

Phrase: "A."
Processing 00000000.tx.727: L., Dawson, V., Dawson, T. 

Phrase: "L., Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1551910:Dawson [Language]

Phrase: "V.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.728: M., and Ross, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."
Processing 00000000.tx.729: A. 

Phrase: "A."
Processing 00000000.tx.730: (2001) Hum. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.731: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.732: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.733: 10, 919-926[Abstract/Free FullText] 60. 

Phrase: "10,"

Phrase: "919-926"

Phrase: "[Abstract/Free FullText"

Phrase: "] 60."
Processing 00000000.tx.734: Zhou, W., Hurlbert, M. 

Phrase: "Zhou,"

Phrase: "W.,"

Phrase: "Hurlbert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.735: S., Schaack, J., Prasad, K. 

Phrase: "S."

Phrase: ","

Phrase: "Schaack,"

Phrase: "J.,"

Phrase: "Prasad,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.736: N., and Freed, C. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Freed,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0332296:free [Functional Concept]
   966   C1880497:Free [Qualitative Concept]
   966   C1996904:Free [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.737: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.738: (2000) Brain Res. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.739: 866, 33-43[CrossRef][Medline] [OrderarticleviaInfotrieve] 61. 

Phrase: "866,"

Phrase: "33-43"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 61."
Processing 00000000.tx.740: Tabrizi, S. 

Phrase: "Tabrizi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.741: J., Orth, M., Wilkinson, J. 

Phrase: "J.,"

Phrase: "Orth,"

Phrase: "M."

Phrase: ","

Phrase: "Wilkinson,"

Phrase: "J."
Processing 00000000.tx.742: M., Taanman, J. 

Phrase: "M."

Phrase: ","

Phrase: "Taanman,"

Phrase: "J."
Processing 00000000.tx.743: W., Warner, T. 

Phrase: "W., Warner,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.744: T., Cooper, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.745: M., and Schapira, A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Schapira,"

Phrase: "A."
Processing 00000000.tx.746: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.747: (2000) Hum. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.748: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.749: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.750: 9, 2683-2689[Abstract/Free FullText] 62. 

Phrase: "9,"

Phrase: "2683-2689"

Phrase: "[Abstract/Free FullText"

Phrase: "] 62."
Processing 00000000.tx.751: da Costa, C. 

Phrase: "da Costa,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035561:Costa [Body Part, Organ, or Organ Component]
   768 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "C."
Processing 00000000.tx.752: A., Ancolio, K., and Checler, F. 

Phrase: "A.,"

Phrase: "Ancolio,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.753: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.754: Biol. 

Phrase: "Biol."
Processing 00000000.tx.755: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.756: 275, 24065-24069[Abstract/Free FullText] 63. 

Phrase: "275,"

Phrase: "24065-24069"

Phrase: "[Abstract/Free FullText"

Phrase: "] 63."
Processing 00000000.tx.757: Mizuno, Y., Yoshino, H., Ikebe, S., Hattori, N., Kobayashi, T., Shimoda- Matsubayashi, S., Matsumine, H., and Kondo, T. 

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Yoshino,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ikebe,"

Phrase: "S."

Phrase: ","

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kobayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shimoda- Matsubayashi,"

Phrase: "S."

Phrase: ","

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kondo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.758: (1998) Ann. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.759: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.760: 44, S99-S109[Medline] [OrderarticleviaInfotrieve] 64. 

Phrase: "44,"

Phrase: "S99-S109"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 64."
Processing 00000000.tx.761: Hsu, L. 

Phrase: "Hsu,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.762: J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M., and Masliah, E. 

Phrase: "J.,"

Phrase: "Sagara,"

Phrase: "Y.,"

Phrase: "Arroyo,"

Phrase: "A.,"

Phrase: "Rockenstein,"

Phrase: "E.,"

Phrase: "Sisk,"

Phrase: "A.,"

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Wong,"

Phrase: "J.,"

Phrase: "Takenouchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hashimoto,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Masliah,"

Phrase: "E."
Processing 00000000.tx.763: (2000) Am. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.764: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.765: 157, 401-410[Abstract/Free FullText] 65. 

Phrase: "157,"

Phrase: "401-410"

Phrase: "[Abstract/Free FullText"

Phrase: "] 65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]
Processing 00000000.tx.766: Saha, A. 

Phrase: "Saha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0672708:SAHA [Organic Chemical,Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.767: R., Ninkina, N. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ninkina,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.768: N., Hanger, D. 

Phrase: "N., Hanger,"

Phrase: "D."
Processing 00000000.tx.769: P., Anderton, B. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.770: H., Davies, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Davies,"

Phrase: "A."
Processing 00000000.tx.771: M., and Buchman, V. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Buchman,"

Phrase: "V."
Processing 00000000.tx.772: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.773: (2000) Eur. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.774: J.

Phrase: "J."
Processing 00000000.tx.775: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.776: 12, 3073-3077[CrossRef][Medline] [OrderarticleviaInfotrieve] Copyright  2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "12,"

Phrase: "3073-3077"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2002 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

